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2. Summary 
The genes that control mouse embryonic development are tightly regulated spatially 
and temporally by the integration of various signaling pathways. The interaction of 
downstream transcription factors with cis-regulatory modules located in the genomic 
landscapes of their target genes is crucial to control gene expression and enable the 
growth and patterning of embryonic tissues. However, in most of the cases, the 
genome wide range of target regions bound by a given trans-acting factor in a tissue-
specific manner is not known. In this thesis, I have taken advantage of epitope-
tagging essential transcriptional regulators such as SMAD4 and HAND2 to gain 
mechanistic insight into their functions during limb and heart development. 
 
In particular, the morphogenesis of the limb bud depends on a self-regulatory system 
of signaling feedback loops in the core of which the BMP antagonist GREMLIN1 
plays a critical role. We analyzed the cis-regulatory landscape of Gremlin1 and 
identified a conserved region that recapitulates several aspects of the dynamic 
expression of Gremlin1 during limb bud development and requires the BMP signal 
transducer SMAD4 to be expanded in the distal anterior part of the limb bud. To 
investigate the Gremlin1 cis-regulatory modules that directly interact with SMAD4-
containing chromatin complexes, I have generated a new mouse line that expresses 
a 3xFLAG epitope-tagged version of SMAD4 from its endogenous locus, with which 
we will perform ChIP-Seq analysis from developing embryonic tissues, including limb 
buds. 
 
Following a similar rationale, I have used ChIP-Seq data from a mouse line 
expressing a Hand23xFLAG allele to provide the first identification of the HAND2 target 
gene networks that function during cardiogenesis, which is severely impaired in the 
absence of HAND2. This analysis indicates that HAND2 directly controls the 
expression of the paralogous genes Tbx2 and Tbx3 in the progenitors of the second 
heart field that give rise to the outflow tract and right ventricle. This regulation is 
mediated by the interaction of HAND2 with tissue-specific cis-regulatory modules 
located in Tbx2 and Tbx3 genomic landscapes. Furthermore, we observed in Hand2-
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deficient embryos that the cells of the atrioventricular canal do not undergo the 
endothelial-mesenchymal transition that normally initiates the formation of the cardiac 
cushions, which are the precursors of the cardiac valves. We established that the 
expression of Snai1, Twist1 and Has2, which are key genes in this process, are 
directly controlled by HAND2-containing chromatin complexes. Epitope-tagging of 
transcription factors is thus a powerful tool to identify the range of cis-regulatory 
modules they bind to, which allows to uncover the transcriptional networks they 
control during embryonic development. 
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4. Introduction 
4.1. Cis-regulatory modules and transcriptional control of 
embryonic development 
The question of how complex, multicellular-types tissues and organs arise from 
undifferentiated progenitor cells during embryonic development is fascinating. Cell 
fates are controlled by robust spatio-temporal and tissue-specific gene expressions, 
which progressively shape the body plan of the developing embryo. Growth and 
patterning are regulated by combinatorial interactions between transcription factors 
and multiple genetic cis-regulatory modules, whose integrated action determines the 
quantitative transcriptional output of a given protein-coding gene.   
 
Cis-regulatory modules (CRMs) are composed of clusters of binding sites for multiple 
transcription factors (TFs) and can act as enhancers, silencers or insulators (Fig.1A). 
An enhancer is able to activate transcription independently of its location or 
orientation relative to a promoter, often in a tissue-specific manner (Bulger and 
Groudine, 2011; Ong and Corces, 2011; Levine, 2010) while a silencer will have the 
opposite effect and repress the expression of a target gene (Petrykowska et al., 
2008). Insulators are CRMs that can either block the action of others CRMs on a 
promoter when located between them, or create barriers to prevent the spreading of 
heterochromatin compaction (Gaszner and Felsenfeld, 2006). Insulators are typically 
interacting with the ubiquitously expressed CTCF zinc-finger protein (Bell et al., 1999; 
Ong and Corces, 2014). Functional redundancy between CRMs acting on the same 
gene can occur, which confers phenotypic robustness (“shadow enhancers”, (Barolo, 
2012; Frankel et al., 2010). CRMs can be intergenic, embedded in introns of 
unrelated neighboring genes, or located in gene deserts (Zeller and Zuniga, 2007; 
Nobrega et al., 2003). In addition to CRMs proximal to the promoter of their target 
gene, CRMs usually operate over distances shorter than 50kb but can occasionally 
act over considerably longer distances (up to 2-3Mb, (Krivega and Dean, 2012)). 
They are often scattered in large genomic landscapes, or archipelagos, and 
cooperate to synergistically act on their target genes (Montavon et al., 2011; Marinic 
et al., 2013).  
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The physical contact between distant-acting CRMs and the basal transcriptional 
machinery at the promoter depends on the three-dimensional architecture of the 
genome and higher-order chromatin interactions, with regions of open euchromatin 
forming loops that bring together multiple genomic elements (Fig.1B). The formation 
of these loops can be initiated de novo following an instructive process or be 
preformed in a ground state, and depends on CRMs-TFs interactions (de Laat and 
Duboule, 2013). 
 
Figure 1. Cis-regulatory modules 
and genomic architecture  
(A) Categories of cis-regulatory 
modules. From top to bottom: basal 
transcriptional machinery (RNA 
polymerase II and general 
transcription factors) bound to the 
promoter of a gene. Enhancer and 
silencer sequences mediate positive 
and negative effects on the 
transcription of a target gene. 
Insulator blocks the activity of an 
enhancer of gene A on gene B. 
Barrier insulator prevents the spread 
of chromatin condensation. Adapted 
from (Noonan and McCallion, 2010). 
(B) Schematic representation of the 
cis-regulatory landscape of a gene. 
The chromatin is composed of DNA 
wrapped around histones to form 
nucleosomes and can be in different 
compaction states. Open chromatin 
loops to bring CRMs in physical 
contact with the promoter and basal 
transcriptional machinery. Adapted 
from (Lenhard et al., 2012). 
 
 
The accessibility of CRMs to TFs during developmental progression depends on the 
state of chromatin compaction. Active CRMs are located in regions of open chromatin 
and are therefore sensitive to digestion by DNA nucleases (Crawford et al., 2006).  
They are also bound by the ubiquitously expressed p300 histone acetyltransferase 
(Visel et al., 2009a). Indeed, the chromatin signature of active CRMs can also be 
determined by the presence of specific post-translational modifications on the 
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histones tails in the nucleosomes flanking these CRMs (Calo and Wysocka, 2013; 
Spitz and Furlong, 2012). The acetylation of the lysine 27 of Histone 3 (H3K27ac), a 
high H3K4me1/H3K4me3 ratio and the absence of the repressive H3K27me3 are all 
typically associated with active CRMs, high levels of H3K4me3 being observed at 
actively transcribed promoters (Fig.2A) (Heintzman et al., 2007; Bonn et al., 2012; 
Creyghton et al., 2010; Rada-Iglesias et al., 2011; Djebali et al., 2012).  
 
The best technique to assess the interactions between a TF of interest and its target 
CRMs is chromatin immunoprecipitation (ChIP, Fig.2B). ChIP relies on the chemical 
crosslinking of proteins and DNA interactions within a tissue or a living cell population 
(typically ~107 cells), followed by shearing the chromatin into small fragments (200-
300bp) by sonication. An antibody recognizing the TF of interest is then used to 
selectively immunoprecipitate the chromatin complexes in which this TF is contained. 
The associated DNA fragments are finally purified and can be used for deep 
sequencing to identify genome-wide target CRMs (ChIP-Seq, (Park, 2009), or for 
qPCR to confirm a specific TF-CRM interaction (ChIP-qPCR).  
Based on these observations, several methods exist to identify CRMs within the 
genome that can be applied to specific tissues or developmental stages (Hardison 
and Taylor, 2012). DNase hypersensitivity profiling and ChIP-Seq using an antibody 
recognizing p300, H3K27ac or H3K4me1 can all identify candidate CRMs genome-
wide (Cotney et al., 2012; May et al., 2012; Blow et al., 2010; Visel et al., 2009a; Shu 
et al., 2011). Chromosome conformation capture (3C) and derivatives (4C, Hi-C…) 
can identify all potential chromatin-chromatin interactions and thus all the CRMs that 
contact a specific promoter (Dekker et al., 2013). In addition to these experimental 
approaches, in silico comparative genomics can identify conserved non-coding 
elements between different species, even if sequence conservation does not always 
implies that the CRM function is conserved (Nelson and Wardle, 2013). Finally, 
computational approaches to identify the occurrence of TF binding motifs can also 
identify candidate CRMs (Narlikar et al., 2010). 
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Figure 2. Chromatin marks and ChIP-Seq procedure 
(A) Representation of genome-wide chromatin signatures for a hypothetical cis-regulatory genomic 
landscape. From top to bottom: transcriptional start sites and exons of active genes (grey arrows and 
boxes) and associated CRMs (blue ovals). Blue: active CRMs are hypersensitive to DNase and are 
marked by p300 binding, H3K4me1 and H3K27ac. Orange: repressive H3K27me3 mark. Green: 
promoter-enriched H3K4me3 mark. Adapted from (Phillips-Cremins and Corces, 2013). (B) Main steps 
of ChIP-Seq procedure. DNA and interacting proteins from cultured cells or embryonic tissues are 
crosslinked and sheared in small chromatin fragments. Immunoprecipitation of the protein of interest 
(red) is achieved using either an antibody recognizing it directly (right) or recognizing an epitope tag 
(left, yellow circle). Following reverse crosslinking, the purified DNA fragments are sequenced and 
mapped to a reference genome. Adapted from (Visel et al., 2009b). 
 
Transcription factors usually recognize small degenerate sequence-specific binding 
motifs of 6-12bp (Loots and Ovcharenko, 2004). The binding motifs of several 
different TFs can be observed within a CRM, leading to possible combinatorial 
binding of various TFs at different developmental time points and in different tissues 
at the same CRM. Furthermore, the binding of a specific TF can be a prerequisite for 
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the recruitment of additional TFs, cofactors and/or chromatin remodeling complexes 
that will modulate their function. Together, the cooperative and/or additive 
interactions between these TFs, or between TFs interacting with different CRMs, will 
determine the transcriptional output of their target genes (Wilczynski and Furlong, 
2010; Yanez-Cuna et al., 2012; Spitz and Furlong, 2012; Farnham, 2009; 
MacQuarrie et al., 2011). Electrophoretic Mobility Shift Assay (EMSA) is traditionally 
used to assess the interaction between a TF and a CRM, but ChIP-qPCR is 
becoming more frequently used. To study the function and spatiotemporal expression 
pattern driven by a candidate CRM, the standard method is a reporter assays in 
which the candidate CRM is used to drive the expression of a reporter gene (LacZ, 
GFP, Luciferase…) in transgenic embryos or transfected cells. Finally, combining 
reporter assays with the mutation of TFs binding sites within a given CRM allows 
analyzing the requirement of specific TFs regarding the functionality and enhancing 
capacity of the considered CRM. 
 
Genome-wide identification of CRMs interacting with a specific TF using ChIP-Seq 
analysis requires high quality antibodies. Tagging TFs with established epitope-tags 
represents an alternative to commercial antibodies that often lack specificity for their 
target protein (Fig.2B). For this, conventional genome editing techniques by 
homologous recombination or cassette exchange in mouse ES cells allow the 
introduction of an epitope tag in the endogenous locus coding for a specific TF. 
Targeting the endogenous locus maintains its transcriptional regulation by native 
promoter and CRMs. It allows studying the spatio-temporal distribution of the TF and 
the identification of its target genes in a physiological context, without off-target 
effects coming from overexpression (Zhang et al., 2008a; Conway et al., 2010).  
While most of the identified mutations associated with congenital developmental 
malformations are mapped to coding sequences, only a few have been located in 
CRMs (Gordon and Lyonnet, 2014; Smemo et al., 2012; Uslu et al., 2014; Lettice et 
al., 2003). The identification and mapping of CRMs is thus crucial for potential 
diagnosis of congenital malformations, and to understand how complex gene 
patterns are regulated during embryonic development. 
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4.2. Morphogenesis of the Heart  
4.2.1. Composition and function of the adult mammalian heart 
The heart is the first organ to form during embryonic development. Unlike other 
embryonic structures and organs, the heart and associated structures of the 
cardiovascular system are essential for the survival of the embryo. Perturbations in 
the complex gene regulatory networks controlling the formation of the cardiac 
structures can lead to various types of congenital heart diseases (CHD), which can 
be observed in 6 to 75 per 1000 live births and are one of the major cause of 
mortality in infants and adults (Bruneau, 2008; Khoshnood et al., 2012; Ishikawa et 
al., 2011; Wren et al., 2012; Brickner et al., 2000). The adult mammalian heart is a 
muscular organ composed of four distinct chambers, two atria and two ventricles, 
separated by cardiac valves. Its rhythmic and coordinated contractions driven by the 
conduction system pump blood to the organs of the body via the blood vessels, a 
function crucial to maintain the homeostasis of the organism (Fig.3A). The anatomy 
of the heart has significantly changed over the course of evolution. From a simple 
linear tube subjected to peristaltic contractions in primitive chordates, through a 
single atrium and single ventricle in fishes, the vertebrate heart evolved to a more 
powerful and complex pump by successive additions of new cardiac structures that 
likely occurred through the acquisition of new regulatory inputs and by gene 
duplications (Olson, 2006; Jensen et al., 2013). The cardiac chambers are mainly 
composed of three concentric tissue layers with different developmental origins: the 
endocardium is the endothelial lining of the heart and is in contact with the blood. The 
myocardium consists mainly of a muscular layer of contractile cardiomyocytes and 
conductive cells. Finally, the epicardium is a specialized epithelium mostly composed 
of connective tissues that envelop and protect the heart (Fig.3A). During 
embryogenesis, the endocardium is separated from the myocardium by a layer of 
extracellular matrix, the cardiac jelly. The cells of the myocardium are derived from 
two different lineages: the primary heart field and the second heart field (Buckingham 
et al., 2005).  
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Figure 3. Anatomy of the adult mammalian heart  
(A) Blood circulation inside the heart (direction indicated by arrows). Deoxygenated blood (blue) 
returning from the body through the superior and inferior vena cava enters the right atrium, where 
cardiac contractions pumps it out through the tricuspid valve into the right ventricle. Delayed 
contractions pumps the blood into the pulmonary arteries through the pulmonary valve. Left and right 
pulmonary arteries are connected to the lungs, where the blood gets oxygenated (red) before returning 
to the heart via the pulmonary veins. The blood enters the left atrium, is pumped through the mitral 
valve into the left ventricle, and pumped out in the aorta through the aortic valve to be distributed to 
the remainder of the organism. Image modified from the Texas Heart Institute website. (B) Cardiac 
conduction system. The electrical impulse is generated in the sinoatrial node and contracts the atria. It 
is transmitted to the atrioventricular node, which propagates it with a delay to the bundle of His (right 
and left branches) along the interventricular septum. From the heart apex, the impulse is transmitted to 
the fast conducting Purkinje fibers, which contracts the ventricles. From Main Line Health website 
(http://www.mainlinehealth.org/oth/Page.asp?pageID= OTH005458). (C) Above view of a transverse 
heart section showing the opening and closure of the cardiac valves following cardiac contractions. 
The mitral (bicuspid) and tricuspid valves are composed of two and three leaflets, respectively. The 
pulmonary and aortic (semilunar) valves are composed of three leaflets called cusps. Adapted from 
(http://www.tokresource.org/tok_ classes/biobiobio/biomenu/transport_system/index.htm). 
 
The cardiac contractions depend on an electrical impulse generated in the 
pacemaker cells of the sinoatrial node. This impulse is transmitted through the 
myocardium of the atria, leading to their simultaneous contraction, to the 
atrioventricular node and further to the ventricles to contract them (Fig.3B). A delay in 
the propagation of the impulse from the atrioventricular node allows non-
simultaneous contractions between the two atria and the two ventricles, necessary 
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for unidirectional blood flow. The heart functions therefore as two serially working 
atrial and ventricular pumps (Christoffels and Moorman, 2009). In the mouse, this 
whole cardiac cycle takes less than 200ms for an average of 500 beats per minute 
(bpm) (Berul et al., 1996; Ho et al., 2011), which is much faster than the average 
human cardiac rhythm of 70bpm and reflects the effects of the size of a organism on 
the speed of its metabolism (Kleiber, 1947). Congenital malformations and aging can 
cause dysfunctions of the pacemaker tissues, resulting in arrhythmias. If the primary 
pacemaker in the sinoatrial node is impaired or if the electrical impulse is not 
propagated, the atrioventricular node can act as an accessory pacemaker and initiate 
an electrical impulse (Christoffels et al., 2010).  
The cardiac valves are essential to avoid blood regurgitation between the chambers, 
and open and close over 700’000 times per day in the mouse. The adult heart 
contains two atrioventricular valves separating atria and ventricles (tricuspid and 
mitral (or bicuspid) valves), and two semilunar valves located between the ventricles 
and the great arteries (pulmonary and aortic valves) (Fig.3A). After the blood is 
pumped from the atria to the ventricles, the atrioventricular valves close and the 
semilunar valves open (Fig.3C). The inverse takes place following blood expulsion 
into the great arteries. Each valve consists of 2-3 leaflets, composed of an outer layer 
of valve endothelial cells (VEC) enveloping three stratified layers of extracellular 
matrix (collagen, proteoglycan and elastin) interspersed with valve interstitial cells 
(VIC). The composition of these extracellular matrix layers is essential for the 
biomechanical properties of the leaflets to open and close, and the VIC and VEC 
plays additional roles in their homeostasis (Hinton et al., 2006; Tao et al., 2012). 
Indeed, in valves diseases the leaflets loose this stratification, leading to improper 
valve closure, backward blood flow and cardiac insufficiencies (Hinton et al., 2006). 
Congenital valve diseases are observed in 5% of live human births, accounting for 
25-30% of all cardiovascular malformations and are a major cause of mortality in 
adults (Armstrong and Bischoff, 2004; Combs and Yutzey, 2009). The most common 
valve diseases (2-4% of the human population) include bicuspid aortic valve (only 
two leaflets), mitral valve prolapse (increased deposition of extracellular matrix) and 
valve calcification (osteogenic process leading to extracellular matrix mineralization) 
(Rajamannan et al., 2003; Tao et al., 2012).  
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4.2.2. Overview of the main steps of cardiac development in the mouse 
The heart of the mouse embryo can first be observed in a crescent-shape structure at 
embryonic day 7.5 (E7.5) (Fig.4A). The cardiac crescent is composed of myocardial 
progenitors from both the primary heart field and the second heart field lineages, 
which will contribute to different structures in the adult heart. These progenitors fuse 
across the embryo midline, forming a linear tube that starts beating at around E8.0. 
This heart tube is mainly composed of cells from the primary heart field and serves 
as a scaffold for second heart field cells that migrate from adjacent splanchnic 
pharyngeal mesoderm to both the venous and arterial poles of the tube (Fig.4A). The 
venous pole, located caudally, is the entry point of the blood in the heart tube (inflow 
tract, prospective atrial chambers). The arterial pole, located cranially, is where the 
blood exits the heart tube (prospective outflow tract). The outflow tract is a transient 
structure that connects the right ventricle to the aortic sac, from which the aortic 
arches arteries arise in the branchial (pharyngeal) arches. At E8.5, the heart 
undergoes a rightward looping that breaks its bilateral symmetry and progressively 
moves the venous pole cranially. Myocardial cells rapidly proliferate and expand to 
shape the future cardiac chambers (Fig.4A). The primary heart field (PHF), marked 
by the expression of Nkx2.5, contributes mainly to the prospective left ventricle and to 
both atria, and partially to the prospective right ventricle. In contrast, the cells of the 
second heart field (SHF), marked by the expression of Isl1, contribute mainly to the 
prospective right ventricle, outflow tract and prospective atria.  
 
From E9.0-E9.5, cardiac neural crest cells delaminate from the dorsal ectoderm of 
the neural tube and migrate through the branchial arches to the outflow tract (Fig.4B) 
(Jiang et al., 2000). The developing heart is in the meantime invaded by another 
population of extracardiac cells: from E8.5-E9.0, cells from the transient proepicardial 
organ located at the venous pole detach and migrate to form both the epicardium that 
envelop the heart and the coronary vasculature that will provide blood supply to the 
heart itself (Fig.4B) (Reese et al., 2002; Männer et al., 2001).  
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Figure 4. Main steps of mouse heart development  
(A) Cardiac development in the mouse. See details in main text. From left to right: cardiac crescent 
stage (E7.5), heart tube stage (E8.0), loping heart (E8.5), formation of the chambers (E10.5) and 
functional four chambers heart (E15.0). Red indicates the primary heart field (PHF) and blue the 
second heart the field (SHF) and their derivative structures. Adapted from (Xin et al., 2013). (B) 
Contribution of extracardiac cell populations to the developing heart at ~E10.5. In purple, cardiac 
neural crest cells (cNCC) migrate from the neural tube through the pharyngeal arches (PhA) and 
invade the outflow tract. In yellow, cells from the proepicardial organ migrate to cover the heart and 
form the epicardium and coronary vasculature. Adapted from (Laugwitz et al., 2008). (C) Formation of 
the compact zone and trabeculations in the ventricular myocardium at ~E.10.5. OFT: outflow tract. RV: 
right ventricle. LV: left ventricle. AVC: atrioventricular canal. RA: right atrium. LV: left atrium. Cell types 
in the bottom panel are indicated. Adapted from (Misra and Garg, 2013). 
 
Between E10.5 and E12, the proliferation of the cardiomyocytes in the myocardium of 
the ventricular chambers leads to the formation of a multilayered compact zone that 
increases the thickness of the ventricular wall to ensure powerful contractions. Some 
of these cells migrate towards the interior of the ventricles and form finger-like 
protrusions called trabeculations, which increases the surface of the myocardium to 
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ensure sufficient oxygenation before the establishment of a functional coronary 
circulation within the myocardium (Fig.4C) (Martin-Puig et al., 2008). The conduction 
system and the cardiac valves are formed during this period of chambers formation 
(see below) (Christoffels et al., 2010; Combs and Yutzey, 2009). The cardiac valves 
develop both in the outflow tract and in the atrioventricular canal, which connects the 
left ventricle to the common atria before they are separated (Fig.4C). Together with 
the formation of these valves, the formation of the interventricular, interatrial and 
atrioventricular septa divide the heart into four functional chambers (Lin et al., 2012). 
Along with chambers septation, the cardiac neural crest cells contribute to divide the 
outflow tract into the pulmonary trunk and the aorta that are finally connected to the 
right and left ventricles, respectively.  
 
4.2.3. From cardiogenic mesoderm to the myocardium and endocardium: 
determination of the cardiac lineages 
The different structures composing the mammalian embryonic heart are derived from 
progenitor cells of three developmentally distinct origins: the cardiogenic mesoderm, 
the cardiac neural crest cells (cNCC) and the proepicardial organ (PEO) (Laugwitz et 
al., 2008). These multipotent progenitors differentiate into several cardiac cell types 
through a complex lineage diversification involving multiple intermediate progenitor 
states (Martin-Puig et al., 2008; Vincent and Buckingham, 2010; Lescroart and 
Meilhac, 2012). 
The cardiogenic mesoderm contains the progenitors that will contribute to the earliest 
cardiac structures derived from both the PHF and SHF (Fig.5). It is marked by the 
transient expression of Mesp1, and can first be detected in the anterior part of the 
primitive streak at the onset of gastrulation (E6.5) (Bondue and Blanpain, 2010). 
Following gastrulation, these progenitors migrate away from the primitive streak (PS) 
to anterior-lateral positions under the head folds, forming two groups of expanding 
lateral plate mesoderm cells on both side of the midline (Fig.5). At E7.0-7.5, these 
heart-forming regions extend across the embryo midline and fuse to form the cardiac 
crescent. Paracrine signals from adjacent tissues contribute to activate the 
expression of cardiac transcription factors in Mesp1+ cells of the cardiac crescent 
(Rana et al., 2013; Harvey, 2002; Zaffran and Frasch, 2002).  
 	
  22 
  
 
Figure 5. Lineage tree of the myocardial and endocardial progenitors  
Representation of the main cellular hierarchies and lineages relationships of the cardiac cells with 
associated genetic marker(s). Brachyury (Bry+) precursors give rise both to the cardiogenic mesoderm 
expressing Mesp1 and the hemangioblast cells that are the progenitors of the hematopoietic and 
endothelial cell lineages. The primary and second heart fields derive from Isl1+/Nkx2.5+/Flk1+ 
multipotent cardiac progenitors (MCP). Following successive transient progenitor states, they give rise 
to the cardiomyocytes of the atria and ventricles, the cells of the conduction system and smooth 
muscle cells. The endocardial cells derive from both Isl1+ SHF progenitors and vascular progenitors 
unrelated with the myocardium. The post-gastrulation stages at which the cardiogenic mesoderm and 
subsequent cardiac crescent can be observed are represented under the corresponding cells they 
contain. PS: primitive streak. HF: head folds. ML: midline(adapted from (Buckingham et al., 2005)). 
This scheme is not exhaustive and is adapted from (Laugwitz et al., 2008), with additional data based 
mainly on (Martin-Puig et al., 2008; Misfeldt et al., 2009; Milgrom-Hoffman et al., 2011).  
 
The multipotent cardiac progenitor cells (MCP) that further express Isl1, Nkx2.5 and 
Flk1 are able to differentiate into all major cell types of the heart: cardiomyocytes, 
smooth muscle cells, endothelial cells and cells of the conduction system (Fig.5) 
(Moretti et al., 2006; Wu et al., 2006; Sun et al., 2007; Martin-Puig et al., 2008). The 
two myocardial lineages are determined at the cardiac crescent stage from these 
MCP cells. Due to their common origin and close proximity in the cardiac crescent, 
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the distinction between the progenitors of the two lineages is mainly due to the timing 
of their differentiation (Meilhac et al., 2004; Meilhac et al., 2003; Dyer and Kirby, 
2009). The PHF cells, embedded in the lateral plate mesoderm, are the first ones to 
differentiate and will form the early heart tube and derived left ventricle (LV). The 
SHF cells, coming from splanchnic pharyngeal mesoderm in the dorsal wall of the 
pericardial cavity, differentiate later and are progressively added to the elongating 
heart tube from both poles to contribute to the outflow tract (OFT), right ventricle (RV) 
and atria (Cai et al., 2003; Zaffran et al., 2004; Meilhac et al., 2004) (Fig.4A). PHF 
cells are marked mainly by the expression of Nkx2.5, but also of Tbx5 and Hand1. In 
contrast, Isl1 expression marks the cells of the SHF, which also express Gata4, 
Foxh1, Tbx1, Fgf8, Fgf10, Mef2c, Hand2 and Nkx2.5 (Buckingham et al., 2005; 
Laugwitz et al., 2008).   
The developmental origin of the endocardium has been controversial regarding the 
stage at which it segregates from the progenitors of the myocardial lineages (Harris 
and Black, 2010; Lescroart and Meilhac, 2012; Puceat, 2013). Two distinct sources 
of endocardial progenitors have been identified (Fig.5). The first population derives 
from the Isl1+ SHF and shares a common precursor with the myocardium (Ferdous et 
al., 2009; Misfeldt et al., 2009). The second population is composed of Flk1+ vascular 
endothelial cells unrelated with the myocardium. This endocardial population 
migrates from a medial position to the cardiac crescent and enters the heart from the 
arterial pole (Milgrom-Hoffman et al., 2011). The endocardial cells in the outflow tract 
and in the atrioventricular canal give rise to the cardiac cushions that are the 
precursors of the cardiac valves (see below) (Puceat, 2013; von Gise and Pu, 2012). 
Furthermore, ventricular endocardial cells invade the myocardium in the compact 
zone and form the endothelium of the coronary arteries between E11.5 and E13.5 
(Wu et al., 2012).  
 
4.2.4. Patterning and differentiation of the second heart field 
The Isl1+ second heart field is located in the dorsal pericardial wall and is patterned 
along the embryo antero-posterior (cranio-caudal) axis, with cells coming from 
distinct but clonally related regions taking different migratory routes for different 
developmental outcomes (Kelly, 2012; Lescroart and Meilhac, 2012; Lescroart et al., 
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2012). This patterning requires retinoic acid upstream of a graded expression of Hox 
genes, but the boundary between the anterior and the posterior SHF is not clearly 
defined (Ryckebusch et al., 2008; Bertrand et al., 2011; Kelly, 2012). 
The cells in the anterior SHF are closely linked to the mesodermal core of the 
branchial arches (Tzahor and Evans, 2011). They are mainly characterized by the 
expression of Fgf10, Fgf8 and Tbx1, and migrate through the arterial pole to 
contribute to the OFT and RV myocardium (Fig.6A) (Kelly et al., 2001; Mjaatvedt et 
al., 2001; Xu et al., 2004; Lescroart et al., 2010). The anterior SHF cells are clonally 
related to the skeletal head muscles, with lateral regionalization that links the 
progenitors of the aorta and pulmonary trunk to the progenitors of the right and left 
facial expression muscles, respectively (Lescroart et al., 2010). The anterior SHF 
should not be mixed up with the “secondary” heart field, which was identified in the 
chicken and originates from a subdomain of the anterior SHF that gives rise only to 
the OFT distal myocardium (Waldo et al., 2001; Dyer and Kirby, 2009). In contrast to 
the anterior SHF, the posterior SHF contributes to the venous pole of the heart with 
clonal relationship between the cells of the superior vena cava, pulmonary vein and 
of both atria (Lescroart et al., 2012). Furthermore, the atria are clonally related to the 
AVC myocardium, and their left/right identity is further determined by asymmetric 
expression of Pitx2 (Domínguez et al., 2012; Galli et al., 2008). 
 
Two major properties discriminate the SHF from the PHF cells: their sustained 
proliferation and their differentiation delay, controlled by paracrine Sonic Hedgehog 
(SHH), Wnt, Fibroblast Growth Factors (FGFs), Bone Morphogenetic Proteins 
(BMPs) and Notch signaling from the surrounding pharyngeal ectoderm and 
endoderm and by autocrine signaling from the pharyngeal mesoderm itself (Fig.6B) 
(Rochais et al., 2009b; Vincent and Buckingham, 2010; Francou et al., 2013). Indeed, 
SHF cells remain in an undifferentiated progenitor state in the pharyngeal mesoderm 
at the time the PHF cells form the heart tube and differentiate into cardiomyocytes. It 
is only after their migration and addition to the heart tube that the exposure to new 
signaling factors differentiate SHF cells into cardiomyocytes or smooth muscle cells, 
associated with downregulation of their early markers Fgf8, Fgf10, Tbx1 and Isl1 and 
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activation of the expression of Nkx2.5, Gata4, Mef2c and Hand2 (Dyer and Kirby, 
2009; Kelly, 2012). 
 
 
Figure 6. Migration and differentiation of second heart field progenitors  
(A) Migration of anterior second heart field progenitors from the pharyngeal mesoderm of the branchial 
arches (BA) towards the heart tube. Blue: sub-lineage originating in the 1st BA and contributing to the 
RV myocardium and to the masticatory muscles. Pink: sub-lineage originating in the 2nd BA and giving 
rise to the OFT myocardium and to the facial expression muscles. From (Lescroart et al., 2010). (B) 
Signaling interactions controlling the balance between FGF-induced proliferation and BMP-induced 
differentiation of second heart field progenitors towards cardiomyocytes. See details in main text. From 
(Francou et al., 2013). 
 
 
The balance between proliferation and differentiation of SHF cells depends mainly on 
opposite effects of FGF and BMP signaling (Fig.6B) (Hutson et al., 2010). Fgf10 and 
Fgf8 functionally overlap and control the survival and progenitor state maintenance of 
the SHF cells that will contribute to the OFT and RV (Ilagan et al., 2006; Park et al., 
2006; Watanabe et al., 2010). The expression of Fgf10 in these progenitors depends 
on a CRM located in its proximal promoter, which is mainly activated by TBX1 and 
ISL1 and repressed by NKX2.5 upon myocardium differentiation (Watanabe et al., 
2012). In addition, FGF signaling is also activated by Wnt/βcatenin in the anterior 
SHF (Cohen et al., 2007). In contrast, the non-canonical Wnt11 later promotes 
differentiation of SHF cells (Cohen et al., 2012; Pandur et al., 2002). BMP signaling 
from the distal prospective OFT antagonizes the proliferative FGF signals through the 
activation of Msx1 and Msx2 in the invading cNCC, but the mechanism by which 
these BMP targets further downregulate FGF ligands and decreases the proliferation 
of SHF progenitors is unclear (Tirosh-Finkel et al., 2010; Hutson et al., 2006). BMP4 
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is required for the septation of the OFT and the formation of the cardiac cushions, 
and its expression in the pharyngeal mesoderm and in the OFT is activated by Wnt 
signaling (McCulley et al., 2008; Ai et al., 2007). Furthermore, autocrine pharyngeal 
mesodermal FGF8 signaling is also required for Bmp4 expression (Park et al., 2008). 
Finally, both Tbx2 and Tbx3 are necessary to activate BMP signaling in the distal 
OFT (Mesbah et al., 2012). These regulatory crosstalks between proliferative FGF 
and differentiating BMP signals suggest that their expression levels are critical to 
reach a signaling threshold necessary to affect cell fate (Vincent and Buckingham, 
2010). The differentiation of SHF-derived structures (OFT, RV) depends further on a 
network of various transcription factors, among which Hand2 plays an essential role 
(see below).  
 
4.2.5. The T-box genes family and the development of the atrioventricular 
canal and atrioventricular node 
The first signs of an electrical activity in the developing heart can be observed at the 
heart tube stage, with pacemaker activity at the venous pole generating slow 
peristaltic contractions (Christoffels and Moorman, 2009; Christoffels et al., 2010). 
This pacemaker activity, both at early and late stage of cardiac development, 
depends on the expression of the potassium/sodium channel Hcn4 (Stieber et al., 
2003). When cardiac chambers start to differentiate, the transmission of the electrical 
impulse depends on rapid conduction through Cx40/Cx43 gap-junction channels in 
atria and ventricles myocardium and on slow conduction through Cx45/Cx30.2 gap-
junctions channels in the AVC and OFT, providing a contraction delay in these two 
compartments (de Jong et al., 1992; Moorman and Christoffels, 2003; Christoffels 
and Moorman, 2009). The primordia that form later the definitive components of the 
conduction system start to differentiate around E9.0-E9.5, and can originate both 
from transdifferentiation of cardiomyocytes or from pre-specified cardiac progenitors 
(Munshi, 2012; Christoffels and Moorman, 2009).  
 
Several members of the T-box family of transcriptional regulators play an essential 
role during cardiac development and in the formation of the conduction system in 
particular, functions that are conserved among vertebrates (Stennard and Harvey, 
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2005; Hoogaars et al., 2007a; Greulich et al., 2011). This family is characterized by a 
highly conserved “T-box” DNA binding domain and consists of at least 17 members 
in mammals. Based on sequence homology, two main subfamilies can be identified: 
the first one contains Tbx1, Tbx18 and Tbx20, while the second contains Tbx2, Tbx3, 
Tbx4 and Tbx5 (Plageman and Yutzey, 2005). The members of this second 
subfamily are closely related, as they evolved by two rounds of gene duplications 
from a single ancestral gene that resulted in two separate paralogous gene clusters: 
the Tbx3/Tbx5 and Tbx2/Tbx4 landscapes (Agulnik et al., 1996). Tbx1 is involved in 
the proliferation of anterior SHF progenitors (Xu et al., 2004; Watanabe et al., 2012), 
Tbx5 is a marker of the PHF involved in the differentiation of cardiomyocytes 
(Bruneau et al., 1999; Bruneau et al., 2001), Tbx18 is important for the formation of 
the epicardium (Wu et al., 2013; Cai et al., 2008), and Tbx4 is not involved in 
cardiogenesis. The main T-box genes involved in the formation of the conduction 
system are the transcriptional repressors Tbx2 and Tbx3. Tbx2 has been implicated 
mainly in the formation of the atrioventricular node (AVN) (Aanhaanen et al., 2011; 
Aanhaanen et al., 2009), while Tbx3 marks the entire cardiac conduction system with 
highest expression in the developing and mature sinoatrial node (SAN), AVN and 
bundle of His (Hoogaars et al., 2004; Hoogaars et al., 2007b; Bakker et al., 2008; 
Horsthuis et al., 2009). Tbx2 and Tbx3 are expressed in the myocardium of the AVC 
and OFT, but not in the atrial and ventricular chambers. Their patterning and 
morphogenesis effect on these compartments occurs by repression of the chamber 
myocardial differentiation gene program, mainly through the direct repression of the 
differentiation marker Nppa (ANF, Atrial Natriuretic Factor) (Habets et al., 2002; 
Christoffels et al., 2004; Harrelson et al., 2004; Dupays et al., 2009; Mesbah et al., 
2008). The AVC and OFT thus retain a low proliferation rate and slow conduction 
mode in comparison to the differentiating chambers. This progressively replaces the 
peristaltic contractions of the heart tube by a pattern of serial contractions combining 
alternate slow conducting and poorly contracted myocardium in AVC and OFT with 
fast conducting and contracting myocardium in the chambers (Moorman and 
Christoffels, 2003; Christoffels et al., 2010).  
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Figure 7. Atrioventricular canal 
and node formation  
Molecular pathways regulating the 
development of the atrioventricular 
canal (avc) and the establishment of 
the boundary with the adjacent 
chambers myocardium. See details 
in main text. Adapted from 
(Christoffels et al., 2010). 
 
 
 
 
The atrioventricular node (AVN) starts to differentiate at E9.5 from the myocardium of 
the AVC, which originates from both the PHF and posterior SHF (Aanhaanen et al., 
2009; Domínguez et al., 2012). The AVC is specified by the expression of Bmp2 in 
the myocardium, which mediates the induction of Tbx2 expression to repress the 
chamber differentiation genes Cx40, Cx43 and Nppa (Fig.7) (Yamada et al., 2000; 
Ma et al., 2005; Harrelson et al., 2004; Christoffels et al., 2004; Habets et al., 2002). 
In the cardiomyocytes of the neighboring chambers, Notch signaling activates Hey1 
and Hey2, which suppress Tbx2 expression thereby restricting it to the AVC 
myocardium and creating the boundaries between the AVC and the heart chambers 
(Rutenberg et al., 2006; Kokubo et al., 2007). Furthermore, Tbx2 expression in 
chambers myocardium is also repressed by TBX20 (Singh et al., 2005; Cai et al., 
2005; Stennard et al., 2005). This repression is not direct but is mediated by 
interfering with BMP2 signal transduction: TBX20 binds to SMAD1/5 and prevents 
their interaction with SMAD4, which in turn prevent them to bind to Tbx2 proximal 
promoter (Fig.7 and Fig.10B) (Singh et al., 2009; Singh and Kispert, 2010). Tbx3 is 
also expressed in the myocardium of the AVC, where it functions together with Tbx2 
to inhibit precocious chamber differentiation (Hoogaars et al., 2004; Singh et al., 
2012). These two genes also have non-redundant functions, Tbx2 being more 
important in the regulation of AVC patterning and Tbx3 in the formation of the AVN 
itself by controlling the expression of the pacemaker gene program (Munshi, 2012; 
Frank et al., 2012; Aanhaanen et al., 2011; Horsthuis et al., 2009). By E13.5, the 
Tbx3/Hcn4/Cx30.2/Cx45 positive cells of the AVN will extend into the left ventricle 
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and connect with both the fast conducting Cx40/Cx43 positive trabeculations and the 
interventricular septum to form the bundle of His (Christoffels et al., 2010). 
 
4.2.6. Formation of the cardiac valves: from endothelial-mesenchymal 
transition to the cardiac cushions  
Epithelial-mesenchymal transition (EMT) is a common developmental mechanism by 
which epithelial cells are converted into mesenchymal cells by the loss of cell-cell 
adhesion and cellular polarity, and the gain of motile and invasive characteristics 
(Fig.8A). For instance, EMT is crucial for the formation of the mesoderm during 
gastrulation, the delamination of the cNCC from the neural tube, and the formation of 
the epicardium (Sauka-Spengler and Bronner-Fraser, 2008; Männer et al., 2001; 
Olivey and Svensson, 2010; von Gise and Pu, 2012). Successive waves of EMT and 
MET (mesenchymal-epithelial transition) are typically required for the formation of 
organs (Thiery et al., 2009; Lim and Thiery, 2012; Kovacic et al., 2012).  
The formation of the cardiac valves is initiated in the endocardium at E9.5 in the AVC 
and E10.5 in the OFT by endothelial-mesenchymal transition (EndMT), a particular 
type of EMT. In response to signals coming from the myocardium, endocardial cells 
delaminate, transform into mesenchymal cells (Fig.8A,B) and migrate into the cardiac 
jelly between the two cellular layers, where they proliferate to form the cardiac 
cushions (Fig.8B). Following proliferative expansion and increased production of 
ECM, the cardiac cushions are remodeled into cardiac valves primordia (von Gise 
and Pu, 2012). The formation of the semilunar valves in the OFT also involves the 
cNCC. After their migration through the branchial arches, these cells invade the 
mesenchyme of the OFT cardiac cushions and contribute to their fusion to form the 
aorticopulmonary septum that divides the OFT into aorta and pulmonary trunk, and 
the associated semilunar valves (Lin et al., 2012). Alterations in the formation of the 
cardiac cushions or in their fusion with the cardiac septa can lead to atrial-septal and 
atrioventricular-septal defects, two frequent types of valves-associated CHDs.  
 
In the AVC, the EndMT is initiated by a crosstalk between myocardium and 
endocardium involving multiple signaling pathways (Fig.8C). Myocardial Bmp2 is 
crucial for both myocardium patterning (see above) and endocardial EndMT (Ma et 
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al., 2005; Rivera-Feliciano and Tabin, 2006). BMP2 paracrine signaling induces the 
expression of Msx1 in the endocardium, which functions to maintain Notch1 
expression  (Ma et al., 2005; Chen et al., 2008). Then, Notch1 endocardial signaling 
promotes the EndMT through the indirect non-cell autonomous activation of 
myocardial Tgfβ2 (Timmerman et al., 2004). Furthermore, BMP2, Notch1 and TGFβ2 
all converge to synergically activate Snai1 expression in the endocardium 
(Timmerman et al., 2004; Niessen et al., 2008; Luna-Zurita et al., 2010). In addition, 
endocardial Notch1 signaling upregulates myocardial Bmp2 expression via paracrine 
Wnt4, and BMP2 signaling also induces Tgfβ2 expression in the myocardium via 
Tbx2 (Wang et al., 2013; Ma et al., 2005; Shirai et al., 2009). This complex 
integration of BMP2/Notch1/TGFβ2 signaling between myocardium and endocardium 
drives and restricts the EndMT to the AVC (Garside et al., 2013).  
 
 
 
Figure 8. Formation of the cardiac valves by endothelial-mesenchymal transition 
(A) Mechanism of epithelial-mesenchymal transition (EMT). During EMT, a cell in an epithelial sheet 
looses its adherent junctions and polarity while gaining migratory and invasive phenotypes. It 
delaminate or ingress depending on the tissue and becomes a mesenchymal cells. From (von Gise 
and Pu, 2012). (B) Main steps of endothelial-mesenchymal transition (EndMT) in atrioventricular (left 
panel) and semilunar (right panel) valves. The atrioventricular valves leaflets are attached to the 
papillary muscles in the ventricles by chordae tendinae (CT). Adapted from (Lin et al., 2012). (C) AVC 
gene regulatory network controlling EndMT. See details in main text. Adapted from  (von Gise and Pu, 
2012). 
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Furthermore, myocardial TBX20 is also important to pattern the AVC upstream of the 
EndMT by regulating Bmp2 expression (Cai et al., 2011). In contrast, endocardial 
TBX20 is not required to initiate the EndMT, but is essential later for cardiac cushion 
maturation and valves elongation by altering Wnt/β-catenin signaling (Cai et al., 
2013). Finally, signaling through the endocardial ErbB3 tyrosine kinase receptor is 
also necessary to induce EndMT (Camenisch et al., 2002), and requires upstream 
activation of ErbB3 by GATA4 (Rivera-Feliciano et al., 2006).  
 
Snai1 and the related gene Snai2 are key mediators of EMT in a variety of 
developmental processes and disease states, such as the initiation of cancer 
metastasis (Barrallo-Gimeno and Nieto, 2005; Carver et al., 2001). During normal 
cardiac cushion development, endocardial Notch signaling induces the expression of 
Snai1, which in turn directly downregulates the expression of the adherent junction 
marker VE-Cadherin (VE-Cad) and hence disrupts cell contacts in the endocardium 
(Timmerman et al., 2004; Luna-Zurita et al., 2010). In addition, Snai1 upregulates the 
expression of the intermediate filament Vimentin (VIM) to reorganize the cytoskeleton 
and gain cellular motility (Cano et al., 2000), and activates the expression of matrix 
metalloproteinases such as MMP15 that degrade the basal surface of endocardial 
cells to facilitate their delamination and migration into the cardiac jelly (Tao et al., 
2011; Song et al., 2000).  
 
One of the main components of the cardiac jelly ECM is hyaluronic acid (HA). HA 
interacts with other ECM components such as the proteoglycans aggrecan and 
versican, thereby contributing to the architecture of the ECM in the cardiac jelly to 
provide a support for the migration of the cardiac cushion progenitors (Bernanke and 
Markwald, 1979). HA also participates in ErbB3 tyrosine kinase receptor-mediated 
signaling transduction, which activates Ras that is required for AVC morphogenesis 
(Camenisch et al., 2000; Camenisch et al., 2002; Lakkis and Epstein, 1998). HA is 
mainly produced by the enzyme Hyaluronan Synthase 2 (HAS2). Has2 expression in 
the myocardium depends of Bmp2 (Ma et al., 2005), and it is also expressed by the 
endocardium and the migrating cardiac cushion mesenchymal progenitors (Fig.8C). 
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Has2-deficient embryos die by E10.0 due to hypoplastic OFT and RV and lack of 
ventricular trabeculation and cardiac cushions (Camenisch et al., 2000).  
 
In the AVC, the transcriptional regulator Twist1 controls the migration, proliferation 
and differentiation of cardiac cushion cells and the subsequent remodeling of the 
cardiac valves (Shelton and Yutzey, 2008; Lee and Yutzey, 2011; Vrljicak et al., 
2012; Chakraborty et al., 2010). One target of Twist1 in the cardiac cushions is Sox9 
(Vrljicak et al., 2012). Sox9 is not required to initiate the EndMT and migration, but is 
activated following delamination and regulates cardiac jelly invasion and proliferation 
of cardiac cushion progenitors (Akiyama et al., 2004). Sox9 is also required at later 
stages for proper distribution of ECM molecules during valves remodeling (Lincoln et 
al., 2007), and its downregulation leads to valve calcification phenotypes (Peacock et 
al., 2010). 
 
Calcineurin/NFATc signaling is also critical for cardiac cushion formation, together 
with VEGF. Nfatc1 is expressed specifically in endothelial cells of the endocardium 
but not the remainder of the vasculature, and is required for the formation of the 
semilunar valves but not for EndMT (Ranger et al., 1998; de la Pompa et al., 1998). 
At E9.0, Calcineurin/NFATc signaling in the AVC myocardium reduces the production 
of VEGF, as low levels of VEGF are required for EndMT. Accumulated levels of 
VEGF ultimately terminate EndMT at E10.5, and a second wave of 
Calcineurin/NFATc signaling in the endocardium directs valves elongation and 
remodeling from E11.0 (Chang et al., 2004; Lambrechts and Carmeliet, 2004). During 
valves remodeling, Nfatc1 prevents a fraction of endocardial cell to undergo EndMT, 
which maintains them in a proliferative state (Wu et al., 2011).  
 
4.2.7. Hand2 is a crucial regulator for the development of second heart field 
derived structures  
Hand2 and its closely related gene Hand1 encode basic helix-loop-helix (bHLH) 
proteins belonging to the Twist-family of transcriptional regulators. These proteins are 
composed of a basic domain followed by two amphiphatic α-helices that are 
separated by a loop of variable length. While the helix-loop-helix motif (HLH) 
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mediates protein-protein interactions, the basic domain is responsible for DNA 
interactions through canonical E-box motifs (CANNTG). In vitro, HAND2 interacts 
with the highest affinity with the CATCTG E-box motif (Dai and Cserjesi, 2002). The 
dimerization of two bHLH proteins via their HLH domain is crucial for E-box 
recognition by two juxtaposed basic domains, and the choice of binding partner 
directly dictates the function and specificity of the bHLH transcriptional complex 
(Massari and Murre, 2000; Conway et al., 2010; Vincentz et al., 2011). The 
phosphorylation status of HAND2 and others Twist-family members at conserved 
Threonine and Serine residues in helix 1 alters their dimerization affinity for others 
bHLH proteins and consequently affects their DNA binding specificity (Firulli et al., 
2005; Firulli et al., 2007; Barnes and Firulli, 2009).  
 
Hand2 (or dHand) is expressed in the deciduum, heart, autonomic nervous system 
and neural crest derivatives and is crucial for the morphogenesis of these embryonic 
structures. In the sympathetic nervous system, Hand2 regulates the expression of 
the norepinephrine biosynthetic enzymes that impact on the cardiac rhythm 
(Morikawa et al., 2007; Hendershot et al., 2008; Morikawa and Cserjesi, 2008; 
VanDusen et al., 2014). In addition, Hand2 also regulates the formation of 
craniofacial structures derived from neural crest cells (Charité et al., 2001; 
Yanagisawa et al., 2003; Funato et al., 2009; Barron et al., 2011; Xiong et al., 2009). 
Hand2 is also essential to activate Shh expression in the posterior forelimb and 
hindlimb bud mesenchyme, necessary for antero-posterior patterning of the limb 
(Charité et al., 2000; te Welscher et al., 2002; Galli et al., 2010). 
The Hand2 genomic sequence, expression pattern and functions are highly 
conserved among vertebrate species (Angelo et al., 2000; Srivastava, 1995; Yelon et 
al., 2000). During mouse cardiac development, Hand2 expression is first detected in 
SHF progenitors at the cardiac crescent stage (E7.5). It is further maintained in the 
whole heart tube before being progressively restricted to the RV and OFT 
myocardium during cardiac looping, with remaining expression in the LV to a lesser 
extent (E8.5). From the heart tube stage, Hand2 expression can also be detected in 
the endocardium and in the splanchnic pharyngeal mesoderm in the dorsal 
pericardial wall. From E9.5, Hand2 is also expressed in the proepicardial organ and 
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derived epicardium, in the branchial arches and in the migrating cNCC that invade 
them, and in the developing vasculature. Its expression is gradually restricted during 
cardiac chambers remodeling to be detected only in the atria by birth (Fig.9A) 
(Srivastava, 1995; Srivastava et al., 1997; Biben and Harvey, 1997; Barnes et al., 
2011; Dirkx et al., 2013). In contrast, Hand1 is expressed mainly in PHF derived 
structures and becomes restricted to the LV when cardiac looping occurs (Fig.9A) 
(Srivastava et al., 1997; Biben and Harvey, 1997). HAND2 and HAND1 can form 
heterodimers, and they function redundantly and in a gene dosage-dependent 
manner for the differentiation of the PHF-derived LV, while Hand1 does not play a 
role in the formation of the SHF-derived RV (Firulli et al., 2000; Firulli et al., 2010; 
McFadden et al., 2005).  
 
Embryos deficient for Hand2 display severe cardiac defects leading to growth 
retardation and embryonic lethality by E10.5 (Srivastava et al., 1997). The heart of 
these embryos appears morphologically normal until cardiac looping, but then 
displays several malformations: an hypoplastic RV that results in an abrupt 
connection between the OFT and LV, a thin myocardium without trabeculation, a 
dilated aortic sac, an absence of the aortic arches arteries, and hypoplastic branchial 
arches (Fig.9B) (Srivastava et al., 1997; Togi et al., 2006). In these mutant embryos, 
Hand1 expression is not affected (Srivastava et al., 1997).  
The conditional inactivation of Hand2 in the epicardial lineage using both Hand1-Cre 
and Wt1-CreERT2 disrupts the secondary epicardial EMT and the formation of the 
coronary vasculature, showing that Hand2 is also required for the formation and 
differentiation of these cardiac structures (Barnes et al., 2011). Furthermore, Hand2 
conditional deletion in SHF progenitors using Isl1-Cre leads to a hypoplastic RV and 
to increased cell death in SHF progenitors in the pharyngeal mesoderm, impairing 
their subsequent migration towards the OFT. This establishes that Hand2 is crucial 
for the survival of the SHF progenitors and for the subsequent formation of the RV 
(Tsuchihashi et al., 2011). Conditional inactivation of Hand2 in cNCC using Wnt1-Cre 
results in misspatterned aortic arches arteries, hypertrabeculation, enlarged RV, 
septation defects in both the ventricles and the OFT, and double-outlet right ventricle 
(DORV) in which both the aorta and the pulmonary trunk are connected to the right 
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ventricle (Holler et al., 2010; Morikawa and Cserjesi, 2008). Interestingly, cNCC-
specific deletion of Hand2 also showed that Hand2 controls the expression of several 
genes involved in the proliferation and differentiation of both cNCC and SHF-derived 
cells in the RV trabecular myocardium (Holler et al., 2010; Morikawa and Cserjesi, 
2008). Indeed, the marker of myocardial chamber differentiation Nppa is 
downregulated in these conditional mutant embryos, which, together with their 
enlarged RV and hypertrabeculation, points to a defect in the control of SHF 
proliferation. This occurs through an interaction between cNCC and SHF progenitors 
that takes place before their migration into the PHF heart tube (Morikawa and 
Cserjesi, 2008; Houweling et al., 2005; Yelbuz et al., 2002). 
 
 
 
Figure 9. Hand2 is a crucial regulator for second heart field differentiation  
(A) Schematic representation of the expression of Hand1 (top panel, blue) and Hand2 (lower panel, 
red) during cardiac development. CC: cardiac crescent. V: ventricle. End: endocardium. OFT: outflow 
tract. LV: left ventricle. See details in main text. Adapted from (Vincentz et al., 2011). (B) Morphology 
of the developing heart in wild-type (top panels) and Hand2-deficient embryos (lower panel). 
Differences can be observed from the stage of cardiac looping (E8.25). From E8.5, the absence of the 
right ventricle (rv, black arrowhead in Hand2+/+) is obvious in Hand2∆/∆ embryos (white arrowhead). a: 
atria. R/L: right/left. D/V: dorsal/ventral. (C) Model of the transcriptional network active in the second 
heart field that controls the development of the right ventricle and outflow tract. Solid lines: direct in 
vivo interactions. Dotted lines: genetic or in vitro interactions. From (Laugwitz et al., 2008). 
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The proliferative role of Hand2 was shown in zebrafish embryos as well, in which it 
can promote the proliferation of SHF-derived cardiomyocytes. Hand2 is also re-
expressed in adult zebrafish heart following cardiac injury, where it increases 
cardiomyocytes proliferation thereby enhancing their cardiac regenerative capacities 
(Schindler et al., 2014; Wills et al., 2008). Similarly, Hand2 expression is reactivated 
in the postnatal mouse heart following cardiac stress, leading to cardiomyocytes 
hypertrophy, cardiac dilation and eventually heart failure (Dirkx et al., 2013). This re-
expression is mediated by the transcriptional inhibition of the microRNA miR-125 by 
Calcineurin/NFATc, as otherwise mirR-125 inhibits Hand2 translation by interacting 
with its 3’UTR  (Dirkx et al., 2013). Negative regulation of Hand2 translation is also 
mediated by interactions between its 3’UTR and the microRNAs miR-1 and miR-
133a, which originate from the same bicistronic precursor  (Zhao et al., 2005; Vo et 
al., 2010). Overexpression of miR-1 leads to defects in the proliferation of the 
cardiomyocytes, which also points to a role of Hand2 controlling the proliferation of 
SHF myocardial cells (Zhao et al., 2005). 
 
The RV-specific expression of Hand2 is controlled by a GATA factors-dependent 
enhancer located in the Hand2 proximal promoter (McFadden et al., 2000). In Gata4-
deficient embryo, the precardiogenic mesoderm fails to fuse to form a heart tube 
(cardia bifida) (Kuo et al., 1997; Molkentin et al., 1997). In these mutant embryos, the 
RV-specific CRM of Hand2 is still able to drive LacZ reporter expression in the two 
primitive hearts with highest intensity in the right one, suggesting that GATA5 or 
GATA6 could compensate for the loss of GATA4 to regulate Hand2 expression in the 
RV (McFadden et al., 2000). Furthermore, GATA factors also regulate the expression 
of the PHF marker Nkx2.5 in the RV through specific CRMs (Searcy et al., 1998; Lien 
et al., 1999; Reecy et al., 1999). Embryos deficient for Nkx2.5 form a heart tube but 
fail to undergo cardiac looping. They show a severe reduction of the expression of 
cardiac differentiation markers, but not of Hand2 (Lyons et al., 1995; Biben and 
Harvey, 1997; Yamagishi et al., 2001). Furthermore, the heart of embryos lacking 
both Nkx2.5 and Hand2 do not form any ventricles but only a single atrium, likely 
originating from the posterior SHF (Yamagishi et al., 2001; Lescroart et al., 2012; 
Srivastava, 2006). 
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The differentiation of the RV from anterior SHF progenitors is also impaired in 
embryos lacking Isl1, the early marker of this lineage (Cai et al., 2003). RV 
hypoplasia can also be observed in embryos deficient for Mef2c, which 
downregulates Hand2 expression (Lin, 1997). Mef2c is a target of several key SHF 
transcription factors including ISL1, GATA4 and FOXH1 (Dodou et al., 2004; von 
Both et al., 2004). Furthermore, MEF2C directly activates the expression of the 
histone methyltransferase Smyd1 (Bop1), which inactivation leads as well to RV 
hypoplasia and Hand2 downregulation (Phan et al., 2005; Gottlieb et al., 2002). 
These and other genetic interactions determine a cascade of transcription factors 
crucial for the development of the right ventricle and the outflow tract (Fig.9C). In 
vitro, HAND2 directly activates the transcription of Nppa synergically with MEF2C, 
GATA4 or NKX2.5 (Zang et al., 2004; Dai et al., 2002; Thattaliyath et al., 2002), but 
no direct endogenous target gene of HAND2 in the second heart field or in other 
cardiac lineages have been identified so far (Vincentz et al., 2011).  
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4.3. The BMP signaling pathway during limb bud development and 
the Grem1 cis-regulatory landscape 
The developing tetrapod limb bud has been extensively used as a model to study the 
interactions between signaling networks and their effects on gene regulation (Zeller 
et al., 2009). It also provides an excellent system to analyze cis-regulatory 
landscapes and the role of individual CRMs using transgenic approaches (Zeller and 
Zuniga, 2007; Spitz and Duboule, 2008). 
The tetrapod limb buds originate, as the cardiovascular system, from the lateral plate 
mesoderm and emerge as pockets of mesenchymal cells surrounded by a monolayer 
of ectodermal cells. Mouse limb buds outgrowth and patterning along the proximo-
distal and antero-posterior axis are controlled by two signaling centers: the zone of 
polarizing activity (ZPA) and the apical ectodermal ridge (AER), which interact in a 
self-regulatory feedback system involving SHH, BMPs, FGFs and the BMP 
antagonist GREMLIN1 (GREM1) (Fig.10A) (Panman et al., 2006; Benazet et al., 
2009; Zeller et al., 2009). 
 
The BMP signaling pathway occupies a central role during mouse limb bud 
development (reviewed in (Pignatti et al., 2014)). It is involved in limb bud initiation, 
outgrowth and patterning and is important for the chondrogenic differentiation of the 
limb skeletal elements (Kobayashi et al., 2005). BMP ligands belong to the TGFβ 
superfamily. In the developing limb bud, BMP2, BMP4 and BMP7 are expressed in 
specific spatio-temporal patterns, and their activity is modulated by various extra-
cellular antagonists. The binding of BMP ligand dimers to serine/threonine receptors 
triggers the phosphorylation of receptor-associated SMADs (R-SMADs, or 
SMAD1,5,8), which mediate canonical BMP signal transduction by associating with 
SMAD4 (co-SMAD). The resulting transcriptional complex is translocated to the 
nucleus, where it interacts with BMP responsive elements (BRE) in the cis-regulatory 
landscapes of target genes (Id1, Msx2…) and activates their expression (Fig.10B). 
SMAD4 is an essential mediator for both BMP and TGFβ signal transduction in the 
development of various tissues. It is composed of two evolutionary conserved MAD 
homology domains (MH) separated by a linker.  
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Figure 10. Limb bud development and BMP signaling pathway 
(A). Interlinked signaling feedback loops control limb bud outgrowth. During the initiation phase, high 
BMP4 (blue) levels in the mesenchyme maintain AER-FGFs (green) and activate the expression of the 
BMP antagonist Grem1 (purple). During the propagation phase, increasing GREM1 levels antagonize 
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BMP4 signaling, which enables FGF signaling from the AER to the underlying mesenchyme for 
proliferative outgrowth and to the ZPA to maintain Shh expression (red). The SHH/GREM1/AER-FGFs 
epithelial-mesenchymal feedback loop is self-terminated as Grem1 is repressed by AER-FGFs and as 
the expanding population of Shh-expressing descendant cells becomes refractory to Grem1 
expression, generating a gap that brings the Grem1 expression domain out of reach of long range 
SHH signaling. This results in an increase in BMP activity, initiating chondrogenic differentiation of 
mesenchymal progenitors. From (Zeller et al., 2009). (B) BMP signaling pathway. See main text for 
details. From (Pignatti et al., 2014). (C) The Grem1-Fmn1 cis-regulatory landscape. Point mutations, 
deletions (∆), inversions and transgene insertions are indicated above or below the landscape. 
Mutations indicated in pale blue cause the limb deformity (ld) phenotype due to disruption of Grem1 
cis-regulation. The three yellow boxes indicate the location of the conserved HMCOs elements. 
Adapted from (Zeller and Zuniga, 2007). 
 
 
 
The N-terminal MH1 domain binds to DNA, mediates protein-protein interactions and 
contains the nuclear localization signal. The C-terminal MH2 domain is 
phosphorylated by type I BMP receptors and mediates heterodimerization with R-
SMADs. Embryos deficient for Smad4 die before E7.5 due to gastrulation defects, 
which preclude the analysis of its specific role during limb bud development (Sirard et 
al., 1998). 
 
Grem1 is a crucial node during limb bud morphogenesis, as its dynamic expression 
is controlled by BMP, SHH and FGF signaling pathways during limb bud initiation, 
expansion and termination, respectively (Fig.10A) (Zuniga et al., 1999; Capdevila et 
al., 1999; Scherz et al., 2004; Verheyden and Sun, 2008; Benazet et al., 2009). 
Grem1-deficient mice lack kidneys and ureters and die shortly after birth. They also 
display limb skeleton patterning defects such as fused ulna and radius and reduction 
in digit number (Michos et al., 2004; Khokha et al., 2003). Grem1 expression in limb 
buds depends on a large cis-regulatory landscape that extends at least in the 
neighboring Formin1 (Fmn1) gene. This region is able to activate reporter expression 
in the limb bud similarly to Grem1 endogenous expression, and contains three 
regions highly conserved between Human, Mouse, Chicken and Opossum (HMCOs), 
that can potentially act as CRMs (Fig.10C) (Zuniga et al., 2004).  
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5. Aims of the Thesis 
During embryonic development, genomic cis-regulatory landscapes integrate inputs 
from multiple signaling pathways to control cell specification, determination and 
differentiation. Understanding the spatio-temporal and tissue-specific control of genes 
expression involves the identification of the cis-regulatory modules necessary for 
their activity and of the trans-acting factors required to activate or repress these 
genes.  
 
In my PhD project I became interested in transcriptional gene regulation during 
mouse limb bud and heart morphogenesis. The first part of this thesis focuses on 
limb bud development and more specifically on components of the Bone 
Morphogenetic Protein (BMP) signaling pathway. The aims of this first part were: (1) 
to analyze the role of the BMP signal transducer SMAD4 during limb bud 
chondrogenesis using in vitro differentiation systems; (2) to study the role of a highly 
conserved region in the cis-regulatory landscape of Grem1 by analyzing its reporter 
activity in transgenic wild-type and mutant embryos (the publications that include the 
results from these two projects are directly presented in this thesis in their published 
version); (3) to globally dissect the transcriptional networks regulated by SMAD4 
during chondrogenesis and to identify the cis-regulatory modules interacting with 
SMAD4 in the Grem1 genomic landscape. Due to the lack of suitable anti-SMAD4 
antibodies for ChIP-Seq, I used cassette exchange and homologous recombination 
approaches in embryonic stem cells to generate a new mouse line that expresses an 
epitope-tagged SMAD4 protein from its endogenous locus.  
 
In the second part of this thesis, my aim was to identify the direct transcriptional 
targets of the essential transcription factor HAND2 during heart development. 
Towards this aim I analyzed ChIP-Seq data previously generated in the laboratory 
using a mouse endogenously expressing an epitope-tagged HAND2 protein. By 
combining gene and protein expression analysis with cellular resolution, ChIP-qPCR 
and transgenic reporter studies, I was able to define the regulatory network controlled 
by HAND2 during second heart field development and in the formation of the cardiac 
cushions. 
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6. Results 
 
6.1. From cis-regulatory modules to trans-acting factors: control of 
Grem1 genomic landscape during limb bud development and 
generation of Smad43xFLAG mice by homologous recombination 
 
6.1.1. Paper 1: “Smad4 is required to induce digit ray primordia and to initiate 
the aggregation and differentiation of chondrogenic progenitors in 
mouse limb buds” 
This publication focuses on the conditional deletion of Smad4 from the limb buds 
mesenchyme using Prx1-Cre mice. I carried out the analysis of the high-density in-
vitro limb mesenchymal cell cultures isolated from wild-type and Smad4-deficient limb 
buds shown in Figure 6. 
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INTRODUCTION
Bone morphogenetic proteins (BMPs) are ligands belonging to the
transforming growth factor beta (TGF) superfamily, which control
inductive processes in early embryos and during organogenesis
(reviewed by Zakin and De Robertis, 2010) and are required for
chondrogenesis, growth and ossification of bones in vertebrates
(reviewed by Wu et al., 2007). BMP ligands interact with two types
of BMP receptors (BMPR1 and BMPR2), which in turn trigger
intracellular signal transduction by phosphorylation of the receptor-
associated SMAD1, -5 and -8 proteins. These in turn form a
complex with SMAD4, an essential mediator of both canonical
BMP and TGF signal transduction (Yang et al., 2002). These
SMAD complexes translocate to the nucleus and regulate the
expression of target genes in concert with other transcriptional
regulators (Feng and Derynck, 2005). Genetic and functional
analysis of mouse and chicken limb bud development has
uncovered important morphoregulatory functions of the BMP
pathway in the establishment and functioning of the two limb bud
signaling centers, namely sonic hedgehog (SHH) signaling by the
posterior mesenchymal organizer and fibroblast growth factor
(FGF) signaling by the apical ectodermal ridge (AER).
During limb bud outgrowth, BMPs and the BMP antagonist
gremlin 1 (GREM1) control the epithelial-mesenchymal signaling
interactions that coordinate outgrowth with patterning and
determination of digit identities (reviewed by Zeller et al., 2009).
During the onset of limb bud development, BMP4 is first required
in the mesenchyme and BMPR1A in the ectoderm for formation of
the AER, as inactivation of these molecules disrupts establishment
of the AER-FGF signaling centre, which results in limb truncations
and loss of dorsoventral polarity (Ahn et al., 2001; Pizette et al.,
2001; Pajni-Underwood et al., 2007; Bénazet et al., 2009). During
initiation of limb bud outgrowth, the SHH signaling centre is
established and restricted to the posterior mesenchyme under the
influence of BMP signaling (Bastida et al., 2004). Concurrently,
BMP4 triggers expression of the BMP antagonist Grem1 in the
posterior limb bud mesenchyme, which causes rapid lowering of
mesenchymal BMP activity (Nissim et al., 2006; Bénazet et al.,
2009). The subsequent distal-anterior expansion of the Grem1
expression domain depends largely on its positive regulation by
AER-FGF and SHH signaling. This self-regulatory
SHH/GREM1/AER-FGF feedback loop coordinates
anteroposterior (AP) with proximodistal (PD) limb bud outgrowth
and patterning (Zúñiga et al., 1999; Michos et al., 2004; Panman et
al., 2006; Bénazet et al., 2009; Probst et al., 2011).
During limb bud outgrowth, low mesenchymal BMP activity is
required to restrict the length of the AER, as inactivation of Bmp4
during this developmental period results in extended AER-FGF
signaling and digit polydactyly (Selever et al., 2004; Bénazet et al.,
2009). As inactivation of Bmpr1a in the mesenchyme also disrupts
limb bud outgrowth (Ovchinnikov et al., 2006), tight control of
BMP activity is required for normal progression of limb
development (reviewed by Zeller et al., 2009).
These signaling interactions are terminated as the
SHH/GREM1/AER-FGF feedback signaling system breaks down
owing to progressive inhibition of Grem1 expression by high AER-
FGF levels and the increasing separation of the Shh and Grem1
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SUMMARY
SMAD4 is an essential mediator of canonical TGF/BMP signal transduction and we inactivated Smad4 in mouse limb buds from early
stages onward to study its functions in the mesenchyme. While this Smad4 inactivation did not alter the early Sox9 distribution,
prefiguring the chondrogenic primordia of the stylopod and zeugopod, it disrupted formation of all Sox9-positive digit ray
primordia. Specific inactivation of Smad4 during handplate development pointed to its differential requirement for posterior and
anterior digit ray primordia. At the cellular level, Smad4 deficiency blocked the aggregation of Sox9-positive progenitors, thereby
preventing chondrogenic differentiation as revealed by absence of collagen type II. The progressive loss of SOX9 due to disrupting
digit ray primordia and chondrogenesis was paralleled by alterations in genes marking other lineages. This pointed to a general
loss of tissue organization and diversion of mutant cells toward non-specific connective tissue. Conditional inactivation of Bmp2 and
Bmp4 indicated that the loss of digit ray primordia and increase in connective tissue were predominantly a consequence of disrupting
SMAD4-mediated BMP signal transduction. In summary, our analysis reveals that SMAD4 is required to initiate: (1) formation of the
Sox9-positive digit ray primordia; and (2) aggregation and chondrogenic differentiation of all limb skeletal elements.
KEY WORDS: BMP signaling, Limb bud, Mouse
Smad4 is required to induce digit ray primordia and to
initiate the aggregation and differentiation of chondrogenic
progenitors in mouse limb buds
Jean-Denis Bénazet1,*,‡, Emanuele Pignatti1,‡, Ashleigh Nugent1, Erkan Unal1,2, Frédéric Laurent1 and 
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expression domains (Scherz et al., 2004; Verheyden and Sun, 2008).
This termination results in a renewed increase in BMP activity during
development of the digit ray primordia (giving rise to metacarpals
and phalanges) (Bénazet et al., 2009), which probably serves two
purposes: first, to control digit identity by signaling from the
interdigit mesenchyme to the distal phalanx-forming region (PFR)
(Dahn and Fallon, 2000; Suzuki et al., 2008; Witte et al., 2010), and
second, to induce apoptosis of the interdigit mesenchyme
(Bandyopadhyay et al., 2006; Pajni-Underwood et al., 2007;
Maatouk et al., 2009; Wong et al., 2012). In agreement with these
dynamic changes in BMP activity, BMPs inhibit chondrogenic
differentiation of early limb bud mesenchymal progenitors while
promoting chondrogenesis at late stages (Karamboulas et al., 2010).
Noggin-mediated BMP antagonism under experimental conditions
showed that BMPs are required to initiate compaction and
chondrogenic differentiation of Sox9-positive mesenchymal
progenitors (Brunet et al., 1998; Pizette and Niswander, 2000; Barna
and Niswander, 2007). Genetic inactivation of both Bmp2 and Bmp4
in the limb bud mesenchyme disrupted formation of the two
posterior-most digit primordia and the ulna (Bandyopadhyay et al.,
2006). Experimental evidence indicated that BMPs participate in
activating Sox9 expression in prechondrogenic progenitors, and Sox9
not only marks the chondrogenic lineage but is essential to initiate
chondrogenesis during formation of skeletal elements (Bi et al.,
1999; Akiyama et al., 2005; Pan et al., 2008).
Genetic analysis of the BMP pathway during chondrogenesis
established that BMP signaling and antagonism are required
recurrently for the proliferation of prechondrogenic progenitors,
chondrocyte differentiation, shaping the skeletal primordia and
formation of the endochondral growth plate (Brunet et al., 1998;
Kobayashi et al., 2005; Yoon et al., 2005). In parallel,
mesenchymal cells receiving different signals are specified as
tendons, ligaments and connective tissues. For example,
chondrogenic differentiation is inhibited and mesenchymal cells
remain in a proliferative, undifferentiated state when they are
exposed to both ectodermal WNT and AER-FGF signaling,
whereas WNT signaling alone promotes the development of non-
specific connective tissue (ten Berge et al., 2008; Gros et al., 2010).
TGF ligands are expressed from early limb bud stages onward,
and inhibition of TGF signal transduction in cultured
mesenchymal cells provided evidence that TGF signaling
functions in early limb buds to alleviate the inhibitory effects of
BMPs on initiation of chondrogenic differentiation (Karamboulas
et al., 2010). Therefore, brief exposure of mesenchymal progenitors
to TGFsignaling seems necessary to allow subsequent induction
of chondrogenesis by BMPs (Roark and Greer, 1994; Karamboulas
et al., 2010). Furthermore, implantation of TGF1-loaded beads
into the interdigit mesenchyme of chicken limb buds is able to
induce formation of ectopic digit phalanges, i.e. trigger ectopic
chondrogenesis (Merino et al., 1999; Lorda-Diez et al., 2011).
Genetic analysis of TGF ligands and receptors in mouse embryos
has revealed their essential roles during limb long bone, joint and
tendon morphogenesis (Sanford et al., 1997; Seo and Serra, 2007)].
Although this genetic analysis revealed essential functions during
limb skeletal development, it is possible that earlier functions in
initiating chondrogenesis were masked by functional
complementation among TGF and/or BMP ligands and receptors
(see e.g. Karamboulas et al., 2010).
As Smad4-deficient (Smad4/) embryos die during gastrulation
(Chu et al., 2004), we used a conditional loss-of-function allele
(Yang et al., 2002) to study its requirement in the limb bud
mesenchyme. Prx1-Cre-mediated conditional inactivation of
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Smad4 in limb bud mesenchyme resulted in the clearance of
SMAD4 protein during early limb bud outgrowth, and the
distribution of Sox9 transcript and SOX9 protein was normal until
at least embryonic day (E) 11.0 in the proximal mesenchyme. By
contrast, Sox9 expression was not activated in the distal Smad4-
deficient limb bud mesenchyme that would normally give rise to
the digit ray primordia. The analysis of SOX9 also indicated that
with the exception of a small proximal aggregate, the aggregation
and condensation of all mesenchymal progenitors to form the
cartilage elements was disrupted in Smad4-deficient limb buds.
Mutant cells failed to deposit extracellular collagen type II (COL
type II) fibres, a hallmark of chondrogenesis, and progressively lost
SOX9, i.e. chondrogenic lineage. In parallel, the expression of
markers for other mesenchymal lineages was upregulated in
Smad4-deficient limb buds without their normal spatial restriction,
which provided evidence for a diversion of Smad4-deficient
progenitors toward non-specific connective tissue.
MATERIALS AND METHODS
Ethics statement concerning animal experiments and mouse
strains
Animal experiments were approved by the legally required regional
commission in strict accordance with Swiss law. All studies were classified
as grade zero, which implies minimal suffering. The 3R and Basel
Declaration principles were implemented. The Prx1-Cre was used to
conditionally inactivate Smad4 (Smad4flox) (Yang et al., 2002) in the
mesenchyme from early limb bud stages onward (Logan et al., 2002), and
the Hoxa13Cre/+ knock-in allele was used for autopod specific inactivation
(Lopez-Rios et al., 2012; Scotti and Kmita, 2012). Prx1-Cre-mediated
inactivation of Bmp2 and Bmp4 was done as described (Bandyopadhyay et
al., 2006).
In situ hybridization and skeletal preparations
Whole-mount in situ hybridization was performed using standard
protocols. Control and experimental embryos were age-matched by
counting somites. To assess the clearance of Smad4 transcript in Smad4-
deficient limb buds, a probe against the deleted region, coding exon 8
(Yang et al., 2002) was used for hybridization. Depending on the analysis,
Smad4+/+, Smad4+/flox, Smad4flox/flox or Smad4!M/+ Prx1-Cretg/+ or
Hoxa13Cre/+ heterozygous embryos were used as controls and collectively
referred to as ‘wild-type controls’. Alcian Blue and Alizarin Red were used
to reveal cartilage and bone.
Optical projection tomography
Optical projection tomography (OPT) imaging (Sharpe et al., 2002) was
used to acquire 3D images and prepare optical sections. RNA hybrids were
detected using nitro-blue tetrazolium and 5-bromo-4-chloro-3"-
indolyphosphate (NBT/BCIP, Roche). Whole-mount immunofluorescence
analysis was done as follows: embryos were permeabilized in cold acetone
(15-30 minutes) and then incubated in blocking solution (PBT with 1%
bovine serum albumin, 1% dimethyl sulfoxide and 5% inactivated bovine
serum) for 20 minutes. SMAD4 was detected using rabbit monoclonal anti-
SMAD4 antibodies, 1:50 in blocking solution (Abcam; 12 hour incubation
at 4°C). Samples were washed extensively and incubated with secondary
antibodies Alexa Fluor 594-conjugated anti-rabbit antibody, 1:250
(Invitrogen; overnight at 4°C). Subsequently, samples were embedded in
1% low melting point agarose (Sigma), dehydrated in 100% methanol and
cleared in BABB. Samples were scanned either at high (1024#1024
pixels) or intermediate resolution (512#512 pixels) in the Bioptonics OPT
scanner using Skyscan software (Bioptonics, MRC Technology). The
GFP1 filter (425/40 nm, 475 nm LP) was used to detect sample anatomy.
No filter (bright field) or the TXR filter (560/40 nm, 610 nm LP) was used
to image NBT/BCIP signals or fluorescently labeled samples, respectively.
OPT scans were reconstructed using NRecon software (SkyScan) and
analysed using the Bioptonics Viewer. Rendering images were taken using
the maximum intensity projection function. For generation of iso-surfaces,
the iso-surface editor of the Bioptonics viewer program was used at 25% D
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iso-surface quality and 50% Gaussian smoothing parameters. Iso-surface
values were determined and compared with the strength and distribution of
the original signal to exclude aberrant iso-surfaces.
Quantification of transcript levels by quantitative real-time PCR
Forelimbs were isolated at E10.5 (35-39 somites) and E11.75 (51-53
somites) and analysed (Bénazet et al., 2009) using the primers listed in
supplementary material Table S1. At least eight samples per stage and
genotype were analysed. All results shown are mean±SD; each dot
represents one sample, and the significance of all differences was verified
using the two-tailed non-parametric Mann-Whitney U-test.
Immunofluorescence analysis
Embryos or forelimb buds were isolated and fixed in 4% PFA overnight at
4°C. Samples were dehydrated stepwise into 100% ethanol, then
transferred to xylene. Subsequently, samples were embedded in Paraplast
wax (Sigma) and sectioned following standard procedures. For most
antibodies, antigen retrieval was achieved by heating the dewaxed sections
at 121°C in 1 atm for 6 minutes in a desktop autoclave. The COL type II
antigen was retrieved by digesting sections with pepsin (1 mg/ml in 10 mM
HCl, pH 2.0) for 15 minutes (37°C). Sections were blocked using PBS
containing 0.3% Triton X-100 and 1% BSA (blocking solution; 1 hour at
room temperature). Following pre-treatment, sections were incubated with
primary antibodies (blocking solution overnight at 4°C). The following
primary antibodies were used: rabbit polyclonal anti-Ki67 1:200
(Millipore); rabbit polyclonal anti-Sox9 1:500 (Millipore); mouse
monoclonal anti-collagen type-II 1:100 (Thermo Scientific); rabbit
polyclonal anti-collagen type-I 1:500 (Abcam). Immunocomplexes were
detected using the following secondary antibodies (1 hour at room
temperature): goat anti-rabbit Alexa Fluor 594 1:500 (Invitrogen), goat
anti-mouse Alexa Fluor 488 1:200 (Invitrogen). Apoptotic cells were
detected by whole-mount Lysotracker analysis (Invitrogen) as previously
described (Benazet et al., 2009).
Limb mesenchymal cell culture and immunofluorescence
Forelimbs were dissected in ice-cold PBS, and 2% trypsin digestion (25
minutes at 4°C) in combination with gently pipetting resulted in single cell
preparations of mesenchymal cells that were plated in DMEM/F12 medium
(supplemented with 0.5% penicillin/streptomycin and 10% FBS, Gibco-
BRL) at 7.5!105 cells/300 l in eight-well chamber slides (Ibidi). After
48 hours’ culturing, samples were washed in PBS and fixed in 4% PFA (30
minutes at room temperature) before permeabilization and antigen
detection as described above. BMP signaling was specifically inhibited by
adding 10 M dorsomorphin (Yu et al., 2008) and TGF signaling was
inhibited by adding 10 M SB431542 (Inman et al., 2002) in 0.1% DMSO
(final concentration in medium). Control cells were cultured in medium
containing 0.1% DMSO. Media were refreshed every 24 hours. The results
shown are representative of eight independent experiments (supplementary
material Fig. S5). Inhibition of p38, which is involved in non-canonical
BMP signal transduction, had no effect on cell aggregation and the onset
of chondrogenic differentiation (data not shown).
RESULTS
Requirement of mesenchymal Smad4 for
propagation of the SHH/GREM1/AER-FGF feedback
loop during mouse limb bud development
Prx1-Cre-mediated conditional inactivation of Smad4 in the
mesenchyme (Smad4"/"M) resulted in fore- and hindlimbs lacking
skeletal elements (Fig. 1A). Stunted paddles replaced the autopod
with digits at embryonic day E14.5 (Fig. 1B, arrowheads). As this
initial analysis pointed to a late onset phenotype, the clearance of
Smad4 gene products was assessed (Fig. 1C,D; supplementary
material Fig. S1A). Mesenchymal transcripts were undetectable by
~E9.5 (Fig. 1C) and proteins from ~E9.75 onward in Smad4"/"M
forelimb buds (Fig. 1D). As the Prx1-Cre transgene is activated in
Fig. 1. Prx1-Cre-mediated inactivation of Smad4
in mouse forelimb bud mesenchyme. (A)Skeletal
preparations at embryonic day E14.5. Note the
absence of all skeletal elements including the scapula
in Smad4"/"M forelimbs (FL) and formation of only a
rudimentary pelvic girdle in mutant hindlimbs (HL).
(B)Brightfield images of wild-type and Smad4"/"M
embryos at E14.5 to reveal the paddle-like limb
morphology. (C)Smad4 transcript distribution (blue-
purple staining) in wild-type, Smad4"/+ and
Smad4"/"M forelimb buds at E9.5 (23-24 somites).
Smad4 transcript levels are reduced in Smad4"/+
forelimb buds and cleared in Smad4"/"M forelimb
buds. (D)Detection of SMAD4 protein (green
fluorescence) by whole-mount antibody staining in
wild-type (29 somites) and Smad4"/"M forelimb buds
at E9.75 (27 somites). SMAD4 levels are also reduced
along the primary axis, as only one Smad4 allele is
functional in Smad4"/"M embryos. The broken line
indicates the approximate position of the virtual OPT
section shown in the right-most panel. SMAD4 is lost
from the mutant mesenchyme, whereas AER
expression remains (arrowheads). (E)Msx2, a direct
transcriptional target of BMP signaling, is
downregulated in Smad4"/"M forelimb buds by E9.75
(26 somites). 1-5: digits 1-5; f, femur; h, humerus; p,
pelvis; p*, rudimentary pelvis; r, radius; s, scapula; t,
tibia; u, ulna.
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the forelimb bud territory before E9.0 (Logan et al., 2002), the
complete functional inactivation of Smad4 in forelimb buds required
~18 hours. In agreement with these inactivation kinetics, the
expression of the BMP target Msx2 was reduced from ~E9.75
onward (Fig. 1E; supplementary material Fig. S1B). By contrast, the
three main Bmp ligands were either unchanged or slightly increased
in mutant limb buds (supplementary material Fig. S2).
Previous analysis provided evidence that activation and initial
upregulation of Grem1 expression in the limb bud mesenchyme
depended on BMP4 signaling (Nissim et al., 2006; Bénazet et al.,
2009). In Smad4!/!M forelimb buds, Grem1 expression was
reduced, but its posterior domain was maintained at E10.25 (Fig.
2A). To discriminate between SMAD4-independent regulation and
the well-characterized positive regulation of Grem1 expression by
SHH signaling (Zúñiga et al., 1999; Panman et al., 2006),
forelimb buds lacking both Shh and Smad4 were analysed. In
contrast to the low expression in Shh!/! forelimb buds (Fig. 2B,
left panel), Grem1 expression was lost from Shh!/!Smad4!/!M
forelimb buds (Fig. 2B, right panel). These results showed that
Grem1 expression in the limb bud mesenchyme is positively
regulated by both SHH and SMAD4-mediated signal transduction.
Contrary to Grem1, Shh expression and signal transduction
appeared normal (Fig. 2C and data not shown), whereas the AER-
Fgf8 expression domain was broadened and levels increased from
~E10.5 onward in Smad4!/!M forelimb buds (Fig. 2D). This
analysis showed that mesenchymal Smad4 is either not required,
or its functional inactivation occurred too late to disrupt
establishment of the AER-Fgf8 expression domain (Bénazet et al.,
2009), in contrast to its direct requirement in the AER (Bénazet
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and Zeller, unpublished). As the SHH/GREM1/AER-FGF
signaling system terminated in wild-type limb buds, the
expression of both Shh (Fig. 2E) and AER-Fgfs (Fig. 2F) persisted
in Smad4!/!M forelimb buds. Rather unexpected from previous
analysis (Scherz et al., 2004; Verheyden and Sun, 2008), these
results reveal that mesenchymal Smad4 is required for correct
termination of the epithelial-mesenchymal feedback signaling
system. In agreement with the initially normal progression of limb
bud development, no striking alterations in cell proliferation were
apparent in Smad4!/!M forelimb buds (supplementary material
Fig. S3A). However, apoptosis of core mesenchymal cells was
increased up to ~E11.5, whereas apoptosis in mutant handplates
was suppressed because of the absence of the interdigit
mesenchyme (supplementary material Fig. S3B; Fig. 3).
The spatiotemporal expression of the 5"-most HoxD and HoxA
genes, which regulate limb bud patterning and outgrowth (reviewed
by Zakany and Duboule, 2007) was not significantly altered up to
E11.5 (data not shown). Fig. 3 shows the expression of select
markers for the autopod, digit and interdigit territories. Hoxa13
correctly delineated the presumptive autopod territory in mutant
limb buds, but none of the putative digit primordia were outlined
(Fig. 3A). Cyp26b1 is normally expressed in the distal part of all
digit primordia including the PFRs (Fig. 3B) (Yashiro et al., 2004).
Smad4!/!M forelimb buds lacked these PFR-like expression
domains and Cyp26b1 was largely confined to the anterior and
posterior margins (Fig. 3B). Dlx5 is normally expressed by the
AER and interdigit mesenchyme in wild-type limb buds (Robledo
et al., 2002), but its expression was confined largely to the AER in
Smad4!/!M forelimb buds (Fig. 3C). These results indicated that
Fig. 2. Effect of mesenchymal Smad4
deficiency on the SHH/GREM1/AER-FGF
feedback loop. (A,B)Grem1 expression in
wild-type, Smad4!/!M, Shh!/! and Shh!/!
Smad4!/!M forelimbs at E10.25 (31-32
somites). (C)Shh expression is not
significantly altered in Smad4!/!M forelimb
buds at E10.5 (35 somites). (D)Expression of
Fgf8 in wild-type and Smad4!/!M forelimb
buds at E10.5 (35 somites). Right panel:
qPCR-based quantification of Fgf8 levels in
forelimb buds at E10.5. Expression is
significantly higher in Smad4!/!M than wild-
type forelimbs (P0.01). Data are shown as
mean±SD. (E,F)Termination of Shh (E) and
AER-Fgf (F) expression is delayed in
Smad4!/!M forelimb buds. The black
arrowheads indicate the prolonged Shh
(E11.75, 50 somites and E12.5, 60 somites)
and anterior AER-Fgf4 expression (at E11.75,
50 somites) in mutant limb buds.
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separation of the mutant mesenchyme into digit ray primordia and
interdigit mesenchyme was disrupted in Smad4!/!M autopods.
Smad4 is required to induce formation of the
Sox9-positive digit ray primordia
Sox9 marks prechondrogenic progenitors from early limb bud
stages onward. As Sox9 prefigures the formation of all
mesenchymal condensations that initiate chondrogenesis and give
rise to the skeletal primordia (Bi et al., 1999; Akiyama et al., 2005),
its expression was assessed (Fig. 4). Despite the early
mesenchymal loss of Smad4 and disruption of BMP signal
transduction (Fig. 1B-D), the Sox9 transcript distribution remained
comparable to wild-type controls until at least E11.0 (Fig. 4A, left
panels). These results indicated that SMAD4 is not required for
activation and patterning of Sox9 during the developmental period
characterized by low BMP activity (Bénazet et al., 2009). The
Sox9-positive progenitors in the proximal mesenchyme normally
give rise to the cartilage elements of the scapula, stylopod
(humerus) and zeugopod (radius and ulna). In wild-type forelimb
buds, the Sox9-positive progenitors giving rise to the carpals and
digit rays (metacarpals and phalanges) were apparent by ~E11.5,
and the Sox9-positive digit ray primordia of all except digit 1 had
formed by ~E12.25 (Fig. 4A, upper right panels) (Zhu et al., 2008).
In Smad4!/!M limb buds, the distalmost zone of Sox9-negative
mesenchyme expanded (Fig. 4A, brackets) and Sox9 expression
was progressively lowered (Fig. 4A, right-most lower panel). This
downregulation was paralleled by a complete loss of the Sox9-
positive primordia corresponding to carpals and digit rays (Fig.
4A,B). By E12.25, the characteristic Sox9-positive domains
prefiguring all of the chondrogenic limb skeletal elements were
largely lost from Smad4!/!M limb buds (Fig. 4A, right-most
panels). By E13.5, only very low Sox9 expression remained in
Smad4!/!M limb buds, whereas Sox9 was abundant in the PFRs and
phalanges of all wild-type digits (supplementary material Fig.
S4A). To gain further insight, OPT (Sharpe et al., 2002) was used
in combination with iso-surface rendering for comparative analysis
of the Sox9 transcript distribution in wild-type and Smad4!/!M
forelimb buds. This analysis revealed thinning of the distal arch of
Sox9-positive cells (Fig. 4B, brackets), whereas the proximal
domain was enlarged in Smad4!/!M forelimb buds (Fig. 4B,
arrowheads; better seen in supplementary material Movie 1).
The requirement of Smad4 for formation of the Sox9-positive
digit rays could be transient, as evidenced by the kinetics of
Hoxa13Cre/+-mediated conditional inactivation of either one
(Smad4!/!A13) or both Smad4 alleles (Fig. 4C, Smad4!A13/!A13;
supplementary material Fig. S4). Inactivation of Smad4 using the
Hoxa13Cre/+ knock-in allele (Scotti and Kmita, 2012) resulted in the
progressive clearance of Smad4 transcripts during autopod
development and specific agenesis of the autopod skeleton
(supplementary material Fig. S4B,C). The functional loss of Smad4
should be faster in Smad4!/!A13 than Smad4!A13/!A13 forelimb
buds, as two conditional alleles have to be inactivated and twice as
much SMAD4 proteins cleared in the latter (Bénazet et al., 2009).
As only one Hoxa13 allele is functional in mouse embryos carrying
the Hoxa13Cre/+ knock-in, we first established that formation of
digit ray primordia was not altered in Hoxa13Cre/+ and
Hoxa13Cre/+Smad4!A13/+ forelimb buds (Fig. 4C). However, only
the two posteriormost digit ray primordia were apparent in
Smad4!/!A13 forelimb buds, whereas the primordia of digit rays 2-
5 formed in all Smad4!A13/!A13 forelimb buds (Fig. 4D). These
results indicated that morphogenesis of anterior digit ray primordia
could require Smad4 for longer or at a later stage than posterior
primordia.
SOX9-positive mesenchymal progenitors fail to
aggregate and initiate chondrogenic
differentiation of all cartilage elements in
Smad4!/!M limb buds
As whole-mount RNA in situ hybridization analysis did not
provide cellular resolution, the SOX9 protein distribution was
analysed on serial sections of forelimb buds (Fig. 5, red
fluorescence). At E10.5, scattered SOX9-positive mesenchymal
cells were detected mainly in the core of both wild-type and
Smad4!/!M forelimb buds (Fig. 5A,B). By E11.75, SOX9-positive
progenitors condensed to initiate formation of the cartilage
elements of the humerus and the ulna/radius and the posterior digit
4 in wild-type limb buds (Fig. 5C) (Zhu et al., 2008). In Smad4!/!M
forelimb buds, a small proximal condensation was apparent (Fig.
5D, arrowhead), but most SOX9-positive cells remained loose and
in a pattern reminiscent of the Sox9-positive distal arch (compare
Fig. 5D and Fig. 4A). During subsequent development, no
organized mesenchymal condensations and cartilage elements
formed in Smad4!/!M forelimb buds (Fig. 5E-H). Rather, the small
proximal condensation disappeared and SOX9-positive cells
dispersed throughout the distal mesenchyme (Fig. 5F,H). Taken
together, this analysis indicated that aggregation of the SOX9-
positive progenitors to initiate chondrogenic differentiation and
Fig. 3. Mesenchymal Smad4 inactivation disrupts the spatial
distribution of genes that mark specific autopod territories.
(A)Hoxa13 expression at E12.5 (60 somites). In wild-type forelimb
buds, the distal parts of the developing digits and perichondria express
the highest levels of Hoxa13 transcript. In Smad4!/!M forelimb buds,
Hoxa13 expression is distally restricted but not localized to specific
structures. (B)Cyp26b1 marks the PFRs of all developing digit primordia
in wild type, whereas no differential expression is apparent in
Smad4!/!M forelimb buds. (C)Dlx5 is expressed by the AER, sub-
ectodermal mesenchyme, and the interdigit mesenchyme in wild type,
which is lacking in Smad4!/!M forelimb buds. The wild-type digit ray
primordia are labelled 1 (thumb) to 5 (little finger).
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formation of cartilage elements was disrupted in Smad4-deficient
forelimb buds.
To gain further insight into the underlying cellular defects,
wild-type and mutant mesenchymal cells were dissociated from
limb buds at E11.5 and high-density cultures were used to assess
their chondrogenic differential potential (Barna and Niswander,
2007). A hallmark of chondrogenic differentiation is the
transcriptional activation of Col2a1, a direct transcriptional
target of SOX9 that encodes the pro-alpha1(II) chain of COL
type II, which is cartilage-specific (Bell et al., 1997; Lefebvre et
al., 1997). In wild-type mesenchymal cultures, cells aggregated
and compacted to form the typical cell-dense condensations
often paralleled by reduced SOX9 expression, and the onset of
chondrogenesis was revealed by abundant COL type II (Fig. 6A).
By contrast, no COL type II was detected in areas of less densely
packed cells (Fig. 6A, enlargements), which revealed that
chondrogenesis was initiated in regions with high mesenchymal
cell density, i.e. after cells had aggregated. By contrast, slightly
lower levels of SOX9 were consistently detected in
mesenchymal cells isolated from Smad4!/!M forelimb buds,
which failed to aggregate and produce COL type II fibres (Fig.
6B). This failure of Smad4-deficient mesenchymal cells to
aggregate appeared more severe than the effects of Noggin-
mediated inhibition of BMP activity in limb bud mesenchymal
cells, which aggregate but fail to undergo subsequent compaction
and initiation of chondrogenesis (Barna and Niswander, 2007).
To gain further insight, we selectively inhibited BMP type I
receptors and thereby BMP signal transduction using
Dorsomorphin (Yu et al., 2008), which disrupted condensation
and COL type II expression of wild-type cells similar to
Smad4!/!M cells (compare supplementary material Fig. S5B and
Fig. 6B). Inhibiting TGF receptors with the selective antagonist
SB431542 (Inman et al., 2002) blocked cell aggregation and
COL type II deposition to a similar extent (supplementary
material Fig. S5B) (Karamboulas et al., 2010). These results
indicated that BMP and TGF signal transduction were both
required for initiating chondrogenesis of mesenchymal
progenitors in culture.
As these experiments revealed striking effects on deposition of
extracellular COL type II fibres, the extent to which Col2a1
expression might be altered in Smad4!/!M forelimb buds was
determined (Fig. 7A). At E11.5, the Col2a1 transcript distributions
in wild-type and mutant forelimb buds were similar and
comparable to Sox9 at this stage (compare Fig. 7A, left panels and
Fig. 4A). As autopod development progressed, Col2a1 was
expressed abundantly by all skeletal elements including digit rays
in wild-type limb buds (Fig. 7A, upper panels). By contrast,
Col2a1 expression remained diffuse and was progressively lost
Fig. 4. Induction of Sox9-positive digit progenitors
and maintenance of Sox9 expression are disrupted
in Smad4!/!M forelimb buds. (A)Spatial distribution of
Sox9 transcript in wild-type (upper panels) and Smad4-
deficient forelimb buds. (B)Iso-surface rendering of the
Sox9 expression domains by OPT analysis. This reveals the
progressive thinning of the distal arch (white brackets) and
absence of Sox9-positive digit primordia in Smad4-
deficient forelimb buds. By contrast, the Sox9 expression
domain probably corresponding to the zeugopod appears
thickened (white arrowheads). (C)Heterozygosity for the
Hoxa13Cre/+ allele alone (S4+/+) or in combination with
inactivation of one Smad4 allele (S4!A13/+) has no effect
on Sox9-positive digit ray primordia. (D)Hoxa13Cre/+-
mediated conditional inactivation of either one (S4!/!A13)
or both Smad4 alleles (S4!A13/!A13) during autopod
development reveals the differential effects on posterior
and anterior digit ray primordia. E10.0: 30-32 somites;
E11.0: 41 somites; E11.5: 44 somites; E12.0: 50 somites.
E12.25-12.5: 53-57 somites. Primordia are indicated as
follows: 1-5, primordia of digit rays 1-5; a, autopod; h,
humerus; r, radius; s, scapula; u, ulna;.
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from Smad4!/!M forelimb buds (Fig. 7A, lower panels). Indeed,
high levels of COL type II protein were detected in all
chondrogenic primordia of the skeletal elements in wild-type limb
buds, whereas only few scattered positive clusters were detected in
Smad4!/!M limb buds (Fig. 7B). Taken together, this analysis (Figs
5-7) revealed the disruption of chondrogenesis and absence of all
cartilage elements prefiguring the limb skeleton in Smad4!/!M
forelimb buds.
To determine the extent to which Smad4-deficient mesenchymal
cells might acquire non-chondrogenic fates, genes marking other
mesenchymal lineages were analysed. Collagen type I (COL type
I) is expressed by diverse connective tissues such as skin, tendons,
ligaments and bones, and muscle-associated connective tissues (see
e.g. ten Berge et al., 2008). In wild-type limb buds, Col1a2 was
detected first in the proximal mesenchyme (Fig. 7C, E11.5). At
later stages, Col1a2 outlined the forming perichondria and tendons
(Fig. 7C, arrowheads). In Smad4!/!M forelimb buds, Col1a2
transcript and protein were detected throughout the mesenchyme
(Fig. 7C,D, lower panels). COL type I localized to the
perichondrium and developing dermis in wild type (Fig. 7D, upper
panels), whereas its expression appeared more widespread and
disorganized in Smad4!/!M forelimb buds (Fig. 7D, lower panels).
As decorin (Dcn) regulates the assembly of collagen fibres
(Danielson et al., 1997), its expression was analysed. In wild-type
limb buds, the initially rather diffuse Dcn expression became
excluded from the chondrogenic cores of all developing cartilage
elements including digit rays (Fig. 8A, upper panels and data not
shown). By contrast, Dcn expression was enhanced and persisted
throughout the mesenchyme of Smad4!/!M forelimb buds (Fig. 8A,
lower panels; supplementary material Fig. S6A). Possible effects
on Dcn expression were also assessed in forelimb buds lacking
both mesenchymal Bmp2 and Bmp4, as the two posteriormost digit
ray primordia are not formed (Fig. 8B) (Bandyopadhyay et al.,
2006). Analogous to the Smad4 deficiency (Fig. 8A), the absence
of these two digit ray primordia results in uniformly increased
expression of Dcn in the posterior mesenchyme of limb buds
lacking both Bmps (Fig. 8B, posterior region indicated by a
bracket). The striking similarity of these alterations indicates that
formation of the posterior Sox9-positive digit ray primordia and
restriction of Dcn expression depends on BMP signal transduction
that is mediated by SMAD4.
In addition, the expression of the transcriptional regulator
scleraxis (Scx, marking tendon and ligament progenitors)
RESEARCH ARTICLE Development 139 (22)
(Schweitzer et al., 2001) was also increased in Smad4!/!M forelimb
buds (supplementary material Fig. S6B). While Scx marked both
dorsal and ventral tendons in wild-type limb buds (Fig. 8C, upper
panels), its expression was upregulated and diffuse in Smad4!/!M
forelimb buds (Fig. 8C, lower panels). This was paralleled by
widespread and diffuse expression of Fjx1, which normally marks
the attachment points of the forming tendons and the developing
joints (Rock et al., 2005), in Smad4-deficient forelimb buds
(supplementary material Fig. S6C). In addition to tendons and
ligaments, limb skeletal muscles form in concert with the limb
skeletal elements. Analysis of the MyoD distribution (marking all
limb muscle primordia) (Francis-West et al., 2003) showed that
dysplastic skeletal muscles were present in the flank and proximal
part of Smad4-deficient forelimb buds, whereas the distal
mesenchyme was devoid of MyoD-expressing cells (supplementary
Fig. 5. SOX9 protein distribution in wild-type and
Smad4!/!M forelimb buds. (A-H)The distribution of nuclear
SOX9 protein (red) was determined on serial histological
sections of limb buds from E10.5 to E13.5. Nuclei were
counterstained using the DNA dye Hoechst (blue). (A,C,E,G)
Wild-type forelimb buds. (B,D,F,H) In Smad4!/!M forelimb buds,
the SOX9-positive cells fail to aggregate and initiate
mesenchymal condensations. Only a small but transient
proximal condensation is formed (arrowhead in D). White
rectangles indicate the positions of the enlargements shown
below. 1-5, digit ray primordia 1-5; c, carpal primordia; D,
distal; d4, digit 4; h, humerus; P, proximal; r, radius; u, ulna.
Fig. 6. Chondrogenic potential of wild-type and Smad4-deficient
mesenchymal cells. (A)Wild-type limb bud mesenchymal cells
(isolated at E11.5) form chondrogenic condensations after 48 hours in
high-density culture. The peripheral cells of the chondrogenic
condensations express the highest levels of SOX9 (red fluorescence).
Cells in the core often express lower levels of SOX9 and produce COL
type II (green fluorescence). (B)By contrast, Smad4!/!M mesenchymal
cells fail to aggregate and produce COL type II. Cell nuclei were labelled
by Hoechst (blue fluorescence). White rectangles indicate the positions
of the enlargements shown below. D
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material Fig. S6D). Taken together, this analysis revealed the rather
diffuse expression of genes marking diverse non-chondrogenic
lineages and general disruption of tissue organization in Smad4!/!M
forelimb buds, which pointed to diversion of chondrogenic to loose
and non-specific connective tissue (Fig. 8D).
DISCUSSION
Our genetic analysis of mesenchymal Smad4 during mouse limb
bud development uncovers its dual requirement for initiating: (1)
formation of the Sox9-positive digit ray primordia; and (2)
aggregation and chondrogenic differentiation of all Sox9-positive
prechondrogenic progenitors that give rise to the cartilage elements
of the future limb skeleton (Fig. 8D). SMAD4 is essential to induce
chondrogenesis because cell aggregation, which is the first step
toward chondrogenic differentiation, is disrupted and mutant
progenitors remain scattered in Smad4!/!M forelimb buds (Fig. 8D)
(see also Pizette and Niswander, 2000; Barna and Niswander,
2007). By contrast, the expression of Sox9, which prefigures the
primordia of the stylopod and zeugopod, is normal up to at least
E11.0 in Smad4!/!M forelimb buds. A role of SMAD4 in activation
of Sox9 expression in early limb buds cannot be formally excluded,
as the protein is only cleared around the time Sox9 is activated in
Smad4!/!M forelimb buds. Nevertheless, the Smad4-independent
phase of Sox9 expression coincides well with the period of low
BMP activity in mouse limb buds (Bénazet et al., 2009), which
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corroborates the proposal that the spatiotemporal regulation of Sox9
expression does not require SMAD4-mediated signal transduction
before handplate formation (this study). Indeed, it has been
proposed that BMPs inhibit Sox9 expression and initiation of
chondrogenic differentiation in the mesenchyme of early limb
buds; an effect that can be alleviated by short-term exposure to
TGF signaling in culture (Karamboulas et al., 2010). However,
inhibition of BMP or TGF signal transduction in vitro disrupted
chondrogenesis in a similar way to the genetic Smad4 deficiency,
but did not cause complete loss of SOX9 (this study).
In addition to Sox9, the mesenchymal expression of the early
chondrocyte marker Col2a1 is activated normally in Smad4!/!M
forelimb buds. During distal progression of limb bud development,
Col2a1 expression is lost concurrent with the failure to refine
SOX9 protein distribution, as expected from direct transcriptional
regulation of Col2a1 by SOX9 (Bell et al., 1997; Lefebvre et al.,
1997). In Smad4!/!M forelimb buds, the progressive loss of Sox9
and Col2a1 was paralleled by widespread and diffuse expression
of markers for other lineages and a general absence of tissue
organization and differentiation. Therefore, SMAD4 appears to
function in signaling networks that restrict non-chondrogenic
progenitors and connective tissue lineages. In agreement with the
diffuse Scx expression in Smad4!/!M forelimb buds, inhibition of
BMP signaling results in ectopic Scx expression without the
formation of additional tendons (Schweitzer et al., 2001). However,
Fig. 7. Loss of cartilage-specific and increase of connective tissue-type collagens in Smad4!/!M forelimb buds. (A)Col2a1 transcript
distribution in wild-type and Smad4!/!M forelimb buds. In Smad4!/!M forelimb buds, mesenchymal Col2a1 expression in the mesenchyme is similar
to that of wild type up to E11.5, but is lost during subsequent stages. The Col2a1 upregulation in the AER of Smad4!/!M forelimb buds was
reproducibly detected at E11.5. (B)The COL type II distribution (green fluorescence) was assessed on serial histological sections. At E16.5, COL type
II marks all developing limb skeletal elements. In Smad4!/!M forelimb buds, a small but transient cluster positive for COL type II was always detected
(arrowheads). (C)Col1a2 expression in wild-type forelimb buds marks connective tissue, perichondria and developing tendons (arrowheads, upper-
right panel). In Smad4!/!M forelimb buds, Col1a2 expression becomes increasingly widespread and diffuse (lower panels). (D)The COL type I
distribution (red fluorescence) was assessed on serial histological sections. In wild-type forelimb buds, COL type I outlines the perichondria and
dermis. The developing dorsal and ventral tendons are not apparent, as sections through the core mesenchyme are shown. In Smad4!/!M forelimb
buds, most mesenchyme expresses this connective tissue-type collagen by E16.5. Labelling of primordia: 2-5, digit rays c, carpals; h, humerus; r,
radius; u, ulna.
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as both Col1a1 and Col1a2 are positively regulated by SCX
(Cserjesi et al., 1995), the ectopic Scx expression in Smad4!/!M
forelimb buds could contribute to the increased COL type I
expression (this study). These molecular changes and the complete
lack of tissue organization in Smad4-deficient limb buds (Fig. 8D)
indicate that SMAD4 functions in the morphoregulatory networks
that pattern diverse limb bud mesenchymal lineages and/or
orchestrate coordinated tissue differentiation. Taken together, these
studies uncover the recurrent differential requirement of SMAD4-
mediated canonical BMP/TGF signal transduction during
specification and aggregation of SOX9-positive prechondrogenic
progenitors and initiation of their chondrogenic differentiation (Fig.
8D).
Although formation of the Sox9-positive primordia of the
stylopod and zeugopod appears Smad4-independent, the induction
of the Sox9-positive digit ray primordia depends critically on
Smad4 and increased BMP activity (Bandyopadhyay et al., 2006;
Bénazet et al., 2009; Lopez-Rios et al., 2012; this study). As the
proximal Sox9-positive domains are enlarged, the mutant pre-
chondrogenic cells may contribute preferentially to proximal
primordia as evidenced by thinning of the distal arch in Smad4!/!M
forelimb buds (this study). Such a differential requirement of
Smad4 might be of evolutionary relevance as the autopod and
digits of tetrapod limbs are so-called neomorphic structures, whose
development may have relied on co-opting novel gene-regulatory
networks (reviewed by Woltering and Duboule, 2010). Our
analysis indicates that limb bud development and formation of
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Sox9-positive digit ray primordia become Smad4 dependent as
BMP activity rises owing to self-termination of the
SHH/Grem1/AER-FGF signaling system (Scherz et al., 2004;
Verheyden and Sun, 2008; Benazet et al., 2009). During this
developmental period, differential BMP signaling appears to
determine digit identities in both chicken and mouse (Dahn and
Fallon, 2000; Suzuki et al., 2008; Witte et al., 2010). As extensive
genetic analysis of TGF signaling in mouse embryos has not
produced similar phenotypes (see e.g. Sanford et al., 1997; Seo and
Serra, 2007), SMAD4-mediated BMP signal transduction is likely
to be predominant during these advanced stages of digit ray
primordia growth and patterning. It has been proposed that the
progenitors giving rise to the digit ray primordia are recruited from
the distalmost limb bud mesenchyme (Suzuki et al., 2008), which
is defective in Smad4!/!M forelimb buds as revealed by the
increasing gap of Sox9-negative cells in the distal mesenchyme
(this study). In addition, temporally controlled Smad4 inactivation
in the autopod provided evidence for its possible differential
requirement for posterior and anterior digit ray primordia. A region
free of the BMP antagonist GREM1 is generated within the
posterior limb bud mesenchyme by the population of Shh
descendants, which is refractory to Grem1 expression and increases
as limb bud development progresses (Scherz et al., 2004). These
results together with the differential requirement observed in this
study indicate that BMP activity might first rise in the posterior
mesenchyme, where Bmp2 and Bmp4 are co-expressed and
required for digit ray formation (Bandyopadhyay et al., 2006). The
Fig. 8. General loss of tissue organization results in diversion towards fascia-like connective tissue in Smad4!/!M limb buds. (A)Dcn
transcript distribution in wild-type and Smad4-deficient forelimb buds visualized by brightfield microscopy (left) and OPT analysis (right panels). The
positions of the virtual OPT cross-sections are indicated by the broken white lines in the middle panels. (B)Prx1-Cre mediated inactivation of Bmp2
and Bmp4 in the forelimb bud mesenchyme (B2B4!M/!M). Left panels show Sox9 expression at E11.75 (51 somites). Middle and right panels show
OPT analysis of Dcn distribution at E11.75. White brackets mark the relevant posterior part of B2B4!M/!M and wild-type forelimb buds. (C)Scx
transcript distribution in wild-type and Smad4-deficient forelimb buds, which becomes normally restricted to the forming tendons by E12.5. OPT
analysis reveals the diffuse Scx expression extending into the core mesenchyme of Smad4!/!M forelimb buds. (D)SMAD4 is required: (1) for digit ray
formation in the distal mesenchyme; and (2) to induce aggregation and chondrogenic differentiation of all Sox9-positive mesenchymal progenitors.
In Smad4!/!M limb buds, mutant mesenchymal cells remain loose and divert toward non-specific connective tissue lineages.
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mechanism that controls BMP-dependent formation of the digit ray
primordia was recently uncovered (Lopez-Rios et al., 2012).
Inactivation of Gli3 in the developing autopod promoted cell cycle
entry and delayed the exit of digit progenitors to chondrogenesis
due to prolonged GREM1-mediated BMP-antagonism in the
anterior limb bud mesenchyme. Taken together, this indicates that
two distinct mechanisms regulate digit ray formation in the
posterior and anterior handplate via BMP-dependent SMAD4-
mediated signal transduction. The spatiotemporal requirements of
BMPs and SMAD4 for posterior and anterior digit ray primordia
(Bandyopadhyay et al., 2006; Lopez-Rios et al., 2012; this study)
is apparently at odds with the genetic analysis of the temporal
requirement of Shh during mouse limb bud development (Zhu et
al., 2008). This analysis showed that digit ray primordia form with
alternating posterior to anterior sequence (starting with d4, d2, d5
and ending with d3), while digit 1 forms in a SHH-independent
manner. However, these apparent discrepancies are resolved if
BMPs and SMAD4 were transiently required to initiate a posterior
and anterior mesenchymal condensation that would subsequently
give rise to the primordia of digits 4 and 5 and digits 2 and 3,
respectively, following the sequence defined by Zhu et al. (Zhu et
al., 2008).
Finally, BMPs are widely used to induce chondrogenesis in ex
vivo models of cartilage and bone engineering, but outcomes are
often conflicting (Jiang et al., 2010; Sanchez-Adams and
Athanasiou, 2012). In light of the complex regulation of
chondrogenesis during limb bud development, ex vivo
developmental engineering of cartilage and endochondral bone
(Scotti et al., 2010) will probably require activation and inhibition
of BMP signal transduction in a spatiotemporally controlled
manner as revealed by the present study. In particular, this study
highlights the temporal kinetics of the SMAD4 requirement during
formation of the Sox9-positive digit ray primordia and its more
general role in inducing aggregation of the mesenchymal
progenitors during the onset of chondrogenesis, which is key to
developmentally engineering cartilage and bone.
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6.1.2. Paper 2: “Conserved cis-regulatory regions in a large genomic 
landscape control SHH and BMP-regulated Gremlin1 expression in 
mouse limb buds” 
 
In this publication, the three conserved HMCO elements located in the Grem1 cis-
regulatory landscape were tested for their capacity to regulate the expression of 
Grem1 during limb bud development. The analysis focuses on the 9kb region that 
includes HMCO1, termed Grem1 Regulatory Sequence 1 (GRS1). The GRS1 region 
was used to generate stable transgenic mouse lines with LacZ reporter. My 
contribution to this project includes the detailed genomic sequence alignment for the 
HMCOs element in additional species (Figure 1 and Figure S1). I also carried out the 
analysis of GRS1-βglob-LacZ transgene reporter expression in seven transgenic 
founders (data not shown), and the subsequent analysis of GRS1-βglob-LacZ 
reporter expression in stable GRS1tg10/+ and GRS1tg2/+ embryos in wild-type and 
various mutant backgrounds (Figures 4-6 and Figures S2-S4). Finally, I prepared all 
figures and genomic schemes of the manuscript. 
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RESEARCH ARTICLE Open Access
Conserved cis-regulatory regions in a large
genomic landscape control SHH and
BMP-regulated Gremlin1 expression in mouse
limb buds
Aimée Zuniga1*, Frédéric Laurent1, Javier Lopez-Rios1, Christian Klasen2,3, Nicolas Matt1,4 and Rolf Zeller1*
Abstract
Background: Mouse limb bud is a prime model to study the regulatory interactions that control vertebrate
organogenesis. Major aspects of limb bud development are controlled by feedback loops that define a self-regulatory
signalling system. The SHH/GREM1/AER-FGF feedback loop forms the core of this signalling system that operates
between the posterior mesenchymal organiser and the ectodermal signalling centre. The BMP antagonist Gremlin1
(GREM1) is a critical node in this system, whose dynamic expression is controlled by BMP, SHH, and FGF signalling and
key to normal progression of limb bud development. Previous analysis identified a distant cis-regulatory landscape
within the neighbouring Formin1 (Fmn1) locus that is required for Grem1 expression, reminiscent of the genomic
landscapes controlling HoxD and Shh expression in limb buds.
Results: Three highly conserved regions (HMCO1-3) were identified within the previously defined critical genomic
region and tested for their ability to regulate Grem1 expression in mouse limb buds. Using a combination of BAC and
conventional transgenic approaches, a 9 kb region located ~70 kb downstream of the Grem1 transcription unit was
identified. This region, termed Grem1 Regulatory Sequence 1 (GRS1), is able to recapitulate major aspects of Grem1
expression, as it drives expression of a LacZ reporter into the posterior and, to a lesser extent, in the distal-anterior
mesenchyme. Crossing the GRS1 transgene into embryos with alterations in the SHH and BMP pathways established
that GRS1 depends on SHH and is modulated by BMP signalling, i.e. integrates inputs from these pathways. Chromatin
immunoprecipitation revealed interaction of endogenous GLI3 proteins with the core cis-regulatory elements in the
GRS1 region. As GLI3 is a mediator of SHH signal transduction, these results indicated that SHH directly controls Grem1
expression through the GRS1 region. Finally, all cis-regulatory regions within the Grem1 genomic landscape locate to
the DNAse I hypersensitive sites identified in this genomic region by the ENCODE consortium.
Conclusions: This study establishes that distant cis-regulatory regions scattered through a larger genomic landscape
control the highly dynamic expression of Grem1, which is key to normal progression of mouse limb bud development.
Background
During embryonic development, the spatio-temporal ex-
pression of transcriptional regulators and morphogenetic
signals is tightly controlled. In fact, different types of con-
genital malformations are caused by mutations affecting
specific cis-regulatory and non-coding genomic regions
that alter the expression of genes or gene clusters in
specific tissues (reviewed in ref. [1-3]). Genome-wide
functional mapping revealed many of the large genomic
landscapes that control the expression of developmental
regulator genes in a global and tissue-specific manner [4].
This study and others reveal that the cis-regulatory
regions controlling gene expression in a particular tissue
are often located several hundred kilobases (kb) or even
megabases (Mb) up- or downstream of the transcriptional
start sites in other loci, and may control the expression of
several genes [5-7]. Recently, it has been shown how mul-
tiple cis-regulatory regions interact to control the
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expression of the 5’HoxD gene complex in the presump-
tive digit territory. The transcriptionally active part of
the 5’HoxD gene cluster forms a so-called regulatory
archipelago in which dispersed cis-regulatory elements co-
operate to control gene expression in the distal limb bud
by interacting with proximal promoters over large dis-
tances [8]. In fact, regulatory landscapes with distant and
dispersed cis-regulatory regions seem to be a recurring
theme in the dynamic spatio-temporal regulation of genes
that are essential for limb bud development (reviewed in
ref. [2,9,10], see also below).
Vertebrate limb bud development is controlled by
interactions between two main signalling centres, the
apical ectodermal ridge (AER) and the zone of polarizing
activity (ZPA) located in the posterior limb mesenchyme.
These two signalling centres interact as part of a self-
regulatory feedback signalling system involving several sig-
nalling pathways [11]. In particular, ZPA cells produce the
Sonic Hedgehog (SHH) signal, which together with
GREMLIN1-mediated antagonism of Bone Morphogenetic
Proteins (BMPs) in the posterior-distal limb bud mesen-
chyme propagates Fibroblast Growth Factor (FGF) signal-
ling in the AER [11-14]. This SHH/GREM1/AER-FGF
feedback-signalling loop promotes distal progression of
limb bud outgrowth and formation of the autopod which
gives rise to carpals and digit rays (reviewed in ref. [15]).
SHH expression in the posterior limb bud mesenchyme is
controlled by a cis-regulatory region located about 800 kb
upstream of the transcriptional start site. Deletion of this
ZPA regulatory region (ZRS) results in loss of distal limb
structures [16], while point mutations within the ZRS result
in anterior ectopic Shh expression and duplications of the
thumb and/or anterior digits in different species [17,18]. In
cells actively transcribing Shh, the ZRS loops out of its
chromosomal territory to the Shh transcription unit, which
reveals how distant cis-regulatory elements control gene
expression [19]. Recently, several transcriptional regulators
have been identified that control Shh expression by directly
interacting with the distant ZRS region. These include
HOX proteins, the bHLH transcription factor HAND2, and
ETS transcription factors, providing a glimpse of the com-
plex transcriptional regulation of Shh in the posterior limb
bud mesenchyme [20-22].
SHH signalling is transduced by the GLI family of
transcriptional regulators and inhibits the constitutive
processing of the full-length GLI3 activator to its repres-
sor form GLI3R (see e.g. ref. [23]). Of the three GLI
transcription factors expressed during limb bud develop-
ment, only Gli3 is essential on its own (see e.g. ref. [24]).
The inactivation of Gli3 alters morphogenetic feedback
signalling and results in formation of additional anterior
digits [23,25-27]. In particular, GLI3 restrains the prolif-
eration of mesenchymal progenitors in the anterior limb
bud mesenchyme and promotes initiation of digit ray
chondrogenesis by directly repressing Grem1 expression
during handplate formation [26].
We have previously shown that the expression of
Grem1 in the limb bud mesenchyme is controlled by a
large genomic landscape downstream of its transcription
unit [7]. In fact, several of the classical limb deformity
mutations that disrupt distal limb bud development and
formation of metanephric kidneys in the mouse are
caused by deletions affecting this cis-regulatory land-
scape rather than directly altering the Grem1 gene
products [7,13,28]. Molecular and genetic analysis in
the mouse identified a 70 kb genomic region located
downstream of the Grem1 transcription unit within the
neighbouring Formin1 (Fmn1) gene that is required
for Grem1 expression in the limb bud mesenchyme
[7,29]. Detailed analysis of this Grem1 genomic land-
scape revealed similarities with the global control re-
gion (GCR) that controls the expression of 5’HoxD
genes in the limb bud mesenchyme [6], but did not
reveal the structural nature and transacting factors
and/or signalling pathways controlling these cis-regulatory
regions.
To gain further insights into the Grem1 landscape, the
potential cis-regulatory activities of the three highest
evolutionarily conserved genomic regions within the
70 kb Grem1 critical region were analysed. In addition
to its expression in the posterior mesenchyme, emphasis
was also given to the coordinated distal-anterior expan-
sion of Grem1 expression, which is key to orderly pro-
gression of limb bud development [14,30]. Combining
BAC with conventional transgenic approaches, we iden-
tified a 9 kb genomic region that is able to recapitulate
major but not all aspects of the dynamic spatio-temporal
Grem1 expression in the limb bud mesenchyme. This
9 kb region was termed Grem1 Regulatory Sequence 1
(GRS1), and contains a core sequence that is essential to
express a LacZ transgene under control of a ß-globin
minimal promoter in a Grem1-like pattern. The GRS1
region drives gene expression into the posterior and
subsequently distal-anterior mesenchyme, i.e. reproduces
aspects of the distal-anterior expansion of Grem1 expres-
sion during progression of limb bud development. By
crossing GRS1 transgenic mice into different mutant con-
texts, we establish that the GRS1 region is controlled by
inputs from both the SHH and BMP signalling pathways
in limb buds. In addition, chromatin immunoprecipitation
(ChIP) shows that GLI3 interacts with the conserved
HMCO1 sequences in the GRS1 region. The functionally
relevant cis-regulatory regions identified by the present
and two previous studies [31,32] map to the endogenous
DNAse I hypersensitive sites within the Grem1 genomic
landscape recently identified by the ENCODE consortium
[33,34]. This indicates that the Grem1 cis-regulatory land-
scape is composed of at least five active cis-regulatory
Zuniga et al. BMC Developmental Biology 2012, 12:23 Page 2 of 15
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regions that control the spatio-temporal expression of
Grem1 in mouse embryos and limb buds.
Results and Discussion
Identification of conserved limb bud regulatory regions
within the Grem1 genomic landscape
Using functional genetics in the mouse, we previously
identified a ~70 kb region located downstream of Grem1
that is required for its expression in the limb bud mesen-
chyme (Figure 1A, [7]). This limb bud cis-regulatory re-
gion is located between coding exons 19 and 23 of the
neighbouring Fmn1 gene. The Evolutionary Conserved
Regions (ECR) genome browser (http://ecrbrowser.dcode.
org/) was used for multiple sequence alignments to com-
pare the mouse genome with different mammalian and
the chicken genomes. This analysis revealed several blocks
of highly conserved sequences among mammalian species,
but only three of them were also highly conserved in the
chicken and termed HMCO1, 2 and 3 (Human-Mouse-
Chicken-Opossum conserved sequences 1 to 3,
Figure 1A). The most conserved parts of these three
HMCO core regions are ~80% identical (for details see
Additional file 1 and Additional file 2). Of these three
regions only HMCO1 is also present in the orthologous
genomic region in frogs (Figure 1A), which express Grem1
during limb bud development [35]. Despite the fact that
Grem1 is expressed during fin bud development [36], no
HMCO homologies are present in the zebrafish genome
(Figure 1A). ClustalW2 alignments (http://www.ebi.ac.uk/
Tools/msa/clustalw2/) of the Fmn1-Grem1 regions from
different species revealed the absence of HMCO homolo-
gies in other ray-finned fish species such as fugu and me-
daka (Figure 1B). In contrast, all three HMCO regions are
present in the genome of coelacanth, a lobe-finned fish
closely related to tetrapods (Figure 1B and Additional file
1) [37]. As the Grem1 and Fmn1 loci are linked in all spe-
cies analysed (Figure 1B), the distance between the ortho-
logous Fmn1 coding exon 22 (located adjacent to
HMCO1) and Grem1 coding exon 2 was determined. Dur-
ing evolution, this distance increased as it is smallest in
the genomes of ray finned fishes and at least ~10-fold lar-
ger in tetrapods and coelacanth (Figure 1B). In addition,
the distance between Fmn1 exon 19 (close to HMCO3)
and exon 22 correlates well with the presence or absence
of the three HMCO regions (Figure 1B and data not
shown). In ray-finned fishes and frogs (lacking all or spe-
cifically HMCO2, 3, respectively), the distance is ~3-7 kb,
while in mammals and coelacanth it ranges from ~50-
70 kb. Thus, the increase of intronic and intergenic
regions in the Fmn1-Grem1 landscape correlates well with
appearance of the three HMCO regions during vertebrate
evolution.
To determine the requirement of each of these three
HMCO regions for Grem1 expression in mouse limb
buds, we used a BAC-based strategy in combination with
analysis of transgenic founder embryos (Figure 2A-D
and Additional file 3). A 250 kb mouse genomic BAC
encoding the critical region and the Grem1 transcription
unit was used to fuse the LacZ gene in frame with the
Grem1 ORF [7]. We assessed the expression of the LacZ
reporter transgene by analysing the spatio-temporal
distribution of ß-galactosidase activity (Figure 2A-D).
Expression of the Grem1-LacZ fusion protein in the
forelimb bud mesenchyme was detected in a posterior-
distal domain (Figure 2A), mimicking the early endogen-
ous Grem1 expression rather accurately. Therefore, the
Grem1-LacZ BAC construct was used to engineer dele-
tions of the three HMCO regions and determine their
requirement for Grem1-LacZ expression in the posterior
mesenchyme. To control for reproducible generation of
expressing BAC transgenic founder embryos, the
Grem1-LacZ BAC (Figure 2A) was injected in parallel to
the BACs with engineered deletions (Figure 2B-D).
While the control Grem1-LacZ BAC was always robustly
expressed in the posterior mesenchyme (Figure 2A), de-
letion of the 520 bp HMCO1 core region resulted in
complete loss of LacZ expression from limb buds
(Figure 2B, n = 5/7 embryos with LacZ expression, for
details see Additional file 3). In contrast, deletion of the
1279 bp HMCO2 core region only caused partial loss of
LacZ expression from the posterior limb bud mesen-
chyme (Figure 2C; Additional file 3). LacZ remained
expressed normally in the majority of founder embryos
carrying a 924 bp deletion of the HMCO3 region
(Figure 2D, n = 3/5 embryos with LacZ expression, for
details see Additional file 3). Taken together, this BAC
transgenic analysis establishes HMCO1 as most critical
for Grem1 expression in the posterior-distal limb bud
mesenchyme. As the HMCO1 core region is highly con-
served in tetrapods and lobe-finned fish but not ray-
finned fish (Figure 1B), it likely represents a cis-regula-
tory region important to tetrapod evolution. The other
two HMCO regions might contribute to robust expres-
sion of Grem1-LacZ in the posterior mesenchyme, as in
particular the deletion of HMCO2 results in significantly
reduced LacZ expression (Figure 2C).
In an attempt to gain further insight into the enhancer
potential and possible interactions of HMCO2/3 with
HMCO1, conventional transgenic approaches using a
minimal human ß-globin promoter (ßglob-LacZ) were
employed. However, neither individual HMCO regions
(data not shown) nor in a combination of all three was
able to drive robust expression of the ßglob-LacZ trans-
gene in the posterior limb bud mesenchyme (Figure 3A,
compare to Figure 2A). Expression of the ßglob-LacZ
transgene under control of all three HMCO core regions
resulted in scattered LacZ positive cells in the anterior-
distal mesenchyme of forelimb buds (left panel,
Zuniga et al. BMC Developmental Biology 2012, 12:23 Page 3 of 15
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Figure 1 (See legend on next page.)
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Figure 3A, n = 3/3). In contrast, the transgene was strongly
expressed in the posterior embryo including hindlimb
buds (right panel, Figure 3A). These results show that a
transgene consisting of an array of the HMCO core
regions is unable to drive LacZ expression into the poster-
ior forelimb bud mesenchyme. This indicates that add-
itional elements of the Grem1 genomic landscape are
required for Grem1 expression in limb buds.
Next, we assessed to which extent a larger genomic
fragment containing HMCO1 and flanking regions could
drive ßglob-LacZ expression into the posterior limb bud
mesenchyme (Figure 3B). Analysis of transgenic founder
embryos revealed that this transgenic construct drives
robust ßglob-LacZ expression in the posterior limb bud
mesenchyme (Figure 3B, see also Figure 4), strikingly
similar to the domain of the parental Grem1-LacZ BAC
construct (Figure 2A). Taken together, these results indi-
cate that this cis-regulatory region enhances Grem1
expression in the posterior limb bud mesenchyme,
which prompted us to term this 9 kb region Grem1
Regulatory Sequence 1 (GRS1, Figure 4A). GRS1 encom-
passes the HMCO1 region next to Fmn1 coding exon 22
and a further downstream region that is highly con-
served in mammals. This region, like HMCO1 overlaps
with a previously identified GLI binding region (GBR,
[32]). In addition, two potential GLI binding sites were
identified by in silico analysis (Figure 4A).
Spatio-temporal activity of the GRS1 region during mouse
limb bud development
To analyze comparatively the activity of the GRS1 region
with respect to the spatio-temporal regulation of Grem1
expression, transgenic mouse strains expressing the
GRS1-ßglob-LacZ reporter construct were established
(Figure 4). Seven transgenic founders were obtained. In
three independent strains, LacZ was expressed in the
posterior fore- and hindlimb bud mesenchyme in a pat-
tern comparable to the transgenic founder embryos
(Figure 3B and data not shown). Two of these three
transgenic strains were analyzed in detail and used to
study the spatio-temporal LacZ distribution (Figure 4B,
C and Additional file 4). Initial analysis revealed that ß-
galactosidase activity of the LacZ transgene was detected
earlier in one strain and is significantly higher than in
the other strain (Figure 4B, compare to Figure 4C). As
levels did not change during subsequent generations
(data not shown), this is likely due to differences in
transgene copy number and/or integration site. There-
fore, the copy number of both strains was determined
by real-time qPCR analysis (Additional file 4). This ana-
lysis revealed that ten copies of the GRS1-ßglob-LacZ
transgene were integrated into the genome of the strain
expressing higher LacZ levels (GRS1tg10), while only two
copies were detected in the GRS1tg2 strain (Additional
file 4). In GRS1tg10/+ embryos, ß-galactosidase activity is
first detected at ~ E10.25 in the posterior forelimb bud
mesenchyme and continuously increases until ~ E11.75
(Figure 4B). From~E11.0 onwards, scattered positive
cells were detected in the anterior mesenchyme, and this
anterior expression increased during distal limb bud out-
growth to form a crescent in the distal-anterior autopod
(right panels, Figure 4B). By E11.75, ß-galactosidase
activity was rather variable, such that the anterior cres-
cent separated from the posterior domain in some fore-
limb buds. In GRS1tg2/+ embryos, the spatio-temporal
pattern is similar, but expression levels are significantly
reduced due to the lower transgene copy number, result-
ing in detection of ß-galactosidase activity from only ~
E10.5 onwards (Figure 4C, arrowhead). In both strains,
GRS1 drove expression of the ßglob-LacZ reporter spe-
cifically in the limb bud mesenchyme, despite some low
ß-galactosidase activity detected in the developing eyes
of GRS1tg10/+ transgenic embryos (Additional file 4). This
analysis reveals the robust nature of the GRS1 region,
which functions in positive regulation of Grem1 expres-
sion in the limb bud mesenchyme. The posterior domain
(See figure on previous page.)
Figure 1 Identification of three highly conserved non-coding regions in tetrapods and a lobe-finned fish. (A) Sequence alignment of the
genomic region critical for Grem1 expression in mouse limb buds [7] using the ECR browser with the mouse genome release 9 (mm9) as
reference genome. The critical genomic region on mouse chromosome 2 is shown in centromeric (CEN) to telomeric (TEL) orientation and is
located downstream of the Grem1 coding exons. As the critical genomic region is part of the Fmn1 locus, the interspersed Fmn1 coding exons
are indicated as open boxes in the scheme. Three blocks of highly conserved non-coding sequences were identified (HMCO1-3) and are
indicated in blue. Conserved coding regions are indicated in black and non-coding regions conserved ≥74% over ≥100 bp are coloured salmon.
The peak detected in the region of HMCO1 in the zebrafish genome corresponds to Fmn1 exon 22. Regions consisting of repetitive sequences
are shown in green (see Additional file 2). (B) Conserved linkage between the Grem1 and Fmn1 loci in vertebrates. Increased intergenic distances
correlate with the presence of HMCO regions in tetrapods and coelacanth in contrast to ray-finned fishes. The phylogenetic tree analysis was
done with the UCSC multiple alignment functions to align the 3' part of the Fmn1 locus and the Grem1 locus from different species. Open boxes
represent the orthologous Fmn1 coding exons 19 and 22, black box represents Grem1 coding exon 2. The intergenic distances between Fmn1
orthologous exon 22 and Grem1 coding exon 2 are indicated to the right of the scheme. ENSEMBL genomes used for alignment: mouse: M.
musculus (mm10); human: H. sapiens (hg19); chimpanzee: P. troglodytes (panTro3); dog: C. familiaris (canFam2); bovine: B. taurus (bosTau6);
opossum: M. domestica (monDom5); chicken: G. gallus (galGal3); lizard: A. carolinensis (anoCar2); frog: X. tropicalis (xenTro2); coelacanth: L.
chalumnae (LatCha1); fugu: T. rubripes (fr3); medaka: O. latipes (oryLat2); zebrafish: D. rerio (danRer7).
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of ß-galactosidase activity at E10.5 (Figure 4B) is compar-
able to the Grem1 transcript distribution in wild-type limb
buds at earlier stages (E9.5-E10.25, Figure 4D). This tem-
poral delay is likely due to postponed transcriptional activa-
tion and/or up-regulation of the GRS1 transgene as the
establishment of a posterior LacZ expression domain is also
only apparent at E10.5 in GRS1tg10/+ transgenic limb buds
(Additional file 5). Therefore, additional cis-regulatory
regions likely control the temporally correct early onset of
Grem1 expression. Similar delays in the onset of LacZ
reporter gene expression have been previously observed by
analyzing the ZRS cis-regulatory region that controls Shh
expression in mouse limb buds [38]. During distal pro-
gression of limb bud development, endogenous Grem1
expression expands distal-anterior within the developing
handplate and begins to fade by E11.75 (Figure 4D), due to
termination of the SHH/GREM1/AER-FGF feedback loop
and GLI3-mediated repression in the anterior limb bud
mesenchyme [11,26,39,40]. In contrast, ß-galactosidase ac-
tivity remains high in the posterior limb bud mesenchyme
of GRS1 transgenic embryos and the distal-anterior expan-
sion of its expression is significantly delayed and only
Figure 2 A BAC-based strategy to assess the requirement of highly conserved non-coding regions (HMCO1-3) for Grem1 expression in
mouse limb buds. (A) A 250 kb BAC spanning the genomic region from Fmn1 exon 19 to 150 kb up-stream of the Grem1 transcription is able
to drive expression of a LacZ transgene (blue arrow; inserted in-frame into the Grem1 ORF) into the posterior limb bud mesenchyme in
transgenic founder embryos. (B) Deletion of the HMCO1 core region (520 bp) abolishes the LacZ expression. (C, D) Deletion of the core HMCO2
region (1279 bp) results in reduced LacZ expression, while deletion of HMCO3 (924 bp) does not alter the LacZ distribution. ß-galactosidase
activity colours expressing cells blue.
Zuniga et al. BMC Developmental Biology 2012, 12:23 Page 6 of 15
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occurs as transcription of the endogenous Grem1 locus is
starting to terminate (E11.5 onwards Figure 4B, C, compare
to Figure 4D).
Grem1 expression is restricted to dorsal and ventral
limb bud mesenchyme and excluded from the chondro-
genic core mesenchyme (Figure 5A), which is relevant to
BMP-mediated induction of chondrogenesis (ref. [26,41]
and Benazet et al., submitted). Furthermore, the LIM-
homeodomain transcription factors Lhx2 and Lhx9 have
been implicated in regulating Grem1 expression pre-
dominantly in the ventral limb bud mesenchyme in re-
sponse to SHH signalling [42]. Therefore, the extent to
which the dorso-ventral transcript distribution is main-
tained by the GRS1 transgene was assessed (Figure 5B).
Indeed, the expression of both the high (Figure 5B) and
low copy transgenes (Additional file 6) remained
excluded from the core mesenchyme throughout limb
bud outgrowth and patterning. Similar to Grem1 tran-
scripts, ß-galactosidase activity is higher dorsally than
ventrally (Figure 5B, compare to Figure 5A). By E11.75,
ß-galactosidase activity expands anteriorly in both the
dorsal and ventral mesenchyme (E11.75, Figure 5B),
reminiscent of the crescent of Grem1 transcript
(Figure 5A and see before), which indicates that the
GRS1 contains cis-regulatory regions controlled by Lhx
transcription factors [42]. Taken together, the results
shown in Figures 4 and 5 establish that the 9 kb GRS1
cis-regulatory region is able to recapitulate major aspects
of Grem1 expression in the limb bud mesenchyme. In
particular, the GRS1 also recapitulates aspects of the
distal-anterior expansion of Grem1 expression in limb
buds (Figure 4, 5), which was not observed in previous
attempts to identify cis-regulatory regions that control
Grem1 expression in limb buds [7,32]. The fact that the
GRS1 transgene recapitulates some aspects of this distal-
anterior expansion is important, as Grem1 transcription
normally expands anteriorly in register with posterior
AER-FGFs and allows propagation of SHH/GREM1/AER-
FGF signalling [14,30]. However, the delay in activation
and lack of termination of the GRS1 transgene (Figure 4)
indicates that other regulatory inputs from the Grem1
genomic landscape are required to regulate its dynamic
expression in mouse limb buds.
The GRS1 cis-regulatory region integrates inputs from the
SHH and BMP signalling pathways
During limb bud initiation, mesenchymal BMP4 signal
transduction is likely required to activate Grem1 expres-
sion in the posterior mesenchyme, while SHH is primar-
ily required for up-regulation and distal-anterior
expansion during progression of limb bud development
[11,14,43]. Furthermore, GLI3 in the anterior mesen-
chyme and AER-FGF signal transduction are required to
restrict and eventually terminate Grem1 expression
(starting ~ E11.5-11.75) [26,40]. Therefore, GRS1tg10/+
embryos lacking key components of both the SHH and
BMP signalling pathway in their limb buds were gener-
ated to gain insight into the possible direct impact of
these main signalling pathways on the GRS1 element
(Figure 6). Analysis of ShhΔ/Δ GRS1tg10/+ embryos
revealed the complete absence of ß-galactosidase activity
in Shh-deficient forelimb buds (Figure 6A). This con-
trasts with the endogenous Grem1 expression, which is
activated but not maintained in Shh-deficient limb buds
[11,14]. These results show that activation of the GRS1
region depends on SHH signalling, which indicated that
it could also participate in ectopic Grem1 activation due
to anterior ectopic SHH signalling in mouse [14] and
chicken limb buds [12]. Furthermore, GLI3 proteins
interact with specific cis-regulatory regions in the Grem1
genomic landscape [32] and genetic analysis has shown
that Gli3 is essential for the spatio-temporally controlled
Figure 3 A 9 kb GRS1 transgene encompassing HMCO1 drives ßglob-LacZ expression into the posterior limb bud mesenchyme. (A) A
transgene encoding the three HMCO core regions downstream of the ßglob-LacZ minimal promoter and reporter results in aberrant ß-
galactosidase activity in the anterior-distal limb bud mesenchyme. An asterisk marks the posterior border of the forelimb bud. A black arrow
marks the anterior border of LacZ expression in the trunk. A white arrowhead points to the hindlimb bud. (B) The GRS1-ßglob-LacZ transgene is
expressed in the posterior limb bud mesenchyme of transgenic founder embryos. The 9 kb GRS1 region was inserted downstream of the ßglob-
LacZ reporter to keep the same arrangement as in the endogenous Grem1 locus (Figure 2A).
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restriction and subsequent termination of Grem1 expres-
sion in the distal anterior mesenchyme [25,26,44]. In
Gli3-deficient GRS1 transgenic (Gli3Xt/XtGRS1tg10/+)
forelimb buds, ß-galactosidase activity in the posterior
limb buds is comparable to GRS1tg10/+ limb buds, while
expression in the anterior mesenchyme is significantly
increased by E11.75 (Figure 6B, compare to right-most
panels, Figure 4B). This late up-regulation of anterior ß-
galactosidase activity indicates that GRS1 is required for
GLI3-mediated termination of Grem1 expression in the
anterior limb bud mesenchyme, which is essential for
the spatio-temporally correct initiation of mesenchymal
condensations and chondrogenic differentiation of anter-
ior digits [26].
BMPs control Grem1 activation in the posterior limb
bud mesenchyme and directly modulate its expression as
part of the self-regulatory SHH/GREM1/AER-FGF feed-
back signalling system. Therefore, a conditional Smad4
loss-of-function allele [45] in combination with the Prx1-
Cre recombinase strain [46] was used to inactivate Smad4
(Smad4Δ/ΔM) and thereby canonical BMP signal transduc-
tion in the limb bud mesenchyme. In Smad4Δ/ΔM mutant
limb buds, endogenous Grem1 expression is down-
regulated but not lost, while Shh expression remains
Figure 4 Comparison of GRS1-dependent ß-galactosidase activity with endogenous Grem1 transcripts during limb bud development.
(A) ECR browser alignment of the 9 kb GRS1 region containing HMCO1. The mouse genome (mm9) is used as reference genome. The
conservation threshold was set ≥74% identity over ≥100 bp (see legend to Figure 1A for details). Above the sequence alignment, a schematic
representation of the GRS1-ßglob-LacZ transgene is shown. GBR: GLI binding region [32]; GLI motifs: consensus GLI binding sites identified by in
silico analysis. (B, C) Distribution of ß-galactosidase activity in forelimb buds of heterozygous embryos of the tg10 (10 copies, GRS1tg10/+, B) and
the tg2 (2 copies, GRS1tg2/+, C) mouse strains between embryonic days E9.5 to E12. (D) Distribution of endogenous Grem1 transcript in the
corresponding stages of wild-type forelimb buds. Arrowheads at E10.5 point to the ß-galactosidase activity and Grem1 transcript in the posterior
limb bud mesenchyme. The brackets at E11.5 serve to indicate the distance between the ß-galactosidase activity (B, C) or Grem1 expression
domain (D) and the AER. Note that ß-galactosidase activity fails to expand distally in comparison to the Grem1 domain.
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Figure 5 Dorsal and ventral restriction of GRS1-mediated ß-galactosidase activity. (A) Grem1 transcript remains restricted to the dorsal and
ventral forelimb bud mesenchyme in wild-type embryos throughout limb bud development. (B) GRS1-mediated expression of ßglob-LacZ is able
to correctly restrict ß-galactosidase activity along the dorso-ventral limb bud axis. D: dorsal; V: ventral.
Figure 6 The GRS1 transgene is controlled by both SHH and BMP activity. (A) GRS1-dependent ß-galactosidase activity is completely lost from
Shh-deficient limb buds (ShhΔ/Δ GRS1tg10/+). (B) In contrast, inactivation of Gli3 results in anterior up-regulation of ß-galactosidase activity at E11.75
(Gli3Xt/Xt GRS1tg10/+). (C) ß-galactosidase activity fails to expand anteriorly in Smad4-deficient limb buds (Smad4Δ/ΔM GRS1tg10/+). (D) ß-galactosidase
activity is up-regulated in Grem1-deficient limb buds from E11.0 onward (Grem1Δ/Δ GRS1tg10/+).
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(Benazet et al., submitted). In Smad4Δ/ΔMGRS1tg10/+ fore-
limb buds, ß-galactosidase activity appears normal in the
posterior mesenchyme, while distal-anterior expansion
fails to occur (Figure 6C, compare to Figure 4B). This
indicates that GRS1 activity is modulated by SMAD4-
mediated signal transduction during the progression of
limb bud development. These results indicate that also the
distal-anterior expansion of Grem1 expression depends on
BMP activity and agree with the observation that genetic
lowering of Bmp4 results in a global reduction of Grem1
expression in the limb bud mesenchyme [11].
Finally, in Grem1-deficient embryos, BMP activity is
increased due to reduced BMP antagonism, which results
in up-regulation of non-functional Grem1 transcript [13].
As BMP signal transduction modulates GRS1 activity
during advanced limb bud development (Figure 6C),
we also determined the potential influence of Grem1
deficiency on GRS1 activity. In Grem1Δ/ΔGRS1tg10/+
E10.5 limb buds ß-galactosidase activity is initially similar
to GRS1tg10/+ limb buds (Figure 6D, compare to
Figure 4B). Subsequently, ß-galactosidase activity is
increased and by E11.75 the entire Grem1Δ/ΔGRS1tg10/+
limb bud is positive (Figure 6D). These alterations of
ß-galactosidase activity in Smad4Δ/ΔM and Grem1Δ/Δ
forelimb buds reveal that GRS1 activity is extensively
modulated by changes in BMP activity, in particular
also the anterior expansion of its expression. Taken
together, this genetic analysis (Figure 6) shows that
GRS1 activity critically depends on SHH and is
modulated extensively by BMP signal transduction.
This analysis identifies the GRS1, located ~70 kb
downstream of the Grem1 transcription unit as a cis-
regulatory region that integrates inputs by both SHH
and BMP signal transduction. However, as previous
analysis provided good evidence that Grem1 is acti-
vated by mesenchymal BMP signalling upstream of
establishing the SHH/FGF feedback loop [11], these
studies point to the existence of additional unknown
BMP response regions that activate Grem1 expression
in the posterior limb bud mesenchyme.
Endogenous GLI3 proteins are part of the chromatin
complexes interacting with specific parts of the GRS1
region in mouse limb buds
The observed loss of GRS1 activity in Shh-deficient limb
buds (Figure 6A) indicated that the GRS1 region could
be regulated directly by GLI proteins. Indeed, two GLI
binding regions without consensus GLI binding motif
(GBR1 and GBR2, [32]) were previously mapped to the
9 kb GRS1 region using transgene-mediated expression
of an epitope-tagged GLI3 transgene in combination
with chromatin immunoprecipitation (ChIP). To study
the potential interaction of endogenous GLI3 proteins
with the GRS1 region in its normal genomic context in
wild-type limb buds, ChIP analyses using antibodies that
detect both the GLI3 activator and repressor protein iso-
forms were performed [26,47]. GLI3 ChIP using extracts
of wild-type and Gli3-deficient limb buds at E11.5
revealed significant enrichment of one specific region
within GRS1 by real-time qPCR analysis (Figure 7A). A
significant ~4-fold enrichment of an amplicon located
within HMCO1 was observed by comparing wild-type to
Gli3-deficient limb buds (amplicon “d”; p = 0.008) and to
a less conserved region (amplicon “e”; located outside
HMCO1 close to a putative GLI binding site;
Figure 7A). In contrast, no significant enrichments of
the other amplicons located in GRS1 were detected
(Figure 7A). As the amplicons located in HMCO2
(Figure 7B) and HMCO3 (Figure 7C) were also not sig-
nificantly enriched, the GLI3-containing chromatin com-
plexes appear to interact rather specifically with a region
within the highly conserved HMCO1 in wild-type limb
buds. These results not only corroborates the identity of
previously identified GBR1 [32], but indicate that this
region mediates the effects of SHH signal transduction
on GRS1 activity in the posterior limb bud mesenchyme.
Spatio-temporal Grem1 expression is regulated by the
interaction of multiple cis-regulatory regions far
downstream of the transcription unit
Previous genetic analysis showed that Grem1 transcription
in limb buds is initiated by BMP signalling and up-
regulated under the influence of SHH and AER-FGF sig-
naling as limb bud development progresses [11]. Finally,
Grem1 expression is terminated concomitantly with the
initiation of digit formation by high levels of FGF signal
transduction and GLI3-mediated repression in the anter-
ior mouse limb bud mesenchyme [26,40]. This dynamic
spatio-temporal regulation of Grem1 expression indicates
that the activity of different cis-regulatory elements may
change over time. The spatio-temporal activity of the
GRS1 transgene (Figure 4B) indicates that it is primarily
regulated by the SHH/GREM1/AER-FGF feedback signal-
ing system as limb bud development progresses. In par-
ticular, its activity is first apparent when the SHH/
GREM1/AER-FGF feedback is already established, and the
expected termination does not occur, as ß-galactosidase
activity remains in the posterior mesenchyme after the en-
dogenous Grem1 transcripts have been down-regulated
(Figure 4B, D). These results indicate that FGF-mediated
termination of Grem1 expression and the underlying
self-regulatory feedback signalling system [40] does
not occur by FGF signal transduction impacting the
GRS1 region. In addition, neither the 70 kb critical region
of the Grem1 landscape (Grem1-LacZ, Figure 2A) nor
transgenes derived from this region (Figures. 2, 3, 4 and
ref. [32]) are able to accurately recapitulate the entire
spatio-temporal distribution of Grem1 transcript in the
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limb bud mesenchyme. Therefore, either the interactions
among these elements or additional as yet unknown cis-
regulatory regions located outside the critical region must
also participate in the regulation of Grem1 expression. In-
deed, there is circumstantial evidence for the latter, as
deletion of the GC-rich Fmn1 coding exon 9 (located
~200 kb downstream of the Grem1 transcription unit)
results in non-complementation with a Grem1 null allele,
causing a hypomorphic Grem1 limb skeletal phenotype,
and significantly reduced Grem1 expression (ref. [29] and
A.Z and R.Z., unpublished data).
Mapping of DNAse I hypersensitive (HS) sites is used
to identify active regulatory regions in chromatin
(reviewed in ref. [48]). Recently, the ENCODE consor-
tium has done genome-wide mapping of HS sites in
several mouse tissues including limb buds (ENCODE
Group, University of Washington) [33,34]. Interestingly,
this analysis revealed three HS sites within the GBRs of
the GRS1 and HMCO2, while no HS sites mapping to
HMCO3 were detected in limb buds at E11.5 (Figure 8).
The five HS sites mapped by the ENCODE consortium
in the Grem1 genomic landscape overlap with the cis-
regulatory elements required for Grem1 expression in
mouse limb buds (Figure 8). The HS site mapping to
HMCO1 overlaps well with the amplicon enriched by
GLI3-ChIP analysis (Figure 7A). In fact, all HS sites in
the Grem1 genomic landscape overlap either with the
GBR regions interacting with GLI3 [26,32] or CTCF
binding sites [31]. Analysis of Ctcf-deficient limb buds
revealed its requirement for up-regulation and distal-
anterior expansion of Grem1 expression [31]. Interest-
ingly, the HS site overlapping with GBR4 [32] is not con-
served between mammals and birds (Figure 8 and data
not shown). While the early GBR4 activity is comparable
to GRS1 in the posterior mesenchyme (Figure 4B), it does
not support distal-anterior expansion of the expression
during subsequent development [32]. Thus, the inter-
action of the GBR4 and GRS1 cis-regulatory regions could
provide Grem1 expression with the necessary robustness
and evolutionary plasticity, as has been postulated for the
transcriptional regulation of HoxD genes by multiple
interacting regulatory regions during limb bud develop-
ment [8]. Taken together, these studies establish that the
five HS sites in the Grem1 genomic landscape are func-
tionally relevant for Grem1 expression in mouse limb
buds, but not all of them are evolutionary highly
Figure 7 Endogenous GLI3 complexes bind to specific HMCO and GBR regions in the Grem1 genomic landscape. (A) Several amplicons
were designed to detect the conserved and functionally relevant regions within the GRS1 region. The exact genomic locations of all amplicons
are listed in Additional file 7. The potential interaction of endogenous GLI3 proteins with these critical amplicons was analysed by ChIP-qPCR
analysis of wild-type (open bars) and Gli3Xt/Xt (black) limb buds at E11.5. Two stars indicate significant enrichment of amplicon “d” in the HMCO1
region (p = 0.008). (B) GLI3 ChIP-qPCR analysis of the HMCO2 region. Amplicons “f” and “g” are located inside HMCO2 and the previously
identified GBR3 [32]. (C) GLI3 ChIP-qPCR analysis of HMCO3. All values are shown as mean± SD.
Zuniga et al. BMC Developmental Biology 2012, 12:23 Page 11 of 15
http://www.biomedcentral.com/1471-213X/12/23
	
   	
    
	
   67   
conserved. Indeed, experimental and comparative evolu-
tionary evidence indicates that alterations in the spatio-
temporal expression of Grem1, and thereby the activity of
the SHH/GREM1/AER-FGF feedback loop, likely contri-
butes significantly to variations in digit numbers and
morphologies (reviewed in ref. [49]).
Conclusions
In this study, we identify GRS1 as a distant cis-regulatory
region that encompasses the highly conserved HMCO1
region and show that it controls important aspects of
Grem1 expression in the posterior and distal-anterior limb
bud mesenchyme. GRS1 activity depends critically on
SHH signalling and endogenous GLI3 protein complexes
interact with specific regions within HMCO1 in wild-type
limb buds. In addition, the anterior expansion of GRS1
activity is also regulated by BMP signal transduction.
These results together with previous studies reveal the
large genomic architecture composed of several distant
cis-regulatory regions that control the highly dynamic
Grem1 expression in response to signalling inputs from
the BMP, SHH and FGF pathways. It is likely that the
interactions among these dispersed cis-regulatory regions
provide the dynamic Grem1 expression in limb buds with
the necessary robustness, but at the same time allow for
evolutionary plasticity of its expression [8].
Methods
Ethics Statement
All the experiments were conducted in strict accordance
with Swiss law following the 3R principles and the con-
duct defined by the Basel Declaration. All studies involv-
ing mice were classified as grade zero by the Animal
Welfare and Ethics Commission of both cantons of
Basel and Argovia, which implies minimal suffering.
Mouse strains
The Shh loss-of-function allele [50], the Gli3 extra-toes-J
allele [51], the Grem1 null allele [13] and the GRS1tg/+
alleles (this study) were maintained in an NMRI back-
ground, while the Smad4 conditional allele (Smad4flox,
[45]) and the Prx1-Cre transgene [46] were maintained
in a C57BL/6 J background.
BAC modifications
BAC constructs were engineered using ET cloning as
previously described [7]. The deletions ΔHMCO1,
ΔHMCO2 and ΔHMCO3 were induced in the Grem1-
LacZ BAC clone using a Kanamycin resistance selection
cassette. All primer sequences are available upon request.
See Additional file 8 for the genomic coordinates of
HMCO1-3.
ßglob-LacZ transgene constructs
An expression cassette was constructed in pKS-Bluescript
using LacZeocin reporter under control of the minimal
human ß-globin promoter sequences [52]. Various combi-
nations of HMCO sequences were inserted downstream
into this cassette. The HMCO1, -2 and -3 core sequences
were amplified by PCR directly from mouse genomic
DNA (primers available on request). The 9 kb GRS1
region was initially subcloned as a 9.6 kb Bgl2 fragment
from BAC RP23-113 H17 (chr2: 113,611,499-113,847,299
(mm10). BacPac Resources, Children’s Hospital, Oakland,
USA). All constructs were linearized with Ksp1 before
microinjection.
Figure 8 The Grem1 genomic landscape harbours multiple distant cis-regulatory regions that orchestrate Grem1 transcription in limb
buds. Mapping of the DNAse I hypersensitive (HS) sites in fore-, hindlimb bud and trunk mesoderm of mouse embryos at E11.5 (ENCODE Group,
University of Washington, [33,34]). A schematic representation of the cis-regulatory landscape that regulates Grem1 expression in the limb bud
mesenchyme is shown below the HS site tracks. Interestingly, the major HS sites co-localise with regions that are functionally required, highly
conserved (HMCO1-3, blue), and/or overlap with experimentally defined GBRs (red, ref. [32] and this study) or a CTCF binding region (green, [31]).
Red arrowheads indicate consensus GLI binding sites identified by in silico analysis. HMCO1 and HMCO2 overlap with limb bud specific HS sites,
while HMCO3 overlaps with a trunk mesodermal HS site. For exact coordinates, see Additional file 8.
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Generation of transgenic founder embryos and transgenic
strains
BAC and ßglob-LacZ transgenic constructs were injected
into the pronucleus of fertilized mouse eggs. Several
founder embryos for each construct were scored for
ß-galactosidase activity (Additional file 3). For the
GRS1-ßglob-LacZ transgene, seven independent trans-
genic mouse strains were established by crossing
founders into the NMRI background. Transgene copy
numbers were determined by real time qPCR [53]
using the Bio-Rad CFX96 Real-Time PCR System in
combination with the iQ SYBR Green Supermix
(Bio-Rad). For each mouse, 20 ng of genomic DNA
were analysed in triplicate. The primers to amplify
the DBH genomic region were used for normalization
and non-transgenic littermate DNA was used as control.
The normalized control levels were set to 2 as the primers
also amplified both alleles of the endogenous HMCO1
regions. The 2-ΔΔCt formula was used to calculate and
normalize transgene copy numbers. In addition to three
different F1 males, three embryos from the F2 and three
embryos from the F3 generation were analysed for the
two transgenic strains shown to ascertain stable transmis-
sion of the transgenes. Primers sequences are available on
request.
Detection of ß-galactosidase activity
Embryos were isolated in ice-cold PBS and staged
according to somites numbers, then fixed in 1% formal-
dehyde, 0.2% glutaraldehyde, 0.02% NP40, 0.01% sodium
deoxycholate in 1x PBS for 20–30 minutes at 4°C. Sub-
sequently, embryos were washed three times in 1x PBS
for 5 minutes at room temperature and incubated over-
night at 37°C and in the dark in 1 mg/mL X-Gal,
0.25 mM K3Fe(CN6), 0.25 mM K4Fe(CN6), 0.01% NP-
40, 0.4 mM MgCl2 and 1% sodium deoxycholate to de-
tect ß-galactosidase activity, which colours cells blue. To
stop the reaction, embryos were washed three times in
1x PBS for 5 minutes each at room temperature.
Chromatin Immunoprecipitation (ChIP)
Forelimbs and hindlimbs of 10 wild-type or Gli3Xt/Xt
embryos at E11.5 were dissected and processed for ChIP
as described [26] using a polyclonal anti-GLI3 antibody
(#2676, Genentech, [47]). To compute the level of en-
richment of a given region, the Ct values of both input
and ChIP samples were compared with those of a nega-
tive control amplicon located in the mouse ß-actin locus
[21]. All results (mean ± SD) were obtained by analysing
three completely independent experiments per genotype.
The significance of all differences was assessed using the
two-tailed, non-parametric Mann–Whitney test. The
coordinates of the relevant amplification are shown in
Additional file 7.
All genomic sequence alignements of the Fmn1-Grem1
locus region were performed using the ECR browser
[54] and the ClustalW2 program [55].
Additional files
Additional file 1: Figure S1. Conservation of the HMCO core regions.
ClustalW2 multiple sequence alignment of the HMCO1, HMCO2 and
HMCO3 core regions of mouse (mm10), human (hg19), chimpanzee
(panTro3), dog (canFam2), bovine (bosTau6), opossum (monDom5),
chicken (galGal3), lizard (anoCar2), frog (xenTro2), and coelacanth
(LatCha1) genomes The corresponding genomic coordinates are
indicated. HMCO1: 73 of 149 nucleotides were conserved in all species;
HMCO2: 182/298 conserved nucleotides, HMCO3: 45/137 conserved
nucleotides.
Additional file 2: Table S1. Genomic coordinates for the sequence
comparisons shown in Figure 1A.
Additional file 3: Table S2. Analysis of transgenic founder embryo.
Additional file 4: Figure S2. Limb bud mesenchymal expression of
GRS1-ßglob-LacZ transgene in two independent transgenic mouse strains.
(A) Expression of the GRS1-ßglob-LacZ transgene is restricted to limb
buds, with expression initiating earlier in forelimb than hindlimb buds.
Note the differences in ß-galactosidase activity in GRS1tg10/+ (left panel)
and GRS1tg2/+ (right panel) transgenic mouse embryos. (B) Using real-time
qPCR, the transgene copy numbers in both the GRS1tg10/+ and GRS1tg2/+
mouse strains were determined in comparison to wild-type mice
(carrying 2 copies of the endogenous GRS1 regions). This analysis
revealed that the GRS1tg10/+ strain carries 10 copies and GRS1tg2/+ 2
copies of the transgene, respectively.
Additional file 5: Figure S3. Comparison of the LacZ mRNA and ß-
galactosidase reporter activity in early limb buds of GRS1tg10/+ embryos.
Distribution of ß-galactosidase activity (A) and LacZ transcripts (B) in
forelimb buds of GRS1tg10/+ embryos at E10.0 and E10.5. Arrowheads
point to the posterior expression domains.
Additional file 6: Figure S4. Dorso-ventral distribution of ß-
galactosidase activity in forelimb buds expressing the GRS1tg2/+
transgene. The GRS1tg2/+ transgene respects the dorsal and ventral
restriction of the mesenchymal expression domains. Note that overall
expression is significantly lower than in GRS1tg10/+ limb buds (compare to
Figure 5B). D: dorsal, V: ventral.
Additional file 7: Table S3. qPCR amplicons for GLI3 ChIP analysis.
Additional file 8: Table S4. Genomic coordinates of identified Grem1
regulatory regions.
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Table S1 
Genomic coordinates for the sequence comparisons shown in Fig. 1A 
Region Species % ID 
(threshold 
74%) 
Length 
(100bp 
threshold) 
Coordinates 
HMCO1 Zebrafish - - - 
HMCO1 Xenopus 74.7% 100 xenTro2 scaffold_37:3687354-3687453 
HMCO1 Chicken 80.2% 381 galGal3 chr5:32849567-32849947 
HMCO1 Opossum 81.3% 430 monDom5 chr1:188935147-188935576  
HMCO1 Dog 80.5% 387 canFam2 chr30:5150126-5150512  
HMCO1 Chimpanzee 81.5% 508 panTro3 chr15:29568244-29568751 
HMCO1 Human 81.5% 508 hg19 chr15:33090437-33090944 
HMCO2 Zebrafish - - - 
HMCO2 Xenopus - - - 
HMCO2 Chicken 80.4% 377 galGal3 chr5:32836351-32836727  
HMCO2 Opossum 80.1% 380 monDom5 chr1:188909506-188909885 
HMCO2 Dog 84.2% 494 canFam2 chr30:5129238-5129731 
HMCO2 Chimpanzee 84.6% 818 panTro3 chr15:29588916-29589733 
HMCO2 Human 84.5% 818 hg19 chr15:33111145-33111962 
HMCO3 Zebrafish - - - 
HMCO3 Xenopus - - - 
HMCO3 Chicken 74% 272 galGal3 chr5:32819753-32820024 
HMCO3 Opossum 77% 331 monDom5 chr1:188837685-188838015 
HMCO3 Dog 78.3% 842 canFam2 chr30:5078806-5079647 
HMCO3 Chimpanzee 80.7% 940 panTro3 chr15:29642824-29643763 
HMCO3 Human 80.1% 937 hg19 chr15:33164854-33165790 
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Table S2 
Analysis of transgenic founder embryo 
Transgene Embryos * Forelimb bud expression Figure  
Grem1-LacZ 3 3 posterior Fig.1B 
Grem1-LacZ ∆HMCO1 
 
7 1 strong 
1 very weak 
5 no expression 
 
 
Fig.1C 
Grem1-LacZ ∆HMCO2 
 
3 2 weak posterior 
1 no expression 
Fig.1D 
Grem1-LacZ ∆HMCO3 
 
5 3 posterior 
2 no expression 
Fig.1E 
HMCO123-ßglob-LacZ 3 3 anterior Fig.2A 
GRS1-ßglob-LacZ 2 2 posterior Fig.2B 
 
* Founder embryos with ß-galactosidase activity anywhere in limb buds and/or trunk 
 
 
	
   	
    
	
   75 
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
	
  	
  	
  	
    
	
   	
    
	
  76 
	
  	
    
Table S3 
qPCR amplicons for GLI3 ChIP analysis 
GLI3 ChIP amplicon Coordinates (mm10) 
a chr2:113691635-113691714 
b chr2:113692244-113692320 
c chr2:113693100-113693179 
d chr2:113693471-113693578 
e chr2:113697427-113697518 
f chr2:113674650-113674732 
g chr2:113675141-113675273 
h chr2:113618703-113618814 
i chr2:113619171-113619319 
  
 Table S4 
Genomic coordinates of identified Grem1 regulatory regions 
Annotation Length Coordinates (mm10) 
HMCO1 520 bp chr2:113693204-113693723 
HMCO2 1279 bp chr2:113674096-113675374 
HMCO3 924 bp chr2:113618678-113619601  
GRS1-ßglob-LacZ transgene 9ʼ831 bp chr2:113689791-113699621 
GBR1 (HMCO1, ChIP amplicons c-d) [32] 439 bp chr2:113693005-113693989 
GBR2 (ChIP amplicons a-b) [32] 700 bp chr2:113691653-113692352 
GBR3 (HMCO2, ChIP amplicons f-g) [32] 985 bp chr2:113674455-113675313 
GBR4 (with GLI binding motif) [32] 439 bp chr2:113640843-113641281 
CTCF binding region [31] 468 bp chr2:113648107-113648574 
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6.1.3. The Grem1 cis-regulatory landscape integrates several signaling inputs 
from multiple CRMs  
In this study, we showed that a 9kb region located in the cis-regulatory landscape of 
Grem1 regulates aspects of the posterior activation and distal anterior expansion of 
Grem1 expression during progression of limb bud outgrowth. This Gremlin1 
Regulatory Sequence 1 (GRS1) is activated by the Sonic hedgehog (SHH) pathway 
and interacts with GLI3 containing protein complexes. Furthermore, GRS1 expansion 
towards the distal anterior part of the limb bud is dependent on BMP signaling, as 
seen by conditionally inactivating the BMP signal transducer SMAD4 in limb bud 
mesenchyme. Several other studies identified additional CRMs located outside of 
GRS1 that contribute to Grem1 expression and interact with GLI3 or CTCF chromatin 
complexes (Vokes et al., 2008; Soshnikova et al., 2010). Together, these data reveal 
that the large cis-regulatory landscape of Grem1 is an archipelago composed of 
multiple CRMs that integrate signaling inputs from various pathways to regulate the 
robust and dynamic expression of Grem1 in limb buds.  
 
As limb bud outgrowth advances, several factors eventually contribute to the 
termination of Grem1 expression and feedback signaling: 1) increasing high levels of 
FGF signaling from the AER repress Grem1 in the distal mesenchyme (Verheyden 
and Sun, 2008); 2) GLI3 represses Grem1 in the anterior limb bud mesenchyme, 
which enables the rise of BMP activity and BMP-dependent initiation of 
chondrogenesis (Lopez-Rios et al., 2012); 3) the induction of TBX2 by BMP signaling 
represses Grem1 by direct interaction of this transcription factor with the GBR4 
element in Shh descendant cells in the posterior limb bud (Farin et al., 2013); and 4) 
Shh descendant cells become unable to express Grem1 in the posterior limb bud 
(Scherz et al., 2004). Our study shows that GRS1 activity is not terminated with the 
same kinetics as endogenous Grem1 expression. In particular, a strong LacZ 
expression domain remains in the posterior mesenchyme. This domain becomes 
spatially separated from the distal anterior domain at E12.0. This suggests that the 
CRM(s) that mediates FGF dependent repression of Grem1 are not part of GRS1. In 
contrast, the anterior expansion and upregulation of GRS1-LacZ domain in Gli3-
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deficient limb buds show that GRS1 encodes CRMs involved in GLI3R-mediated 
repression of Grem1 expression.  
The GBR4 CRM interacts both with the GLI3 and TBX2 transcriptional regulators and 
is able to direct LacZ expression in the posterior but not anterior mesenchyme 
(Lopez-Rios et al., 2012; Farin et al., 2013; Vokes et al., 2008). This region, located 
~50kb upstream of GRS1, was called GLI Responsive Element 1 (GRE1) in a recent 
study (Li et al., 2014). GRE1 is activated by SHH and bound by GLI3A chromatin 
complexes in the posterior limb bud, and its activity is not affected by inhibiting FGF 
signaling. In addition to its enhancer activity in the posterior limb bud, GRE1 
participates in GLI3R-mediated silencing of Grem1 in the anterior mesenchyme (Li et 
al., 2014). GRE1 and GRS1 are both directly regulated by SHH/GLI3 and may thus 
be functionally redundant and/or are likely required cooperatively for regulating the 
dynamic expression of Grem1 in the limb bud mesenchyme. 
 
The activation of Grem1 expression in the posterior limb bud mesenchyme requires 
BMP signaling and the HOX transcriptional regulators upstream of SHH signaling. 
SHH signaling is subsequently required to upregulate and distal-anteriorly expand 
Grem1 expression (Zuniga et al., 1999; Panman et al., 2006; Nissim et al., 2006; 
Benazet et al., 2009; Sheth et al., 2013). Interestingly, the expression of the GRS1 
reporter requires SHH signaling and β-galactosidase activity is first detected only 
after initiation of Grem1 endogenous expression in the limb bud mesenchyme. Thus, 
the BMP Responsive Elements (BRE) and HOX CRMs are not encoded by the GRS1 
and remain to be identified.  
In Smad4∆/∆M limb buds, the initial expression of Grem1 in the posterior mesenchyme 
is reduced, fails to expands anteriorly, and is lost in Shh∆/∆;Smad4∆/∆M forelimb buds 
(Benazet et al., 2012). Thus, Grem1 initiation depends on positive regulation by both 
SHH and SMAD4-mediated BMP signal transduction. Moreover, the absence of 
anterior expansion of GRS1 expression domain in Smad4∆/∆M limb buds suggests that 
GRS1 contains BREs controlling SMAD4-dependant expansion of Grem1 expression 
after its initial activation (this study and (Benazet et al., 2012). The distal anterior 
expansion of Grem1 expression is also regulated by CTCF and HOX transcriptional 
regulators (Soshnikova et al., 2010; Sheth et al., 2013).  
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To summarize the integration of these various signaling inputs by multiple CRMs 
located in Grem1 cis-regulatory landscape, we propose the following kinetics for the 
regulation of Grem1 expression: 1) An early expression domain is initiated in the 
posterior limb bud mesenchyme by BMP signaling and HOX transcriptional regulators 
through CRMs that need to be identified. This posterior domain is maintained by 
SHH/GLI3A inputs acting on the GLI-binding regions in GRS1 and GRE1 CRMs. 2) 
The dynamic expansion of Grem1 expression in the distal anterior mesenchyme 
depends on BMP/SMAD4 signal transduction impacting on GRS1 and on CRMs 
regulated by CTCF and HOX complexes. This distal-anterior domain is likely silenced 
by GLI3R impacting on GRE1 CRM. 3) The termination of the posterior domain may 
in part be mediated by TBX2 interacting with GRE1. 4) In contrast, termination of the 
distal-anterior domain likely depends on GLI3R-mediated repression via the GRS1 
and GRE1 CRMs and unknown FGF-responsive elements. DNase HS sites mark all 
the known Grem1 CRMs. Each of them likely encodes binding sites for the different 
trans-acting factors that fulfill different activities depending on the specific spatial and 
temporal developmental context.  
 
GLI3 direct interactions with relevant regions in GRS1 and GRE1 have been well 
characterized (this study and (Li et al., 2014)). The next major challenge is to 
understand how Grem1 cis-regulatory landscape integrates BMP signaling inputs. 
We are attempting this by identifying the CRMs that interact with SMAD4-containing 
chromatin complexes. 
 
6.1.4. Identification of SMAD4 target CRMs during limb bud development: the 
need for a new tool 
In addition to the role of SMAD4 in the regulation of GRS1 activity (Zuniga et al., 
2012), we showed that Smad4 is crucial for the initiation of digits primordia and 
chondrogenesis (Benazet et al., 2012). Furthermore, limb bud ectodermal Smad4 is 
required for AER initiation and for AER-FGF mediated termination of epithelial-
mesenchymal signaling (Benazet and Zeller, 2013). Despite the inactivation of 
Smad4 in limb buds affects the expression of a large number of downstream genes, 
there is no evidence that these genes are direct SMAD4 transcriptional targets. 
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We thus decided to initiate a genome-wide analysis of the SMAD4 chromatin 
complexes in limb buds using ChIP-Seq to: 1) identify SMAD4 interacting CRMs in 
Grem1 regulatory landscape and 2) to get further insights into the direct BMP targets 
that are involved in chondrogenic differentiation. 
Several SMAD4 ChIP-Seq studies using cell lines in combination with different types 
of antibodies have been published (Koinuma et al., 2009; Qin et al., 2009; Fei et al., 
2010; Kennedy et al., 2011; Morikawa et al., 2011). Therefore, we tested supposedly 
ChIP-grade anti-SMAD4 antibodies on a known BRE located in the promoter of the 
gene Id1 using wild-type embryonic limb buds, but no SMAD4 chromatin complexes 
were detected (data not shown). Therefore, we decided to introduce a 3xFLAG 
epitope tag in the endogenous SMAD4 protein as we have successfully done for 
HAND2 (see Chapter 6.2).  
 
6.1.5. Generation of Smad43xFLAG mice by homologous recombination 
Targeting and testing ES cells for SMAD43xFLAG expression 
Two previous attempts were made to produce a mouse line expressing a 
SMAD43xFLAG protein using cassette exchange approaches. However, the resulting 
Smad43xF-dRMCE and Smad43xF-R26 alleles were expressed at levels too low for 
genome-wide ChIP-Seq analysis (see Appendix 12.1). Therefore, we decided to 
introduce the 3xFLAG epitope tag in the endogenous SMAD4 protein using 
conventional homologous recombination. A targeting vector consisting of two 
homology arms flanking the 3’-end of Smad4 coding sequence, in which the 3xFLAG 
was inserted in frame between the exon 12 and the 3’UTR, was constructed 
(Fig.11A). A floxed Neomycin selection cassette was inserted downstream of Smad4 
locus in the 3’ homology arm. This targeting vector was linearized and electroporated 
in R1 embryonic stem (ES) cells to generate the Smad43xF-HR allele (Fig.11A, 
thereafter referred as S43xF-HR). 662 ES cells clones were picked (together with 
A.Zuniga) and 424 of them screened for correct recombination by Southern Blot 
using a probe located outside of the 5’ homology arm (Fig.11A and Fig.11B, top 
panel).  
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Figure 11. Expression of the Smad43xFLAG-HR allele in mouse ES cells 
(A) Homologous recombination strategy. Top scheme: linearized targeting vector containing two 
homology arms flanking the 3’-end of Smad4 coding sequence. A 3xFLAG epitope tag was fused in 
frame between coding exon 12 and the 3’UTR. A floxed Neo cassette is inserted downstream of 
Smad4 locus in the 3’ homology arm. Homologous recombination generates the Smad43xFLAG-HR allele 
(bottom scheme). The restriction sites used for Southern Blot analysis are indicated in italic, and the 
Southern Blot probes are shown as green boxes. (B) Southern Blot analysis of seven ES cells clones. 
Wild-type R1 ES cells were used as control. Left panel: Genomic DNA digested with BamHI and 
blotted with the 5’ probe shown in (A). The sizes of the expected wild-type and 5’-recombined bands 
are indicated on the left. Middle panel: 3’ probe blot following BamHI digestion. Right panel: blot 
probed for the Neo cassette following BamHI digestion. (C) Western Blot detection of the SMAD43xFLAG 
protein in extracts of several different S43xF-HR/+ ES cells clones. Wild-type R1 ES cells and the 
negative clone 22B5 were used as controls, while S43xF-dRMCE/+ ES cells were used as a control for a 
low SMAD43xFLAG expression (see Appendix 12.1). Clones 22B6 and 22D8 express the highest levels 
of SMAD4 (~63kDa). ACTIN (42kDa) was used as a loading control and is present in similar amounts 
in all samples. (D) qPCR on Smad4 cDNA from wild-type, S43xF-dRMCE/+ and several clones of the    
S43xF-HR/+ ES cells. Intermediate expression in clone 22E4 indicates that this is a mixed clone. (E) 
Immunofluorescence detection of the SMAD43xFLAG protein in undifferentiated wild-type or S43xF-HR/+ ES 
cells. Green: SMAD43xFLAG protein. Blue: nuclei stained by Hoechst. Scale bar: 50µm 
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Positively recombined ES cells clones were further screened for correct 3’ 
recombination (Fig.11A and Fig.11B, middle panel). Finally, single insertion of the 
Neomycin cassette was assessed to exclude ES cell clones with random integration 
of the targeting construct (Fig.11A and Fig.11B, bottom panel). In total, 29 of the 424 
ES cell clones carried the S43xF-HR allele (6.8%, similar to the expected 3-6% of 
correct targeting on Smad4 locus (Chu et al., 2004; Takaku et al., 1998)). In addition, 
Western Blot analysis detected the intact SMAD43xFLAG protein in ES cells (Fig.11C). 
Western Blot analysis also allowed identifying mixed ES cell clones expressing the 
tagged protein at lower levels (Fig.11C, compare ES cell clones 22B6, 22D8 to 22E4. 
Clone 22B5 is a negative control). Finally, the levels of the SMAD43xFLAG protein in 
the different ES cells clones carrying the S43xF-HR allele was much higher compared to 
those in ES cells carrying the damaged S43xF-dRMCE allele (Fig.11C and Appendix 
12.1). These results and the mixed nature of some ES cell clones, such as 22E4, 
were confirmed by qPCR analysis (Fig.11D). Immunocytochemistry showed that the 
3xFLAG epitope tag allows detection of endogenous SMAD4 proteins both in the 
cytoplasm and nuclei of ES cell clones (Fig.11E). Three of the tested clones were 
karyotyped and did not show any obvious chromosomal abnormalities (data not 
shown).  
 
Smad43xFLAG allele: a new tool for future ChIP-Seq studies 
Eight of the positive S4+/3xF-HR ES cells clones were injected in C57BL/6 blastocysts at 
the Transgenic Mouse Core Facility (TMCF, Basel, see Fig.12A). Chimeric males 
were obtained from three independent clones and mated to CMV-Cre females 
(C57BL/6 background) to delete the floxed Neo selection cassette. Four chimeras 
transmitted the S43xF-HR allele to 67-100% of their offspring (Fig.12B). Germline 
transmission was assessed by coat color (Fig.12A) and confirmed by PCR 
genotyping. CMV-Cre-mediated deletion of the floxed Neo selection cassette resulted 
in the S43xF-HR∆Neo allele (Fig.12C). Specific primers were used to discriminate 
between the S4wt, S43xF-HR and S43xF-HR∆Neo alleles (Fig.12C, arrows, and Fig.12D). 
Mice homozygous for the S43xF-HR∆Neo allele are viable and obtained in the expected 
Mendelian ratio from two independent ES cell clones (data not shown).  
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Figure 12. Establishment of Smad43xF/3xF mouse strain 
(A) Schematic representation of the generation of chimeras and F1 offspring from S43xF-HR/+ ES cells 
(adapted from (Pettitt et al., 2009). (B) Table summarizing the percentage of germline transmission 
observed for each of the chimeras derived from S43xF-HR/+ ES cells clones (22B6, 31A6 and 31E1). (C) 
Schematic representation of the S4wt (top), S43xF-HR (middle) and S43xF-HR∆Neo (bottom) alleles. The 
S43xF-HR∆Neo allele is obtained by CMV-Cre mediated recombination of the loxP sites in the S43xF-HR 
allele. Arrows indicate primers used for the genotyping of these alleles. (D) PCR genotyping of all 
three considered alleles. The sizes of the expected bands are indicated on the right. (E) Detection of 
the SMAD43xFLAG protein in limb buds of S43xF/3xF embryos (E11.75). Protein extracts from wild-type 
limb buds were used as control. (F) RT-qPCR analysis of E11.75 limb buds from S4+/+, S43xF/+ and 
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S43xF/3xF embryos. Normalized Smad4 transcript level using the junction between exon 8-9 (left panel), 
exon 12-3’UTR junction (middle panel) and FLAG-3’UTR (right panel) for amplification. (G) The anti-
FLAG M2 antibody was used to detect SMAD43xFLAG proteins in frozen sections of limb buds. From left 
to right: wild-type forelimb (E10.5), S43xF/3xF forelimb (E10.5) and S43xF/3xF forelimb (E11.5). Scale bar: 
100µm (50µm in high magnification). 
 
 
The Smad43xFLAG strain was established by breeding the Smad43xF-HR∆Neo allele from 
the ES cell clone 31A6 into a NMRI background (to obtain the most embryos possible 
for future analysis). The SMAD43xFLAG protein is detected with high sensitivity and 
specificity in limb bud tissues from Smad43xF/+ (not shown) and Smad43xF/3xF embryos 
(E11.75, Fig.12E). The levels of Smad4 transcripts in Smad43xF/+ and Smad43xF/3xF 
limb buds were similar to wild-type controls (E11.75, Fig.12F, left panel). In 
heterozygous embryos, the S4wt allele was expressed as expected at ~50% in 
comparison to Smad4+/+ embryos (Fig.12F, middle panel). Conversely, in 
heterozygous embryos the S43xF allele was expressed at ~50% in comparison to 
Smad43xF/3xF embryos (Fig.12F, right panel). Altogether, these data establish that the 
Smad43xF-HR∆Neo allele is expressed like the wild-type allele, which makes this allele a 
promising tool to study SMAD4 chromatin complexes and protein interactions in vivo. 
Finally, we performed immunohistochemistry on frozen limb bud sections to assess 
SMAD4 in vivo localization (together with J.Leclercq). As seen by whole-mount 
antibody staining (Benazet et al., 2012), SMAD4 is evenly distributed throughout limb 
bud mesenchyme at E10.5 and E11.5 (Fig.12G). In most of the limb bud cells, 
SMAD4 proteins are detected both in the cytoplasm and nuclei (Fig.12G, high 
magnification). 
We will now use the Smad43xF-HR∆Neo allele to determine the genome-wide range of 
SMAD4 target sequences using ChIP-Seq analysis. To this aim, we have collected 
limb buds from around 600x E10.75-E11.0 embryos (37-42 somites). The chromatin 
of these limb buds was crosslinked and snap frozen and is now being processed for 
ChIP-Seq analysis. The range of SMAD4 interacting sequences will provide us 
interesting insights into the transcriptional networks regulated by SMAD4 during 
mouse limb bud development. In addition, identifying the CRMs that interact with 
SMAD4 chromatin complexes in the Grem1 cis-regulatory landscape will be of 
particular interest to understand how this complex landscape integrates various 
signaling inputs. 
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6.2. From trans-acting factor to cis-regulatory modules: 
identification of the direct transcriptional targets of HAND2 
during heart morphogenesis  
6.2.1. The Hand23xFLAG allele is a new genetic tool to study HAND2 distribution 
during heart development  
By taking advantage of the straightforward and high efficient strategy to target mouse 
ES cells using Dual Recombinase-Mediated Cassette Exchange (dRMCE, 
(Osterwalder et al., 2010a), a mouse line with a 3xFLAG epitope-tag inserted into the 
endogenous Hand2 locus was generated by M.Osterwalder. The generation and 
characterization of this Hand23xFLAG allele is described in (Osterwalder et al., in 
press). Briefly, the 3xFLAG epitope tag was fused in frame the N-terminal part of the 
Hand2 coding sequence and used to replace the corresponding region in conditional 
Hand2 R1 ES cells by dRMCE (Galli et al., 2010) (Fig.13A). The insertion of this 
epitope tag does not affect the expression and the function of the Hand2 gene 
products, and the tagged HAND2 proteins are readily detected in all Hand2 
expressing tissues (heart, limb buds and branchial arches) with high specificity and 
sensitivity, both by Western Blot and by immunohistochemistry (Osterwalder et al., in 
press). Homozygous Hand23xF/3xF develop normally and do not exhibit any phenotype 
or sign of embryonic lethality as observed in Hand2-deficient embryos (Srivastava et 
al., 1997). The Hand23xFLAG allele is thus a new fantastic tool to study the 
endogenous spatio-temporal distribution of HAND2 proteins and identify its 
downstream functional interactions during heart, limb buds and branchial arch 
morphogenesis.  
 
During the onset of heart development, Hand2 transcripts are mainly expressed in 
the myocardium of second heart field (SHF) derived structures such as the outflow 
tract (OFT) and right ventricle (RV), the endocardium of various cardiac 
compartments, the proepicardial organ (PEO) and derived epicardium, and structures 
derived from cardiac neural crest cells (cNCC) (Srivastava, 1995; Biben and Harvey, 
1997; Srivastava et al., 1997; Barnes et al., 2011). In contrast to these studies, 
relying on whole-mount or section in situ-hybridization, we used 
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immunohistochemistry to detect the HAND23xFLAG proteins with the M2 anti-FLAG 
antibody (Sigma). This allowed us to determine the HAND2 proteins distribution with 
higher single-cell resolution than using conventional in-situ hybridization techniques 
and allowed us to co-localize HAND2 with other proteins (see below). 
 
 
 
Figure 13. The Hand23xFLAG allele is expressed throughout cardiac development  
(A) Schematic illustration of the Hand23xFLAG allele (Osterwalder et al., in press). The 3xFLAG epitope 
tag (yellow box) is fused in frame downstream of the endogenous Hand2 ATG translation start site. (B-
F) Distribution of the endogenous HAND23xFLAG protein during heart development at (B) E8.0, (C) E8.5, 
(D-E) E9.5 and (F) E11.5. Enlargement of the boxed areas are shown in (B’-F’). (B-E) Transverse 
paraffin sections and (F) sagittal frozen section from the left side of the embryo. The section in (D) is 
localized more cranially than the section in (E). Scale bars: 50µm. Open arrowhead: splanchnic 
pharyngeal mesoderm, white arrowhead: myocardium, white arrow: endocardium, white asterisk: 
mesenchymal cells of the cardiac cushions, open arrow: epicardium. avc: atrioventricular canal, ba: 
branchial arches, cc: cardiac cushions, la: left atrium, lv: left ventricle, oft: outflow tract, ra: right atrium, 
rv: right ventricle, v: common ventricular chamber. 
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We initially wanted to establish HAND2 proteins distribution during key stages of 
early cardiac development. At E8.0, HAND23xFLAG proteins are detected in the entire 
primary heart tube in both the myocardial and endocardial layers and in the adjacent 
splanchnic pharyngeal mesoderm (Fig.13B-B’). During cardiac looping (E8.5), 
HAND23xFLAG remains in the endocardium of the two developing ventricles. In 
contrast, HAND23xFLAG proteins remain in the myocardium of the right ventricle while 
they are absent from the myocardium of the left ventricle (LV)(Fig.13C-C’). At E9.5, 
HAND23xFLAG proteins are detected in the myocardium and endocardium in a region 
extending from the outflow tract to the right ventricle, (Fig.13D-D’) and in the 
endocardial cells of the atrioventricular canal (AVC, Fig.13E-E’). At E11.5, 
HAND23xFLAG proteins are present not only in the endocardium but also in the cells of 
the cardiac cushions (CC), formed by endothelial-mesenchymal transition (EndMT) in 
both OFT and AVC (Fig.13F-F’). HAND23xFLAG proteins are also detected in the 
epicardium at this stage. HAND23xFLAG proteins are nuclear, which agrees with their 
function as a transcription factor. In summary, our analysis of the cardiac 
HAND23xFLAG distribution confirms and refines its previously described expression 
pattern to single cell resolution during early heart development.  
 
6.2.2. ChIP-Seq analysis using pooled Hand2 expressing tissues identifies the 
genome-wide HAND2 target regions in association with tissue-specific 
gene functions 
Over the past two decades, numerous studies have been published aiming to 
decipher the functions of HAND2 during cardiogenesis, and genes downregulated 
during altered heart development in Hand2-deficient embryos had been identified. 
These putative HAND2 target genes include Gata4, Irx4, Nppa, Plxna2 and Cx40 
(Srivastava et al., 1997; Bruneau et al., 2000; Thattaliyath et al., 2002; Morikawa and 
Cserjesi, 2008; McFadden et al., 2005). However, none of these genes has been 
confirmed as direct endogenous target of HAND2, and the gene regulatory networks 
controlled by HAND2 during normal embryonic development remained unknown 
(Vincentz et al., 2011). Therefore, we used the Hand23xFLAG allele to identify the direct 
transcriptional targets of HAND2 during embryonic development.  
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For this purpose, M.Osterwalder and colleagues performed a chromatin 
immunoprecipitation in combination with deep sequencing (ChIP-Seq) using the 
Hand23xFLAG allele and the M2 anti-FLAG antibody. This analysis was performed 
using pooled Hand2 expressing embryonic tissues (heart, limb buds and branchial 
arches, see Fig.14A) from a pool of approximately 150 Hand23xFLAG/+ and 
Hand23xFLAG/3xFLAG embryos at E10.5. Hand2 is expressed at high levels in all these 
tissues, with the expression in cardiac tissues being very similar as observed at 
E11.5 (Fig.13F-F’ and data not shown). Expressing tissues were pooled to generate 
the significant amounts of chromatin immunoprecipitates required to assemble the 
genomic library for deep-sequencing. In addition, this allows the identification of both 
tissue-specific and shared candidate HAND2 targets genes. 
The HAND23xFLAG ChIP sample and the input control sample were sequenced using 
an Illumina Genome Analyzer in the Laboratory of Quantitative Genomics (D-BSSE, 
ETHZ, Basel). The resulting sequence tags were mapped to the reference mouse 
genome (NCBI37/mm9) and enrichment of ChIP versus input for each sequence tag 
were computed by R.Ivanek using MACS-based peak calling analysis (Model-based 
Analysis of ChIP-Seq data), see (Zhang et al., 2008b). The HAND23xFLAG ChIP-Seq 
peaks were visualized using the UCSC browser (Karolchik et al., 2014). A wild-type 
control ChIP sample was also processed and sequenced in parallel to the 
HAND23xFLAG sample to identify non-specific antibody-related false hits. Such false 
hits were excluded from further analysis, which reveals a major advantage of using 
epitope-tagged transcription factors for ChIP-Seq experiments. Analysis of the input 
was a critical control to confirm that the signal enrichment of the sequence tags in the 
HAND23xFLAG ChIP is representative of real transcription factor binding and not due to 
an experimental or computational bias (Rozowsky et al., 2009). To restrain the 
HAND23xFLAG ChIP-Seq dataset to the statistically relevant enriched genomic regions, 
only the 2000 highest enriched peaks according to MACS analysis (Top 2000, 
Fig.14B, left panel, green) were considered for further analysis using GREAT 
(Genomic Regions Enrichment Annotations Tool), (McLean et al., 2010). Most of the 
target regions mapped between 10-100kb from known transcriptional start sites 
(TSS), and encoded bona-fide E-box consensus CRTCTGKHTT sequences that 
were identified using the Homer software (Heinz et al., 2010).  
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Figure 14. ChIP-Seq using HAND23xFLAG embryos reveals HAND2 candidate target genes in 
developing heart and limb buds  
(A) Hand23xFLAG embryos were used for ChIP-Seq analysis from pooled dissected Hand2 expressing 
tissues at E10.5 (white arrowhead: heart. Black arrow: forelimb bud. Black arrowhead: branchial 
arches). For details see (Osterwalder et al., in press). (B) The top 2000 enriched genomic regions 
(green, left diagram) and their 2402 associated genes (green, right diagram) were intersected with 
regions bound by the transcriptional co-activator p300 in developing hearts (E11.5, red) and limb buds 
(E11.5, blue). (C) Gene Ontology analysis shows that genes associated with regions bound by both 
HAND2 and p300 are involved in cardiac (red, 240 genes) or limb bud (blue, 349 genes) development, 
respectively.  
 
This consensus sequence matches the CATCTG HAND2 binding site identified 
previously (Dai and Cserjesi, 2002). These whole-genome data are described in 
(Osterwalder et al., in press). The 2402 genes associated to the Top 2000 enriched 
genomic regions represent HAND2 candidate target genes in developing hearts, limb 
buds and branchial arches. To identify potential cardiac targets of HAND2, we 
intersected the Top 2000 peaks with regions interacting with the transcriptional co-
activator p300 in developing hearts (Blow et al., 2010) (Fig.14B, red), and limb buds 
(Visel et al., 2009a) (Fig.14B, blue) using the UCSC browser. p300 is a critical 
histone acetyltransferase that is part of the majority of enhancer-associated protein 
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complexes (Eckner et al., 1994; Yao et al., 1998; Visel et al., 2009a). Tissue-specific 
p300 ChIP-Seq datasets (Blow et al., 2010; Visel et al., 2009a) thus provide an 
additional validation of the range of HAND2 target sequences that act as potential 
cis-regulatory modules (CRMs) in heart and/or limb bud tissues development. 
GREAT analysis further identified the genes in proximity to the Top 2000 regions 
bound by both HAND2 and p300. The weak overlap suggests that most of the 
regions interacting with HAND2 are not associated with active genes, in agreement 
with the function of HAND2 as a transcriptional repressor (Fig.14B). The biological 
relevance of these genes was determined by Gene Ontology (GO) analysis 
(Ashburner et al., 2000) (Fig.14C). In each tissue, HAND2 interacting regions were 
associated with genes involved in development (e.g. GO “embryo development” or 
“embryonic morphogenesis”) and in DNA binding (e.g. GO “regulation of DNA 
binding”, not shown), relevant for HAND2 function as a transcription factor. Moreover, 
tissue-specific HAND2 p300 bound regions were associated with either cardiac 
(Fig.14C, red) or limb bud development GO terms, respectively (Fig.14C, blue). 
Notably, cardiogenesis related GO terms were representative of heart compartments 
with known Hand2 functions (e.g. GO “cardiac neural crest cell development involved 
in outflow tract morphogenesis” and GO “cardiac right ventricle morphogenesis”). In 
addition to Hand2 itself, several genes relevant to heart development were identified 
among the 240 genes associated with regions interacting with both HAND2 and 
p300. Table 1 summarizes the main functions of some of these genes. 
 
Table 1. Genes involved in cardiac development associated with a genomic region 
interacting with HAND2 and p300 
Gene Function 
Putative 
HAND2 
target 
References 
Hes1 OFT development - (Rochais et al., 2009a)  
Sox4 Ventricular septation and OFT formation - (Schilham et al., 1996)  
Tgfβ2 Inducing role in the EndMT process resulting in 
cardiac cushion formation, and cardiac valves 
remodeling 
- 
(Ma et al., 2005; Rivera-Feliciano 
and Tabin, 2006; Shirai et al., 
2009; Azhar et al., 2011) 
Tbx2 
Tbx3 
Tbx20 
Involved at several steps of cardiogenesis 
(Chambers differentiation, AVC patterning, 
formation of cardiac cushions, cardiac valves, and 
conduction system) 
- 
(Hariri et al., 2012; Greulich et al., 
2011; Hoogaars et al., 2007a; 
Stennard et al., 2005; Plageman 
and Yutzey, 2005)  
Plxna2 Cardiac neural crest cells migration Yes (Brown et al., 2001; Morikawa and Cserjesi, 2008)  
Cx40 
(Gja5) 
Heart-specific gap-junction coding gene Yes (Delorme et al., 1995; Kirchhoff et al., 2000; McFadden et al., 2005) 
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In contrast, the cis-regulatory landscapes of the putative HAND2 targets Gata4 and 
Nppa contain no associated ChIP-Seq peak. We used a Hi-C dataset representing 
the range of potential distant chromatin-chromatin interactions (Dixon et al., 2012), 
but could not detect any distant HAND23xFLAG ChIP-Seq peak associated with Gata4 
or Nppa, suggesting that these two genes are indirect targets of HAND2 (data not 
shown).  
Crossing the HAND23xFLAG ChIP-Seq data with the p300 tissue-specific genome-wide 
targets datasets thus identified tissue-specific targets and likely biological functions 
for Hand2. Therefore, this Gene Ontology analysis validates pooling embryonic 
tissues for ChIP-Seq analysis. In addition, it narrows the range of potential HAND2 
targets genes involved in each of the relevant developing tissues. A complete and 
functional analysis of the HAND2 target genes during limb bud development was 
performed by Osterwalder and colleagues (Osterwalder et al., in press), while I 
focused on the analysis of potential HAND2 target genes during heart development.  
 
6.2.3. HAND2 controls the expression of genes involved in early second heart 
field morphogenesis 
The transcriptional regulators Tbx2 and Tbx3 function during early development of 
second heart field (SHF) derived structures (Harrelson et al., 2004; Mesbah et al., 
2008; Mesbah et al., 2012). Both genes were identified by ChIP-Seq analysis as 
associated with genomic regions interacting with HAND23xFLAG chromatin complexes 
(Table 1, see chapter 6.2.10 for the analysis of their cis-regulatory landscapes). SHF 
progenitors reside initially in the splanchnic pharyngeal mesoderm in the dorsal wall 
of the pericardial cavity, before progressively migrating to the primary heart tube to 
contribute to the myocardium of the OFT and RV (Kelly, 2012). These cardiac 
structures and the pharyngeal mesoderm express high levels of HAND2 (Fig.13B-D), 
and are hypoplastic in Hand2-deficient embryos (Srivastava et al., 1997). We 
therefore wanted to gain insights into HAND2 functions in the transcriptional networks 
governing SHF morphogenesis by looking at the early expression of key cardiac 
genes. The early marker of the SHF Isl1 remains expressed normally in the 
pharyngeal mesoderm of Hand2-deficient embryos (E8.25, Fig.15A-B), indicating that 
the SHF forms normally. 
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Figure 15. Expression of early cardiac development markers in wild-type and Hand2-deficient 
embryos 
Effects of Hand2 inactivation on the expression of cardiac genes at E8.25-E8.5. (A-B) Isl1 expression 
is not altered (right side view). (C-D) Tbx2 expression is ectopically expressed in pharyngeal 
mesoderm (arrowheads, compare with Isl1 expression domain in (A)). (E-F) Tbx3 expression is 
expanded towards the OFT (arrowheads). (G-J) Nppa expression is reduced at E8.25 (G-H, front 
view) and lost in the RV at E9.5 (I-J, arrowheads). (K-L) Wnt11 expression is reduced in the OFT 
(arrowheads). (M-X) The expression of Tbx1 (M-N), Tbx5 (O-P), Nkx2.5 (Q-R), Mef2c (S-T), Bmp4 (U-
V), and Fgf8 (X-Y) are not altered in Hand2-deficient embryos.  
 
 
Interestingly, Tbx2 and Tbx3 are expressed ectopically in the Isl1 positive cells of the 
pharyngeal mesoderm (compare Fig.15C with Fig.15A and Fig.15D with Fig.15B), 
and expands to the OFT (compare Fig.15D,F with Fig.15C,E). In contrast, the 
expression of Nppa, which is repressed by TBX2 and TBX3 and required for cardiac 
	
   	
    
	
   93 
chambers differentiation (Habets et al., 2002; Hoogaars et al., 2004; Houweling et al., 
2005) is reduced in Hand2-deficient embryos (E8.25, Fig.15G-J), and totally absent 
from the hypoplastic RV (E9.5, Fig.15I-J, arrowheads (Morikawa and Cserjesi, 2008; 
Thattaliyath et al., 2002). These data indicate that the ectopic expression of 
Tbx2/Tbx3 in myocardial progenitors of the anterior SHF in Hand2-deficient embryos 
(Fig.15D,F) accounts for the loss of Nppa expression in the right ventricle, while the 
right ventricle hypoplasia might be an indirect consequence of these alterations. 
Wnt11 is also essential for the differentiation of SHF cells in the OFT and RV (Cohen 
et al., 2012; Zhou et al., 2007; Pandur et al., 2002), and its expression is strongly 
reduced in the OFT of Hand2-deficient embryos (Fig.15K-L). A region located 58kb 
upstream of Wnt11 is among the highly enriched candidate CRMs associated to 
HAND23xFLAG chromatin complexes, but this remains to be verified and functionally 
analyzed further (data not shown).  
In contrast, the expression of several other important cardiac genes involved in the 
balance between proliferation and differentiation of the SHF progenitors was not 
affected by the loss of Hand2 (Tbx1, Tbx5, Nkx2.5, Mef2c, Bmp4, Fgf8: Fig.15M-X). 
In conclusion, Hand2 controls distinct aspects of the formation of SHF derived 
structures through a specific set of cardiac regulators (Tbx2, Tbx3, Wnt11).  
 
6.2.4. HAND2 controls the expression of genes associated with known cardiac-
specific enhancers  
The VISTA enhancer browser is a database consisting of conserved enhancer 
elements that were tested for LacZ reporter expression (Visel et al., 2007; Attanasio 
et al., 2013). It can therefore be used to identify overlaps between known cardiac 
enhancers and the putative CRMs identified by HAND23xFLAG ChIP-Seq analysis. 
Indeed, this analysis identified Furin and Myocardin (Myocd) as potential direct 
HAND2 target genes. These two genes have been previously established as 
essential for cardiac development and their landscapes encode VISTA enhancers 
that are expressed in the heart and interact with HAND2 and p300 protein 
complexes. 
Furin encodes a proprotein convertase that activate signals from the TGFβ family 
such as BMP4, TGFβ1 and BMP10 by proteolytic cleavage (Cui et al., 1998; Cui et 
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al., 2001; Dubois et al., 2001; Susan-Resiga et al., 2011). In the developing heart, 
both the endocardial and myocardial layers express Furin (Roebroek et al., 1998). 
Embryos deficient in Furin suffer from cardia bifida, which may still result in formation 
of a short single heart tube that fails to undergo looping, and eventually die around 
E10.5 (Roebroek et al., 1998; Constam and Robertson, 2000). Endothelial-specific 
inactivation of Furin results in ventricular septation defects and cardiac valve 
thickening, which is paralleled by reduced BMP4 activation processing (Kim et al., 
2012).  
MYOCD is a transcriptional co-activator of serum response factor (SRF) that 
modulates the expression of tissue-specific SRF-target genes by functioning as a 
switch between smooth and cardiac skeletal muscle differentiation (Wang et al., 
2001; Li et al., 2003; Wang et al., 2003; Long et al., 2007; Hoofnagle et al., 2011). 
Myocd expression is restricted to these two types of muscles cells, and its 
inactivation induces embryonic lethality by E10.5 due to defective smooth muscle 
vasculature (Li et al., 2003). In adult mice, Myocd function is critical for 
cardiomyocytes survival (Huang et al., 2009). 
We used the UCSC browser to visualize the HAND23xFLAG ChIP-Seq peaks together 
with the cardiac p300 ChIP-Seq peaks and the conservation of these regions in 
placental mammals (Fig.16A,E). All other panels representing ChIP-Seq data are 
organized in accordance with Fig.16A,E. The Furin cis-regulatory landscape encodes 
a -43kb region, highly enriched for HAND2 and p300 binding (green bar in Fig.16A). 
This region overlaps (blue bar in Fig.16A) the VISTA enhancer mm169 that is 
expressed in the heart (Fig.16B) and abdominal region (data not shown, see VISTA 
browser). The direct interaction of HAND2 complexes with this enhancer was 
confirmed by ChIP-qPCR using embryonic hearts (E10.5, Fig.16C. See chapter 9.4.6 
for fold enrichments calculations). This analysis established the significant 200-fold 
enrichment of HAND2 interactions with Furin -43kb enhancer in comparison to an 
unrelated other region chosen for its absence of enrichment by ChIP-Seq analysis (-
50kb, Fig.16A and Fig.16C). To determine if Furin is indeed a direct transcriptional 
target of HAND2, we compared its expression in wild-type and Hand2-deficient 
embryos (E9.0-E9.25, Fig.16D). Furin expression is altered in Hand2 mutant hearts, 
in particular in the endocardium (Fig.16D, right panels, arrows). 
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Figure 16. Furin and Myocd are direct targets of HAND2 in the developing heart 
UCSC browser windows representing the Furin (A) and Myocd (E) cis-regulatory landscapes. 
Distances to TSS are indicated in kb. HAND23xFLAG  ChIP-Seq peaks are shown in green and p300 
ChIP-Seq peaks in hearts (E11.5) are shown in black, above the placental mammal conservation 
(Cons) plot (PhyloP, UCSC Genome Browser). Green bars indicate HAND23xFLAG peaks in the top 
2000 enriched regions. (B,F) LacZ reporter expression of the VISTA browser enhancers represented 
by blue bars in (A) and (E). (C,G) ChIP-qPCR establishing binding of HAND23xFLAG chromatin 
complexes at Furin (C) and Myocd (G) associated cardiac enhancers in E10.5 hearts. No enrichment 
was seen in control regions. Mean ±SD (n=3) is shown. (D,H) Expression of Furin (D) and Myocd (H) 
in wild-type and Hand2∆/∆ embryonic hearts (E9.0-9.5) using whole mount RNA in-situ hybridization. In-
situ hybridization on paraffin sections shows the specific loss of Furin from the endocardium (indicated 
by arrows). 
 
 
Similarly, HAND2 containing chromatin complexes are enriched at an intronic region 
located +60kb upstream of the Myocd TSS (Fig.16E, green bar), which overlaps with 
the heart-specific VISTA enhancer mm67 (blue bar inFig.16E, expression in Fig.16F). 
Direct interaction of HAND2 with this CRM was confirmed by ChIP-qPCR (Fig.16G). 
In agreement, Myocd expression is altered in Hand2-deficient embryos (Fig.16H). 
Together, these results indicate that Hand2 is required for Furin and Myocd 
expression, and that these genes are likely direct HAND2 targets whose expression 
is regulated by cardiac enhancers. 
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6.2.5. Hand2-deficient mouse embryos lack the delaminated endocardial cells 
in the atrioventricular canal 
In response to myocardial signals, endocardial cells in the AVC undergo an 
endothelial-mesenchymal transition (EndMT) around E9.5. These cells delaminate 
and migrate into the cardiac jelly, where they proliferate and form the cardiac 
cushions that will ultimately give rise to the cardiac valves (Armstrong and Bischoff, 
2004; von Gise and Pu, 2012; Kovacic et al., 2012; Lim and Thiery, 2012; Lin et al., 
2012). As HAND2 is expressed by both the endocardium of the AVC and the 
mesenchymal cells of the cardiac cushions (Fig.13E-F), we investigated if HAND2 
regulates endocardial genes that control EndMT mechanism and formation of the 
cardiac cushions.  
 
Using sagittal sections, I first studied the morphological alterations of the AVC in 
Hand2-deficient embryos. Compared to wild-type hearts in which AVC endocardial 
cells delaminate normally (E9.5, Fig.17A, asterisk in top panel), a total absence of 
delaminated cells was apparent in Hand2-deficient embryos (E9.5, Fig.17A, bottom 
panel). Furthermore, the superior and inferior layers of the endocardium were not in 
contact, leaving an opening in the AVC lumen (Fig.17A). To confirm that the absence 
of delaminated cells was not due to increased endocardial cell death, wild-type and 
Hand2-deficient hearts were analyzed by TUNEL (E9.5, Fig.17B). No increase in 
apoptotic cell number was observed in Hand2-deficient hearts, which thus excludes 
cell death as likely cause of delamination failure. In addition, the expression of the 
transcription factor NFATC1 (Nuclear Factor of Activated T cells) was analyzed as it 
is expressed specifically in endothelial cells of the endocardium and not required for 
EndMT. Its functions in maintaining the endocardial lineage are crucial for valve 
remodeling at later stages (Ranger et al., 1998; de la Pompa et al., 1998; Wu et al., 
2011; Chang et al., 2004). NFATC1 is coexpressed with HAND2 in the endocardium 
and remains expressed normally in Hand2-deficient embryos (Fig.17C). This analysis 
indicate that the endocardium of Hand2-deficient embryos is normally patterned with 
respect to the fates of cardiac valve progenitors. The absence of delaminated cells is 
thus not due to an endocardial defect but likely a consequence of defective EndMT 
and/or migration of the cardiac cushion progenitors. 
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Figure 17. Absence of delaminated endocardial cells in the atrioventricular canal (AVC) of 
Hand2-deficient embryos 
(A) Hematoxylin-eosin staining of sagittal heart sections in Hand2-deficient embryo (lower panel) 
compared to wild-type embryos (top panel) (E9.5). Black arrow: endocardium, black asterisk: 
mesenchymal cells of the cardiac cushions, lv: left ventricle, avc: atrioventricular canal, la: left atrium. 
(B) TUNEL assay using sagittal heart sections of Hand2-deficient embryos (lower panel) and wild-type 
controls (top panel) (E9.5). Apoptotic cells are shown in green, nuclei are counterstained with Hoechst 
(blue). White arrow: endocardium, white arrowhead: myocardium. (C) The endocardial marker 
NFATC1 co-localizes with HAND2 in the AVC (white arrow, top panel) and remains expressed in 
Hand2-deficient embryos (open arrow, lower panel). Scale bar: 100µm.  
 
6.2.6. HAND2 directly regulates Has2-mediated extracellular matrix deposition 
in the cardiac jelly 
To gain further insight into the defective delamination of AVC endocardial cells, the 
glycosaminoglycans in the extracellular matrix (ECM) were stained by alcian blue. 
Glycosaminoglycans are required for the migration of cardiac cushion progenitors 
into the cardiac jelly. Indeed, the ECM in the cardiac jelly of the AVC appears 
reduced in Hand2-deficient hearts in comparison to wild-type controls (Fig.18A). This 
suggests that the endocardial cells are unable to migrate properly, which would 
explain the lack of cardiac cushion progenitors in the absence of Hand2 (Fig.17A).  
The enzyme Hyaluronan Synthase 2 (Has2) produces one major component of the 
ECM, the hyaluronic acid (HA). Has2 is downregulated by Hand2-deficient embryos, 
which, together with its requirement for cardiac jelly and cardiac cushion formation, 
points to it being a potential direct HAND2 target (Tsuchihashi et al., 2011; 
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Camenisch et al., 2000). Indeed, our ChIP-Seq analysis revealed two HAND2 binding 
regions within the proximal promoter of Has2 located 2.4kb downstream and 0.9kb 
upstream of the TSS, respectively (Fig.18B). ChIP-qPCR analysis of E10.5 
HAND23xFLAG hearts established that HAND2 complexes interact with the +2.4kb 
region but neither to the -0.9kb nor to a control region (Fig.18C). In agreement, the 
expression of Has2 is altered in the AVC of Hand2-deficient hearts (Fig.18D).  
 
 
Figure 18.  
The production of 
extracellular matrix in 
AVC cardiac jelly is 
regulated by HAND2, 
possibly by direct 
regulation of Has2 
expression 
(A) Alcian Blue staining 
of sagittal heart sections 
in Hand2-deficient 
embryos (right panel) 
and wild-type controls 
(left panel) (E9.5). (B) 
UCSC browser windows 
representing the Has2 
proximal promoter 
region. Green bars 
indicate HAND23xFLAG 
peaks in the top 2000 
enriched regions. The 
light blue bar at -0.9kb 
represents the location 
of a published enhancer 
that is active in limb 
buds (Liu et al., 2013). 
(C) ChIP-qPCR 
establishing direct interaction of HAND23xFLAG chromatin complexes with the Has2 proximal promoter 
in E10.5 hearts (E10.5). The -4.3kb region is used as negative control. Mean ±SD (n=3) is shown. (D) 
Expression of Has2 in wild-type and Hand2∆/∆ embryonic heart by whole mount (left panels) and 
section (right panels) in-situ hybridization (E9.5). (E) Transgenic embryo (E10.5, n=1) showing LacZ 
expression under control of the  +2.4kb CRM in the Has2 intronic region indicated by a dark blue bar in 
panel (B). The transgene is not expressed in the heart (E’) but in the dorsal and ventral forelimb bud 
mesenchyme (E’’) and in the dorsal hindlimb bud mesenchyme (E’’’). 
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These results support the proposal that Has2 is as a direct target of HAND2 in the 
developing heart. To assess the potential transcription enhancing activity of the 
+2.4kb region, we used a LacZ reporter assay in transgenic mouse embryos. 
Preliminary analysis shows that the region encompassing the Has2 +2.4kb HAND2 
peak (Fig.18B, dark blue bar) drives reporter expression in the somites, second 
branchial arch and in the limb buds of a transgenic embryo at E10.5 (n=1, Fig.18E). 
However, no LacZ reporter expression was detected in the heart (Fig.18E’). In limb 
buds, the LacZ expression is restricted to the dorsal and ventral forelimb sub-
ectodermal mesenchyme (Fig.18E’’) and to the dorsal hindlimb (Fig.18E’’’). 
Preliminary ChIP-qPCR analysis confirms that HAND2 complexes bind to this +2.4kb 
region in developing limb buds (E10.5, data not shown). The lack of reporter 
expression in the heart may be an effect of the transgene insertion site and needs to 
be investigated by the generation of additional independent transgenic founders 
embryos (currently ongoing). This is important as our other findings support a role of 
HAND2 in regulating Has2 during the formation of the cardiac cushions.  
 
6.2.7. Twist1 but not Sox9 is a direct transcriptional target of HAND2 during 
cardiac cushion formation  
Twist1 and Sox9 are required for the proliferation and differentiation of the 
mesenchymal cells of the cardiac cushions (Shelton and Yutzey, 2008; Akiyama et 
al., 2004) and regions interacting with HAND2 complexes were detected in the 
regulatory landscapes of both genes. We therefore investigated if alterations in these 
two putative HAND2 targets could contribute to the disruption of cardiac cushion 
morphogenesis in Hand2-deficient embryos. HAND2 complexes interact with several 
regions within Twist1 cis-regulatory landscape; the most enriched being located at 
+10kb and at +130kb from Twist1 TSS (Fig.19A). ChIP-qPCR analysis confirmed that 
both regions are enriched in HAND2 containing chromatin complexes in developing 
hearts (E10.5, Fig.19B). Furthermore, preliminary ChIP-qPCR results indicate that 
the binding region at +130kb is not enriched in limb buds, suggesting that it could be 
a heart-specific CRM bound by HAND2 complexes (data not shown). Therefore, the 
corresponding genomic region encoding this peak is currently being used to generate 
LacZ reporter transgenic embryos (dark blue bar in Fig.19A). 
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Figure 19. HAND2 directly control Twist1 expression in the cells of the cardiac cushions 
(A) UCSC browser windows representing the HAND23xFLAG ChIP-Seq peaks within Twist1 cis-
regulatory landscape. The green bar at +130kb from Twist1 TSS indicates top2000 enriched region. 
The dark blue bar at +130kb represents the genomic region used to generate transgenic reporter 
embryos. The light blue bar at +10kb represents the location of the VISTA enhancer hs1880 not active 
at E11.5. (B) ChIP-qPCR establishing direct interaction of HAND23xFLAG chromatin complexes with the 
Twist1 +10kb and +130kb regions in hearts (E10.5), but not with the control region located at +135kb. 
Mean ±SD (n=3) is shown. (C) Expression of Twist1 in wild-type and Hand2∆/∆ embryonic heart at 
E9.5. (D,F) TWIST1 is co-expressed with HAND2 in the mesenchymal cells of the cardiac cushions 
(white asterisks) but not endocardial cells (white arrow) at E9.5 (D) and E10.5 (F). (E) TWIST1 is not 
expressed by the AVC of Hand2-deficient embryos (open arrow: endocardium). (G) TWIST1 is also 
co-expressed with SOX9 in the mesenchymal cells of the cardiac cushions (white asterisks) at E10.5. 
Scale bar: 100µm 
 
 
In contrast, the human orthologous region encompassing the putative HAND2 CRM 
at +10kb does not drive LacZ reporter expression in transgenic reporter embryos 
(E11.5, VISTA element hs1880, light blue bar in Fig.19A). Twist1 expression is totally 
lost from the AVC of Hand2-deficient hearts (E9.5, Fig.19C), in agreement with 
Twist1 being a direct transcriptional target of HAND2. Indeed, the TWIST1 protein is 
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co-expressed with HAND2 in the progenitors that have delaminated after the initial 
EndMT (Fig.19D, white asterisks). In Hand2-deficient hearts, no cells expressing 
TWIST1 are detected in the AVC as expected from the absence of delaminated cells 
(Fig.19E). By E10.5, TWIST1 is co-expressed in all cardiac cushion progenitors with 
HAND2 (Fig.19F) and SOX9 (Fig.19G). In summary, this analysis shows that Twist1 
expression depends on HAND2 during cardiac cushion formation. The CRM identified 
130kb upstream of Twist1 TSS is likely involved in mediating direct transcriptional 
regulation of Twist1 expression by HAND2 after delamination. 
 
The expression of Sox9 is downregulated in the AVC of Twist1-deficient embryos 
(Vrljicak et al., 2012). The co-expression of HAND2, TWIST1 and SOX9 by cardiac 
cushion progenitor cells suggests that Sox9 may also be a direct target of HAND2 in 
these cells, but no region interacting with HAND2 in Sox9 genomic landscape in 
developing hearts could be confirmed to date (ChIP-Seq and ChIP-qPCR, data not 
shown). In wild-type embryos, SOX9 expression initiates on the atrial side of the AVC 
in cells that have undergone EndMT. In these cardiac cushion progenitors, SOX9 is 
coexpressed with HAND2 (E9.5, Fig.20A, white asterisks). 
 
 
 
Figure 20. Sox9-mediated 
cardiac jelly invasion is 
not regulated by HAND2 
(A) SOX9 is co-expressed 
with HAND2 in the 
mesenchymal cells of the 
cardiac cushions (white 
asterisks) but not 
endocardial cells (white 
arrow) at E9.5. (B) In Hand2-
deficient embryos, SOX9 
remains expressed in 
endocardial cells (open 
arrow). Scale bar: 100µm 
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The remainder of the AVC endocardium expresses only HAND2 (Fig.20A, white 
arrow). Interestingly, in Hand2-deficient hearts SOX9 is expressed in endocardial 
cells located on the atrial side of the AVC (Fig.20B, open arrow), at the atrial-
ventricular position where the first delaminated SOX9-positive cells normally would 
appear. As these cells express SOX9 but fail to delaminate, it suggests that the initial 
EndMT, prior to Sox9-dependant cardiac jelly invasion, might be impaired in Hand2-
deficient hearts.  
 
6.2.8. Snai1-dependent initiation of endothelial-mesenchymal transition in the 
atrioventricular canal is regulated by HAND2 
We have shown that Hand2-deficient embryos lack delaminated cardiac cushion 
progenitors, and have obtained evidence that this phenotype could be caused by 1) 
deficient Has2-mediated control of ECM production impairing cellular migration; and 
by 2) a defect in Twist1-mediated regulation of the proliferation of post-EndMT 
delaminated cardiac cushion progenitors. We therefore wondered whether the initial 
EndMT was also affected by the Hand2 deficiency, and investigated the expression 
of the EMT inducing transcription factor SNAI1 and its downstream effectors.  
Consistent with the hypothesis of a likely underlying EndMT defect in Hand2 mutant 
hearts, Snai1 expression was totally lost from mutant AVC by E9.5 (Fig.21A). 
Furthermore, several HAND2 interacting regions were identified within Snai1 genomic 
landscape (Fig.21B). ChIP-qPCR analysis confirmed the existence of HAND2 binding 
regions located 45kb, 58kb and 59kb downstream of Snai1 TSS in developing hearts 
(E10.5, Fig.21C). The genomic region encompassing the peaks at +58/59kb (blue 
bar in Fig.21B) was used to generate LacZ reporter transgenic mouse embryos (n= 
5, Fig.21D). This CRM is active in the branchial arches, craniofacial structures 
(Fig.21D’), forelimbs, and epicardium (Fig.21D’’). The extent of cardiac expression 
will require histological analysis. The pattern of LacZ reporter expression in these 
embryonic structures is similar to the Snai1 endogenous expression at an equivalent 
developmental stage (E10.5, (Sefton et al., 1998)).  
To gain further insight into the potential disruption of the EndMT in Hand2-deficient 
hearts, VE-Cad and VIM distribution were studied. Both these genes are established 
Snai1 targets during cardiac cushion formation (Timmerman et al., 2004; Cano et al., 
2000; Batlle et al., 2000). 
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Figure 21. Snai1 expression and the downstream endothelial-mesenchymal transition are 
altered in the AVC of Hand2-deficient embryos 
(A) Expression of Snai1 in wild-type and Hand2∆/∆ embryonic heart at E9.5. (B) UCSC browser 
windows representing the regions enriched in HAND23xFLAG chromatin complexes in Snai1 cis-
regulatory landscape. The green bar at +58-59kb from Snai1 TSS indicates top2000 enriched region. 
The dark blue bar represents the genomic region used to generate transgenic reporter embryos. (C) 
ChIP-qPCR establishing direct interaction of HAND23xFLAG chromatin complexes with the Snai1 +45kb, 
+58kb and +59kb regions in hearts (E10.5). The +64kb region is used as negative control. Mean ±SD 
(n=3) is shown. (D) Transgenic embryo (E10.5, n=5) showing LacZ expression under control of the 
CRM located +58/59kb from the Snai1 TSS. The transgene is active mainly in craniofacial structures 
(D’) and in the epicardium (D’’). (E) In the wild-type AVC, VE-Cad is expressed at intercellular 
junctions in the endocardium (red, white arrow) but not delaminated cardiac cushion cells (white 
asterisk). VIM is expressed by both endocardial and cardiac cushion cells. (F) The endocardium of 
Hand2-deficient embryos expresses VE-Cad but not VIM (red, open arrow) but not VIM. Scale bar: 
50µm 
 
 
In wild-type embryos, VE-Cadherin marks the intercellular junctions between the cells 
of the endocardium (Fig.21E, white arrow) while it is no longer expressed by the 
delaminated progenitors (Fig.21E, white asterisk). In contrast, VIM is expressed by 
both endocardial (Fig.21E, white arrow) and delaminated progenitors (Fig.21E, white 
asterisk). Remarkably, VE-Cad remains expressed by the endocardium of Hand2-
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deficient hearts (Fig.21F, open arrow), while VIM is lost from these cells (Fig.21F, 
white arrow). Endocardial cells of the AVC in Hand2-deficient embryos lack Snai1 
expression and characteristic EndMT changes that normally allow them to initiate 
delamination and migration. Both SNAI1-mediated disassembly of VE-Cad positive 
junctions between endocardial cells and the activation of the motile cellular 
phenotype in VIM positive cells are disrupted in the absence of HAND2. Together, 
these findings indicate that HAND2 regulates EndMT by directly controlling Snai1 
expression.  
 
6.2.9. The Hand2 loss-of-function affects the EndMT upstream signaling but 
not the patterning of the myocardium 
The EndMT of the AVC endocardial progenitors is initiated by BMP2 signaling from 
the surrounding myocardium and additionally involves myocardial TGFβ2 and 
endocardial GATA4 and Notch1 (Ma et al., 2005; Rivera-Feliciano et al., 2006; 
Timmerman et al., 2004; Luna-Zurita et al., 2010). As HAND2 appears to directly 
regulate the expression of key genes involved in EndMT, we investigated if the 
upstream myocardial signaling events are also altered by loss of Hand2 functions.  
In the myocardium of E9.5 Hand2-deficient embryos, Bmp2 is expressed in a smaller 
subdomain of the AVC than in wild-type (Fig.22A) and the expression of its 
downstream effector Msx1 is lost from the endocardium (Fig.22B). In addition, in 
Hand2-deficient embryos Gata4 expression is also lost from the endocardium 
(Fig.22C) and Tgfβ2 expression from the myocardium (Fig.22D). In contrast, Notch1 
expression is not affected by the loss of Hand2 (Fig.22E). These alterations raise the 
possibility that in addition to a direct role in EndMT, Hand2 also functions in 
regulating these signaling cascades in the endocardium, possibly downstream of 
Notch1 and BMP2 and upstream of Gata4. The reduced Bmp2 expression in the 
AVC myocardium (Fig.22A) could be a consequence of a patterning defect in the 
AVC, which would impact on myocardium-endocardium signaling. For this reason, we 
also analyzed the expression of Tbx2 and Tbx3 that are required downstream of 
Bmp2 for the patterning of the AVC by inhibiting chamber differentiation through 
Nppa repression (Ma et al., 2005; Christoffels et al., 2004). 
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Figure 22. Expression of 
EndMT-inducing signals in 
wild-type and Hand2-deficient 
embryos 
(A) The Bmp2 expression 
domain in the AVC myocardium 
of Hand2-deficient embryos is 
reduced in comparison to wild-
type embryos (E9.5, 
arrowheads). (B,C) The 
expression of Msx1 (B) and 
Gata4 (C) are lost from the 
endocardium of the AVC in 
Hand2-deficient embryos (E9.5, 
arrows). (D) Tgfβ2 expression is 
lost from the myocardium of the 
AVC in Hand2-deficient embryos 
(E9.5, arrowheads). (E) Notch1 
expression is not significantly 
altered in Hand2-deficient hearts. 
 
 
 
 
In Hand2-deficient embryos, the expression of TBX2 and TBX3 is not altered in the 
myocardium of the AVC (Fig.23A-10D) and remains complementary to Nppa 
expression in the left ventricle and atrium (Fig.23E). Finally, the delineation of LV-
AVC boundary by Hey2 is also not altered by the inactivation of Hand2 (Fig.23F), 
which shows that the AVC myocardium is correctly patterned in spite of the more 
restricted Bmp2 expression domain. Therefore, the defects in the EndMT in Hand2-
deficient embryos cannot be a consequence of altered myocardial signaling. The loss 
of Tgfβ2 and Msx1 expression (Fig.22B,D) is rather caused by an intermediate role of 
HAND2 between the Notch1/Bmp2/Tgfβ2 endocardium-myocardium feedback loops 
and the direct regulation of the Snai1 dependent EndMT. 
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Figure 23. The myocardium of the AVC is normally patterned in Hand2-deficient embryos 
(A-D) In wild-type embryos (E9.5), TBX2 (A) and TBX3 (C) are expressed in the myocardium of the 
AVC (white arrows) whereas HAND2 is expressed in the endocardium (white arrowheads). In Hand2-
deficient embryos, both TBX2 (B) and TBX3 (D) remain expressed by the myocardium (open 
arrowheads). Scale bar: 50µm (E) Nppa expression is identical in the LV and LA myocardium of wild-
type and Hand2-deficient embryos. (F) The LV-AVC boundary is marked by the limit of Hey2 
expression domain and remains in Hand2-deficient embryos. 
 
6.2.10. Tbx2 and Tbx3 are direct targets of HAND2 during cardiac development  
We showed that Hand2 deficiency alters Tbx2 and Tbx3 expression in SHF 
progenitors (E8.25, Fig.15C-F), but not their expression in the myocardium of the 
AVC (E9.5, Fig.23A-D). Several regions within both Tbx3 and Tbx2 cis-regulatory 
landscapes were identified by the HAND23xFLAG ChIP-Seq analysis (Fig.24A and 
Fig.25C).  
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Figure 24. The Tbx3 -18kb element is bound by HAND2 chromatin complexes in developing 
hearts and displays cardiac-specific enhancer activity 
(A) UCSC browser windows representing HAND23xFLAG ChIP-Seq peaks in theTbx3 cis-regulatory 
landscape. The green bars at -58kb and -18kb from Tbx3 TSS indicate top2000 enriched regions. The 
dark blue bar represents the genomic regions used to generate transgenic reporter embryos which 
expression are shown in (C) and D). (B) ChIP-qPCR from embryonic hearts (E10.5, red, left panel) 
and limb buds (E10.5, green, right panel) establish that HAND2 chromatin complex interact 
preferentially with the Tbx3 -18kb CRM in developing hearts and with the -58kb CRM in limb buds. (C) 
The Tbx3 -18kb CRM shows heart-specific enhancer activity in LacZ-reporter transgenic embryos. The 
transgene is expressed in the AVC, OFT and interventricular septum (IVS). (D) In contrast, the -58kb 
CRM drives reporter expression in limb buds and flank mesoderm but not in the developing heart. (E) 
The Tbx3 -18kb CRM is active in the cells of the prospective atrioventricular node. 
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Tissue-specific ChIP-qPCR established that the region located -18kb upstream of the 
Tbx3 TSS was enriched mostly in HAND2 chromatin complexes isolated from 
developing hearts (E10.5, Fig.24B, left panel), while the -58kb region was enriched 
mostly in developing limb buds and flank tissues (E10.5, Fig.24B, right panel). To 
further determine if these candidate CRMs function as transcriptional enhancers, 
transgenic mouse embryos using a LacZ reporter construct were produced by 
M.Shoukry in the laboratory of A.Visel (Berkeley, USA). This analysis reveals that the 
-18kb CRM enhances expression in the AVC, OFT and interventricular septum 
(Fig.24C). In contrast, the activity of the -58kb CRM is restricted to the posterior-
proximal forelimb bud and flank mesenchyme (Fig.24D). The CRM-LacZ reporter 
expression patterns are consistent with the ChIP-qPCR binding profiles (Fig.24B), 
which reveal tissue-specific functional relevance of the HAND2 interaction with these 
two Tbx3 CRMs. The CRM located at -18kb is expressed in the atrioventricular node 
(AVN) in the cells that express Tbx3 in the myocardium adjacent to the cardiac 
cushions (Fig.24E, (Christoffels et al., 2010). Prior to formation of the AVN, no LacZ 
expression driven by this CRM was observed (data not shown). Interestingly, this 
CRM is located within the 160kb genomic landscape (spanning from -83kb to +77kb) 
previously identified as regulating Tbx3 expression in both AVN and limb buds 
(Horsthuis et al., 2009). Our ChIP-Seq analysis not only identified a discrete AVN-
specific CRM within Tbx3 cis-regulatory landscape, but also established this CRM as 
interacting directly with HAND2 chromatin complexes during the regulation of Tbx3-
mediated development of the cardiac conduction system. 
Next, we determined the TBX3 and HAND2 protein distribution at E11.5, when Tbx3 -
18kb CRM drives reporter expression in the AVN (Fig.24E), but no evidence of cells 
co-expressing both transcription factors was obtained. While TBX3 is confined to the 
myocardium (Fig.25A, white arrowheads), HAND2 is expressed in the endocardium 
(Fig.25A, white arrows) and mesenchymal cells of the cardiac cushions (Fig.25A, 
white asterisks). One possible explanation is that the Tbx3 -18kb CRM is repressed 
in HAND2 expressing cells and is active in the myocardium of the AVN due to the 
lack of HAND2 chromatin complexes. The enrichment of HAND2 complexes at this 
CRM in limb buds (Fig.24B, right panel), in combination with lack of LacZ reporter 
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expression (Fig.24C) is in agreement with the proposal that the HAND2 chromatin 
complexes repress this CRM.  
 
 
Figure 25. HAND2 directly interacts with a CRM located in Tbx2 cis-regulatory landscape in 
developing hearts 
(A) Expression of TBX3 (red) and HAND2 (green) in the AVC at E11.5. TBX3 is expressed by 
myocardial cells (white arrowheads) and HAND2 in endocardial cells (white arrows) and mesenchymal 
cells of the cardiac cushions (white asterisks). (B) Expression of TBX2 (red) and HAND2 (green) in the 
AVC at E11.5. TBX2 is expressed in myocardial cells (white arrowheads) and co-expressed with 
HAND2 in mesenchymal cells of the cardiac cushions (white asterisks). Scale bar: 100µm. (C) UCSC 
browser windows representing HAND23xFLAG ChIP-Seq peaks in the Tbx2 cis-regulatory landscape. 
The green bars at -112kb and -32kb from Tbx2 TSS indicate top2000 enriched regions. The light blue 
bar at -112kb indicates a limb bud enhancer (Infante et al., 2013). The dark blue bar at -32kb indicates 
the genomic region used to generate transgenic reporter embryos. (D) ChIP-qPCR from E10.5 
embryonic hearts (red, top panel) and limb buds (green, bottom panel) establishes that HAND2 
chromatin complexes interacts preferentially with the Tbx2 -32kb CRM in the heart and with the -112kb 
CRM in limb bud. 
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In contrast to TBX3, TBX2 is coexpressed with HAND2 in the cardiac cushion cells at 
E11.5 (Fig.25B, white asterisks). Of the two candidates CRMs interacting with 
HAND2 within Tbx2 regulatory landscape, the CRM located 112kb upstream of Tbx2 
(Fig.25C, light blue bar) has previously been shown to act as a transcriptional 
enhancer active in the posterior limb bud mesenchyme (Infante et al., 2013). 
Accordingly, the enrichment of HAND2 chromatin complexes encompassing this 
CRM was higher in developing limb buds than hearts (Fig.25D). In contrast, the -32kb 
candidate CRM is enriched both in developing hearts and limb buds (Fig.25D). 
Transgenic embryos using this region are currently being generated (dark blue bar in 
Fig.25C, results not yet available). Given the colocalization of TBX2 and HAND2 in 
mesenchymal cells of the cardiac cushions (E11.5, Fig.25B), we expect this -32kb 
CRM to drive LacZ expression in developing cushions. If the enrichment of this CRM 
in HAND2 chromatin complexes isolated from limb buds is functionally relevant 
(Fig.25D, lower panel), LacZ expression should also be detected in limb buds.  
 
Another member of the T-box gene family important for cardiac development is 
Tbx20. While myocardial Tbx20 regulates Bmp2 expression in the AVC, endocardial 
Tbx20 is not required for EndMT (Cai et al., 2011; Cai et al., 2013). A prominent 
HAND2 ChIP-Seq peak was identified 200kb upstream of the Tbx20 TSS (Fig.26A, 
green bar). This region is the orthologous of a human VISTA enhancer element 
(hs463, Fig.26A, dark blue bar) that drives LacZ reporter expression in the heart of 
transgenic embryos (Fig.26B). However, no changes in Tbx20 expression were 
detected in the developing hearts of Hand2-deficient embryos (Fig.26C). This agrees 
with previous observations indicating that Tbx20 acts upstream of Hand2 (Singh et 
al., 2005; Takeuchi et al., 2005). Nevertheless, the high enrichment of HAND2 
chromatin complexes at the CRM located -200kb from Tbx20 points to a possible 
involvement of HAND2 at late stages on Tbx20-mediated maturation of the cardiac 
cushions (Cai et al., 2013).  
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Figure 26. HAND2 directly interacts with a cardiac CRM located in Tbx20 cis-regulatory 
landscape  
(A) UCSC browser window showing a region from the HAND23xFLAG ChIP-Seq top 2000 enriched 
region located 200kb upstream of Tbx20 TSS (green bar). The dark blue bar represents the location of 
the VISTA enhancer hs463. (B) Tbx20 expression in the endocardium (arrows) and myocardium 
(arrowheads) of wild-type and Hand2-deficient embryos. (C) LacZ reporter activity driven by the VISTA 
enhancer hs463. 
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7. Discussion 
7.1. Identification of HAND2 target gene networks that function 
during heart morphogenesis 
The development of the four-chambered mammalian heart depends on complex spatial 
and temporal coordination of signaling pathways and transcription factors directing the 
proliferation and commitment of myocardial and endocardial progenitors into multiple 
cell types (Lescroart and Meilhac, 2012; Vincent and Buckingham, 2010). The wide 
range of life-threatening congenital heart diseases resulting from perturbations during 
cardiogenesis reflects the complexity and importance of the tightly regulated 
mechanisms governing heart development (Bruneau, 2008). It is thus crucial for both 
diagnosis and potential regenerative therapies to understand how hierarchical gene 
regulatory networks interact to orchestrate the morphogenesis of cardiac structures 
(Srivastava and Olson, 2000; Olson, 2006; Srivastava, 2006; Rana et al., 2013; Xin et 
al., 2013; Wamstad et al., 2014). Transcription factors active in the second heart field 
have been well studied, but knowledge on the gene networks regulated by HAND2 and 
its direct targets is limited (Rochais et al., 2009b; Dyer and Kirby, 2009; Kelly, 2012; 
Vincentz et al., 2011). Mutations of HAND2 have been linked to human congenital heart 
diseases, which makes the identification of the gene networks controlled by HAND2 of 
particular interest (Shen et al., 2010; Strehle et al., 2012). 
 
7.1.1. Genome-wide identification of cardiac CRMs 
Several studies have determined the genomic target range of transcriptional co-
activators and the distribution of different chromatin modifications marks in the heart 
(May et al., 2012; Blow et al., 2010; Shen et al., 2012). In contrast, so far few ChIP-Seq 
datasets from cardiac transcription factors (TFs) are available. Many of them are cell 
type or lineage specific and have been generated using commercial ChIP-grade 
antibodies in adult tissues. For example, TBX3, which is expressed by the conduction 
system, has been overexpressed in the adult myocardium to study its target range (van 
den Boogaard et al., 2012). This approach identified common transcriptional targets of 
TBX3, NKX2.5 and GATA4, but overexpression likely does not reflects the 
physiological TF-chromatin complexes and is potentially prone to the identification of 
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false positive interactions. Expression of several biotinylated cardiac TFs in cultured 
HL1 cardiomyocytes also led to the identification of cardiac cis-regulatory modules 
(CRMs), but targets in cultured cells may differ from those in vivo  (He et al., 2011; 
Massie and Mills, 2008). In another study, TBX20 binding regions in adult hearts were 
identified using a BAC transgenic mouse line expressing a Tbx20 allele tagged by 
eGFP, but a transgenic approach may again not reveal all endogenous targets  (Shen 
et al., 2011). Altogether, the limitations of these studies show the importance of using 
endogenous levels of expression of TFs for ChIP-Seq approaches to accurately profile 
the DNA binding of transcriptional regulators. For this purpose, epitope tagging of TFs 
for high-throughput genome-wide approaches has become a powerful tool (Zhang et 
al., 2008a; Kidder et al., 2011; Landt et al., 2012). In particular, mouse alleles that 
express endogenously epitope-tagged TFs have been successfully used for ChIP-Seq 
analysis in various embryonic tissues (Attanasio et al., 2014). We have also chosen to 
insert a 3xFLAG epitope into the HAND2 protein to identify the CRMs interacting with 
HAND2 in a physiological manner during mouse embryogenesis. As the ChIP-Seq 
analysis used in this study was done using pooled Hand2-expressing embryonic 
tissues, we plan to perform a cardiac-specific ChIP-Seq analysis to identify additional 
heart-specific targets of HAND2. 
 
7.1.2. HAND2 and its target CRMs in the heart: direct and indirect DNA-binding 
interactions 
The genome-wide range of HAND2-containing chromatin complexes does not imply 
that all candidate CRMs are directly bound by HAND2. For instance, embryos 
homozygous for a mutant form of HAND2 deficient for DNA-binding exhibit right 
ventricle (RV) hypoplasia and lethality two to three days later than Hand2 null embryos 
(Liu et al., 2009). This suggests that the control of gene expression during second heart 
field (SHF) patterning may be regulated independently of the direct interaction of 
HAND2 with DNA, while the subsequent growth of the ventricle requires direct binding 
of HAND2 to its target CRMs (Liu et al., 2009). These mutant embryos also display 
disorganized and enlarged cardiac cushions by E11.5, which points to a role of Hand2 
in the formation of these structures. The DNA binding mutation of Hand2 does not 
affect the expression of the HAND2 genetic targets Gata4 and Nppa, suggesting that 
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these genes are regulated by HAND2 in a DNA-binding independent manner 
(Srivastava et al., 1997; Thattaliyath et al., 2002; Liu et al., 2009). In agreement, our 
results suggest that Gata4 and Nppa are indirect targets of HAND2 as the ChIP-Seq 
analysis and Hi-C data did not detect any HAND2 candidate CRMs in their cis-
regulatory landscapes (Dixon et al., 2012).  
In addition, heterodimerization of HAND2 with other transcriptional regulators as part of 
chromatin complexes adds another level of complexity to the attempt to identify direct 
HAND2 target CRMs (Vincentz et al., 2011). Indeed, several studies have shown that 
HAND2 interacts with the Nppa promoter as part of a complex with MEF2C, GATA4 
and/or NKX2.5, and that at least some of these interactions do not require E-box motifs 
(Zang et al., 2004; Dai et al., 2002; Thattaliyath et al., 2002). It is tempting to speculate 
that the CRMs that are directly interacting with HAND2 should encode the consensus 
E-box sequence CANNTG (Dai and Cserjesi, 2002). In contrast, this sequence could be 
absent from CRMs to which HAND2 binds indirectly. Indeed, 47% of the peaks 
identified in the HAND23xFLAG ChIP-Seq analysis were enriched in motifs containing a 
variant of the E-box sequence (Osterwalder et al., in press), showing that in about half 
of the candidate CRMs HAND2 might not directly bind to DNA. The identification of 
potential HAND2-interacting proteins within transcriptional complexes could be 
achieved by searching known transcription factor binding sites motifs in the identified 
CRMs, or by Mass Spectrometry that takes advantage of the 3xFLAG tag that we have 
introduced in HAND2.  
 
7.1.3. HAND2 target genes in the progenitors of the second heart field 
Our analysis mainly focuses on HAND2 transcriptional targets at E9.5, which is the 
developmental stage at which Hand2-deficient embryos are still alive that is closest to 
the stages used for ChIP-Seq analysis. The early embryonic lethality could likely be 
circumvented by conditionally inactivating Hand2 e.g. in the endothelial compartment 
using the Tie2-Cre or Nfatc1-Cre alleles to study its functions in the endocardium in 
more details (Kisanuki et al., 2001; Wu et al., 2012).  
Our data show that both the myocardium and endocardium of the AVC in Hand2-
deficient embryos are not affected by apoptosis at E9.5. However, the apoptosis is 
increased already at E8.5 in the bulbus cordis that connects the OFT to the RV and by 
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E9.5 also in the pharyngeal mesoderm and OFT (data not shown and (Yamagishi et al., 
2001; Tsuchihashi et al., 2011)). These two studies concluded that Hand2 is required 
for the survival of SHF cells. In particular, the RV hypoplasia is caused by the defective 
contribution of SHF progenitors to the heart (Yamagishi et al., 2001; Tsuchihashi et al., 
2011). Therefore, we analyzed several markers of the SHF at the stage where these 
cells start to invade the heart tube (E8.25-E8.5). In Hand2-deficient embryos, we 
observed ectopic expression of Tbx2 and Tbx3 in the anterior SHF progenitors in the 
pharyngeal mesoderm (the Tbx2 and Tbx3 cis-regulatory landscapes are discussed 
below). In another study, early induction of a Tbx2 transgene at E7.5 severely alters 
cardiac development and results in hypoplasia of the heart tube. This alteration is 
caused by impaired deployment of the SHF progenitors, reduced myocardial 
proliferation, and repression of the chamber differentiation markers Nppa and Cx40 
(Dupays et al., 2009). As TBX2 directly repress Nppa expression (Habets et al., 2002), 
and as Nppa expression is lost from the hypoplastic RV in Hand2-deficient embryos, 
we can establish a signaling cascade with direct (Tbx2) and indirect (Nppa) effects of 
Hand2 on the development of the RV.  
 
The expression of Nkx2.5 in the pharyngeal mesoderm is necessary for the 
development of the SHF (Zhang et al., 2014). The ChIP-Seq analysis also identified a 
CRM highly enriched in HAND2 chromatin complexes in the Nkx2.5 proximal promoter 
(data no shown). This CRM drives LacZ reporter expression in Hand2-expressing 
structures such as the OFT and RV (Tanaka et al., 1999). As Nkx2.5 expression is not 
affected in Hand2-deficient embryos, this suggests a very robust regulation of its 
expression through additional cardiac CRMs or compensation by other TFs and reflects 
the central role of Nkx2.5 for cardiac development. 
 
7.1.4. Furin and Myocd are direct transcriptional targets of HAND2 
We identified Furin as a new direct target of HAND2 in the endocardium of the AVC. 
Indeed, the inactivation of Furin in endothelial cells results in malformation of the mitral 
and tricuspid valves, which are derived from the AVC cardiac cushions and do not form 
in Hand2-deficient embryos (see below) (Kim et al., 2012; Lin et al., 2012). FURIN is 
involved in processing of BMP10, and in Bmp10-deficient embryos, the formation of the 
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cardiac cushions and trabeculations is impaired and the ventricular wall remains 
hypoplastic (Susan-Resiga et al., 2011; Chen et al., 2004). Bmp10 participates in 
ventricular chamber formation by activating the expression of Tbx20 (Zhang et al., 
2011). In agreement, the inactivation of Tbx20 disrupts trabeculation and cardiac 
cushion formation (Stennard et al., 2005). Both the acellular AVC cardiac cushions and 
hypotrabeculation phenotype are reminiscent of the ones observed in Hand2-deficient 
embryos. In addition, Hand2 expression in the whole ventricular myocardium in 
transgenic mice promotes the formation of trabeculations and the expression of Bmp10 
(Togi et al., 2006). Finally, Bmp10 is transactivated by the MYOCD/SRF complex, 
which induces cardiomyocytes proliferation and chamber maturation (Huang et al., 
2012). This is interesting in light of our observation that Myocd is a direct target of 
HAND2. Together, these results suggest that the trabeculation and cardiac cushion 
defects in Hand2-deficient embryos may be partially mediated by impairing downstream 
BMP10 signaling via Furin or/and Myocd. This will be analyzed further by assessing 
Bmp10 expression in Hand2 constitutive and/or conditional mutant embryos.  
 
7.1.5. A causal link between atrioventricular canal defects and embryonic 
lethality in Hand2-deficient embryos? 
The AVC of Hand2-deficient embryos displays two major defects compared to wild-
types. First, the cells delaminating from the endocardium to form the cardiac cushions 
are absent (see below). Second, there is an opening between the superior and inferior 
layers of the endocardium that leaves the AVC lumen open, in contrast to wild-type 
hearts. Such defects in AVC closure have only been described for Endoglin-deficient 
embryos (Bourdeau et al., 1999). Endoglin is expressed by the endocardium and by the 
endothelium compartment of blood vessels. Its inactivation results in defective EndMT, 
acellular cardiac cushions and embryonic lethality by E10.5. (Bourdeau et al., 1999). In 
addition, the inactivation of Bmp2, Has2, Cspg2 or Tbx20 also alter the formation of the 
cardiac cushions and leads to embryonic lethality prior to E10.5-E11.5, similarly to 
the Hand2 inactivation (Rivera-Feliciano and Tabin, 2006; Camenisch et al., 2000; 
Yamamura et al., 1997; Mjaatvedt et al., 1998; Cai et al., 2011). All these mutants also 
display a failure in the AVC lumen closure, despite this phenotype is not described in 
these studies. In zebrafish, the two sides of the AVC are brought together by the 
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contractions of the myocardium (Scherz et al., 2008). Thus, myocardial contraction 
failure is a possible explanation to the defective closure of the AVC. In physiological 
conditions, the electrical impulse driving peristaltic cardiac contractions in early 
embryos at the heart tube stage is generated in the venous pole. Conduction is rapid in 
atria and ventricles, while in the AVC and OFT the conduction is slow resulting in a 
contraction delay in these compartments (de Jong et al., 1992; Moorman and 
Christoffels, 2003; Christoffels and Moorman, 2009). The primordia of the future 
components of the adult conduction system start to develop at ~E9.5, which is around 
the onset of embryonic lethality in Hand2-deficient mouse embryos  (Christoffels and 
Moorman, 2009; Christoffels et al., 2010; Srivastava et al., 1997). Unidirectional blood 
flow without regurgitation is also established at this stage and requires coordinated 
cardiac contractions and formation of the AVC cardiac cushions (Nishii and Shibata, 
2006). Thus, irregular contractions and absence of cardiac cushions results in 
retrograde blood flow into the atria, which reduces cardiac output and leads to death 
(Scherz et al., 2008). In Hand2-deficient mouse embryos, cardiac contractions are 
observed at E9.5 but appear slightly less coordinated in comparison to wild-type 
controls. This observation would require recording and careful analysis to firmly 
establish this phenotype (Nishii and Shibata, 2006). Together, these results are in 
agreement with the proposal that defective AVC closure in Hand2 and other mutants 
may be causally linked to impaired blood pumping and thus to their early embryonic 
lethality.  
 
In conclusion, the cardiac failure and lethality of Hand2-deficient embryos is likely multi-
factorial, including atresia of the aortic arches arteries, massive cell death of SHF 
progenitors in the branchial arches, hypotrabeculation that reduce the myocardial 
surface and impairs oxygenation, and absence of cardiac cushions and possibly 
impaired cardiac contractions ((Srivastava et al., 1997; Aiyer et al., 2005) and this 
study). This plethora of defects illustrates the complexity of heart morphogenesis and of 
the regulatory networks controlled by HAND2 in this process.  
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7.2. Gene networks controlling endothelial-mesenchymal transition 
in the atrioventricular canal are directly regulated by HAND2 
Previous studies have postulated a role for Hand2 in cardiac cushion formation but no 
direct involvement or mechanism was established (Camenisch et al., 2000; Liu et al., 
2009; Holler et al., 2010; Vincentz et al., 2011; VanDusen and Firulli, 2012). The 
HAND23xFLAG ChIP-Seq analysis identified CRMs in the cis-regulatory landscapes of 
several genes with a role in the EndMT and differentiation of the AVC cardiac cushions. 
Our in-depth analysis of these interactions uncovered a gene network controlled by 
HAND2 that functions in the initiation of EndMT and cardiac cushion formation. The 
block in EndMT initiation has not been analyzed in previous studies and is 
morphologically strikingly similar to the consequences of inactivating other genes 
functioning in this process (e.g. Cspg2, which encodes the extracellular matrix protein 
Versican (Yamamura et al., 1997; Mjaatvedt et al., 1998)). 
 
7.2.1. Hand2 participates in extracellular matrix deposition within the cardiac 
jelly 
The deposition of extracellular matrix (ECM) in the cardiac jelly of the AVC is required 
for the migration of the mesenchymal cells of the cardiac cushions (Bernanke and 
Markwald, 1979). Versican and hyaluronic acid (HA) are both ECM components of the 
cardiac jelly. Inactivation of the HA producing enzyme Has2 also disrupts cardiac 
cushion formation and results in phenotypes similar to those observed in Hand2-
deficient embryos (Camenisch et al., 2000). Our study establishes that Has2 
expression in the AVC depends on Hand2, and that Has2 is a direct target of HAND2-
containing chromatin complexes (Fig.27A). However, at this stage it is not clear how 
HAND2 complexes regulate Has2 expression in the developing heart. The CRM we 
identified in the first intron of Has2 drives reporter expression in the limb buds, 
suggesting that the previously described limb enhancer of Has2 located in its proximal 
promoter is part of a larger CRM (Liu et al., 2013). 
We showed that the ECM in the cardiac jelly is reduced in Hand2-deficient mouse 
embryos, and several studies support an involvement of Hand2 in the composition and 
modeling of ECM components. Conditional deletion of Hand2 within the PEO and 
epicardium results in disorganization of Fibronectin (Fn1) fibrils in the epicardial ECM 
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(Barnes et al., 2011). In Hand2-deficient zebrafish embryos, the Fibronectin network is 
also disorganized (Le et al., 2005). Detailed analysis suggests that Hand2 negatively 
regulate Fn1 expression, which allows cardiomyocyte movements required for fusion of 
the cardiac tube (Garavito-Aguilar et al., 2010). This is likely an indirect effect as Fn1 
transcripts are not altered in Hand2-deficient mouse embryos (Barnes et al., 2011), and 
no evident HAND2-enrichments are detected around the Fn1 locus by ChIP-Seq 
analysis. In addition, Hand2 regulates the expression of matrix metalloproteinases 
(MMP), which in turn degrade laminin and enable the migration of lateral plate 
mesodermal cells and leftward gut looping in zebrafish (Yin et al., 2010). In the mouse, 
MMPs belonging to the ADAMTS family function in the formation of the cardiac jelly in 
the AVC by cleaving Versican in the cells that undergo EndMT (Kern et al., 2006). 
Haploinsufficiency for Adamts9 causes valves malformations (Kern et al., 2010), and 
interestingly, several members of the ADAMTS family contain one to several regions 
enriched in the HAND23xFLAG ChIP-Seq analysis. However, these HAND2 associated 
regions have not yet been analyzed to establish if HAND2 acts indeed upstream of 
ADAMTS metalloproteinases in mouse embryos.  
Together, these data indicate that Hand2 participates in regulating the ECM 
composition in vertebrate embryos. In particular, HAND2 may directly participate in 
remodeling the ECM components of the AVC cardiac jelly, which in turn contribute to 
the migration of the mesenchymal cells of the cardiac cushions. In addition, it would be 
interesting to determine if the functions of Hand2 in controlling ECM 
components/regulators are also relevant in other embryonic and adult tissues or in 
pathological situations such as cancer (Lu et al., 2012). 
 
7.2.2. HAND2 directly regulates Twist1 and Snai1 expression during formation of 
the AVC cardiac cushions  
In addition to the ECM formation, the secondary EMT of epicardial cells is also affected 
by the inactivation of Hand2 (Barnes et al., 2011). Therefore, we decided to investigate 
other potential direct targets of HAND2 that are required for the EndMT in the AVC. In 
particular, Twist1, Sox9 and Snai1 function at crucial steps of the AVC cardiac cushion 
morphogenesis (Vrljicak et al., 2012; Akiyama et al., 2004; Timmerman et al., 2004). 
Our ChIP-Seq analysis identified potential CRMs in all of their cis-regulatory 
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landscapes. Indeed, the expression of both Twist1 and Snai1 is lost from the AVC in 
Hand2-deficient embryos, while Sox9 expression remains normal. In agreement, ChIP-
qPCR from embryonic hearts confirmed that HAND2 chromatin complexes interact with 
CRMs within the Twist1 and Snai1 but not Sox9 cis-regulatory landscapes, which 
allowed us to conclude that Twist1 and Snai1 are direct transcriptional targets of 
HAND2 (Fig.27A). 
 
TWIST1 is expressed in the AVC upon delamination of endocardial cells, most likely as 
a consequence of its regulation by HAND2. Previous studies have shown that Twist1 
regulates the expression of genes involved in the proliferation of AVC cardiac cushion 
cells but is, on its own, not required for their formation (Chakraborty et al., 2010; 
Vrljicak et al., 2012; Vincentz et al., 2008). However, the migration of the cNCC that 
populate the OFT cardiac cushions is impaired or delayed in Twist1-deficient embryos. 
These cNCC form nodules that express Hand2 inside the mesenchyme of the cardiac 
cushions (Vincentz et al., 2008). Interestingly, Hand2 is required for the migration of the 
cNCC in the OFT (Holler et al., 2010). As our study establishes direct transcriptional 
control of Twist1 by HAND2, this regulation could also be operational in migratory 
cNCC. In fact, previous analysis already suggested that the absence of EndMT and 
cardiac cushion phenotype in Twist1-deficient embryos could be due to functional 
redundancy with Hand2 (Vincentz et al., 2008). TWIST1 forms heterodimers with 
HAND2 and other bHLH TFs, and these interactions are regulated by phosphorylation 
that dictate the DNA binding specificity of the transcriptional complexes (Firulli et al., 
2005; Firulli et al., 2007). The Hand23xFLAG allele could be a suitable tool to assess this 
protein-protein interaction by co-immunoprecipitation of the transcriptional complexes 
from developing hearts followed my Mass Spectrometry. Finally, we have initiated 
transgenic reporter analysis to determine the activity of the Twist1 +130kb candidate 
CRM. We expect this element to be active in the cardiac cushions of the AVC, but if 
LacZ reporter expression is also detected in the cushions of the OFT, this would 
support the proposal that Twist1 expression in the cNCC is regulated by HAND2.  
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Figure 27. A model of the regulatory network controlled by Hand2 during endothelial-
mesenchymal transition and cardiac cushion formation in the atrioventricular canal 
(A) Model of HAND2 functions during cardiac cushion formation. Snai1, Has2 and Twist1 are newly 
identified direct targets of HAND2 during initiation of EndMT, migration of delaminated cells and/or 
cardiac cushion proliferation. (B) Schematic representation of the gene whose expression is altered in 
Hand2-deficient embryos (grey), and (C) proposed model of HAND2 as an intermediate relay in the 
signaling interactions between Notch1, Bmp2 and Tgfβ2. Dashed green arrows indicate interactions that 
remain to be tested or confirmed. 
 
Genetic targets of TWIST1 in the cardiac cushions of the AVC include Bmp2 and Sox9, 
whose expression is reduced in the AVC of Twist1-deficient embryos (Vrljicak et al., 
2012). As Sox9 expression is initiated in endocardial cells of Hand2-deficient embryos, 
it suggests that TWIST1 upregulates Sox9 expression in cells after delamination for 
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proper cardiac cushion remodeling but is not necessary for Sox9 activation (Lincoln et 
al., 2007). 
 
SNAI1 is a prototypic transcription factor involved in many different physiological and 
pathological EMT processes by controlling genes that induce changes in cell shape, 
adhesion and motility (Barrallo-Gimeno and Nieto, 2005; Thiery et al., 2009). In 
particular, SNAI1-mediated downregulation of E-Cadherin genes is a key event in the 
initiation of EMT (Batlle et al., 2000; Cano et al., 2000). The formation of the cardiac 
cushions is no exception, as SNAI1-mediated downregulation of the vascular E-
Cadherin (VE-Cadherin) is necessary for progression of the endocardial EMT 
(Timmerman et al., 2004; Vestweber, 2008). In parallel, SNAI1 upregulates Vimentin 
expression to increase the motility of the delaminating cells (Cano et al., 2000; Ivaska, 
2011; Mendez et al., 2010). In addition to the total absence of Snai1 in the AVC, VIM 
expression is not activated and VE-Cad junctions are maintained in the endocardium of 
Hand2-deficient embryos. These results indicate that Hand2 is required for Snai1 
activation and initiation of the EndMT. Indeed, HAND2 chromatin complexes interact 
with two candidate CRMs in the Snai1 cis-regulatory landscape. As Snai1 acts 
cooperatively with Snai2 to induce the EndMT (Niessen et al., 2008), we also looked 
into a potential direct regulation of Snai2 by HAND2 but no experimental evidence in 
favor of such direct regulation were obtained (data not shown). 
 
Despite Snai1 is expressed in the premigratory and migratory neural crest cells, it is not 
required for their initial delamination (Sefton et al., 1998; Murray and Gridley, 2006). 
The Snai1 CRM we identified by ChIP-Seq analysis drives LacZ reporter expression in 
migratory neural crest cells, craniofacial structures, and in the epicardium. Indeed, 
Snai1 is important both for the development of craniofacial structures and for the EMT 
of epicardial cells (Cordero et al., 2011; Murray et al., 2007; Tao et al., 2013). 
Interestingly, Hand2 is also expressed in craniofacial neural crest derivatives and 
regulates the formation of the palate, mandible and tongue (Charité et al., 2001; 
Yanagisawa et al., 2003; Funato et al., 2009; Barron et al., 2011; Xiong et al., 2009). 
Hand2 is also involved in the EMT of epicardial cells and their differentiation into 
coronary vasculature (Barnes et al., 2011). We have thus identified a CRM active in 
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several embryonic tissues where both Snai1 and Hand2 are expressed, suggesting that 
Snai1 might be a universal target of HAND2. The precise role of this Snai1 CRM during 
cardiac cushion formation and in other biological contexts remains to be investigated.  
 
To gain further insight into the roles of HAND2 in the EndMT, we will use AVC explant 
culture, which has been successfully used to determine the role of different TFs in 
EndMT and cardiac cushion formation (Runyan and Markwald, 1983; Camenisch et al., 
2000; Akiyama et al., 2004; Timmerman et al., 2004; Luna-Zurita et al., 2010; 
Moskowitz et al., 2011). This assay allows dissection of the molecular mechanisms and 
interactions that control the formation of cardiac cushions by analyzing the migratory 
and invasive capacities of the endocardial cells. Initially, we will compare wild-type 
versus Hand2∆/∆ AVC explants in culture. In addition, Hand2 could be specifically 
inactivated in explants using Adeno-Cre viral particles in combination with the Hand2 
conditional allele, and we could also attempt rescue experiments by re-expressing 
Hand2 using viral vectors as well. Adding hyaluronic acid to Hand2-deficient cultured 
explants could provide insights into the extent to which Has2-mediated ECM defects 
contribute to the failure to form the cardiac cushions in these mutants.  
 
7.2.3. HAND2 is an intermediate factor in the myocardial/endocardial signaling 
events that induce the EndMT 
To determine the possible involvement of myocardial signals in the disruption of Snai1-
mediated EndMT in Hand2-deficient embryos, we looked at the expression of Bmp2, 
Tgfβ2, Notch1 and other key genes involved in the myocardial-endocardial crosstalk 
that patterns the AVC and initiates the EndMT. Our results indicate that the AVC 
myocardium is correctly patterned in the absence of HAND2, and that Hand2 acts 
downstream of the relevant signals and upstream of activating Snai1. Furthermore, this 
gene expression analysis allowed us to make some assumptions regarding the exact 
position and role of HAND2 in the signaling network that control the EndMT in the AVC. 
 
The loss of the BMP2 target Msx1 in the endocardium shows that the absence of 
Hand2 alters BMP2 downstream signaling (Fig.27B). Endothelial deletion of the BMP 
signal transducer Smad4 results in defective EndMT and in acellular cardiac cushions, 
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as in Hand2-deficient embryos (Moskowitz et al., 2011). Furthermore, Smad4 
genetically interacts with Gata4 in the endocardium, and both proteins can 
heterodimerize and cooperatively activate the expression of target genes in the AVC 
endocardium (Moskowitz et al., 2011). The new Smad43xFLAG allele that I generated 
could thus be used to study the impaired signaling activity of BMP2 in the endocardium 
of Hand2-deficient embryos (Fig.27C). We are currently generating the compound 
Hand2∆/+;Smad43xF-HR/+ mice to assess this hypothesis.  
In the endocardium, Notch1 signaling represses Bmp2 expression through Hey1 and 
Hey2, which in turns prevents endocardial cells to acquire a cardiomyocyte cell fate 
(Luna-Zurita et al., 2010). In Hand2-deficient embryos, Notch1 and Hey2 are expressed 
normally and there is no ectopic activation of Bmp2 in the endocardium. This indicates 
that Hand2 is not part of the Notch1-HEY1/2-BMP2 endocardial signaling module.  
The myocardial expression of Tgfβ2 depends on both Notch1 signaling through a 
postulated retrograde endocardial to myocardial signal (Timmerman et al., 2004), and 
on BMP2 signaling through Tbx2 (Ma et al., 2005; Shirai et al., 2009). In addition, 
Notch1 promotes paracrine endocardial to myocardial Wnt4 signaling that in turns 
regulates Bmp2 expression (Wang et al., 2013). In Hand2-deficient embryos, the 
expression of Tgfβ2 but not of Notch1, Bmp2 and Tbx2 is lost (Fig.27B). This suggests 
that Tgfβ2 is regulated indirectly by Hand2 downstream of Notch1. In this model, 
Hand2 would occupy an intermediate signaling role between Notch1 and the other 
postulated endocardial signal that regulates Tgfβ2 expression, rather than in the 
Notch1-Wnt4-BMP2-TBX2 signaling module (Fig.27C).  
 
Finally, Snai1 expression in the endocardium and subsequent EndMT depends on the 
synergic action of Notch1, TGFβ2 and BMP2 signaling (Timmerman et al., 2004; 
Niessen et al., 2008; Luna-Zurita et al., 2010; Garside et al., 2013). Our data 
established that HAND2 is also directly required for the activation of Snai1 expression. 
To determine whether HAND2 acts in parallel or as an intermediate transcriptional relay 
in these signaling interactions will require further analysis of embryos deficient for some 
of the other key genes discussed here (Fig.27C). 
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7.2.4. A role for Hand2 in cardiac valves maturation and remodeling? 
The cardiac valves are derived from the cardiac cushions. The ChIP-Seq analysis 
identified numerous potential CRMs associated with genes that function in cardiac 
valve remodeling. However, the lethality of Hand2-deficient embryos prior to the stage 
of valve remodeling precludes the analysis of Hand2 functions during cardiac cushion 
maturation. Nevertheless, we established that HAND2 chromatin complexes bind a 
cardiac enhancer of Tbx20, which controls proliferation of the valve endothelial cells 
during valve elongation (Fig.27A) (Cai et al., 2013). Other likely direct targets of HAND2 
with ChIP-Seq peaks in their cis-regulatory landscapes include Col1a1, which is 
important for valves structure and maintenance, and Scleraxis, required for 
differentiation and ECM organization during valve remodeling (Peacock et al., 2008; 
Levay et al., 2008). The conditional removal of Hand2 from the mesenchymal cells of 
the cardiac cushions from E10.5 does not affect cardiac valves maturation (VanDusen 
et al., 2014). Therefore, the requirement of Hand2 for EndMT initiation is a critical step, 
whereas Hand2 appear to be dispensable during cardiac cushion remodeling, maybe 
due to a compensatory mechanism mediated by Twist1 (see above).  
 
7.3. The paralogous Tbx2 and Tbx3 genomic landscapes encode 
heart and limb bud specific CRMs bound by HAND2 chromatin 
complexes  
The HAND23xFLAG ChIP-Seq analysis identified several candidate CRMs in the cis-
regulatory landscapes of the T-box genes Tbx2 and Tbx3. Using these candidate 
CRMs in LacZ reporter assays, we identified one heart and one limb bud specific CRM 
within the Tbx3 ~160kb cis-regulatory landscape. In addition to the heart and limb buds, 
this large landscape is able to activate reporter expression in the eye, snout and 
mammary glands (Horsthuis et al., 2009). As Hand2 is not expressed in these other 
structures where the two identified CRMs are also not active, it appears that Tbx3 
expression is regulated by an archipelago containing several other tissue-specific 
CRMs. Indeed, a recent study used chromatin architecture profiling from embryonic 
hearts and established that the Tbx3 promoter physically contacts the HAND2-
interacting cardiac CRM and an additional pan-cardiac enhancer (van Weerd et al., 
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2014). Both CRMs synergize to activate Tbx3 expression in the atrioventricular 
conduction system. In addition, the cardiac-specific CRM that we identified by 
HAND23xFLAG ChIP-Seq analysis requires the synergic action of GATA4 and SMADs to 
be active (van Weerd et al., 2014). This CRM is able to drive LacZ reporter expression 
in the myocardium of the AVC, where the atrioventricular node will form. As HAND2 is 
not expressed in these cells, it is possible that this CRM is repressed by HAND2 
chromatin complexes. In addition, the ectopic expression of Tbx3 at early stages in 
Hand2-deficient embryos argues in favor of a general repressive effect of HAND2 on 
this gene during cardiac development. The additional HAND2-independent CRM(s) 
accounting for robust expression of Tbx3 could explain why genetic inactivation of 
Hand2 does not results in ectopic activation of Tbx3 expression at the onset of cardiac 
conduction system formation, but only at earlier stages.  
 
The Tbx3/Tbx5 and Tbx2/Tbx4 landscapes are likely similar, as they evolved by two 
rounds of gene duplication from a single ancestral gene (Fig.28A) and (Agulnik et al., 
1996). Indeed, we also detected two CRMs interacting with HAND2 chromatin 
complexes in the Tbx2 landscape. The activity of one of them is currently being 
analyzed, while the other drives LacZ reporter expression in the posterior limb bud 
mesenchyme (Infante et al., 2013). An additional HAND23xFLAG ChIP-Seq peak located 
closer to Tbx4 was reported to be a Tbx4 hindlimb enhancer (Menke et al., 2008). 
When we compare the HAND2 ChIP-Seq profiles for the Tbx2/Tbx4 and Tbx3/Tbx5 cis-
regulatory landscapes, we observe a similar distribution that argues in favor of similar 
cardiac and limb bud CRM activities in both landscapes (Fig.28B). However, the 
functions of Tbx5 and Tbx4 have diverged as they are specifically functioning in 
forelimb and hindlimb induction, respectively. The amphioxus ancestral Tbx4/5 gene 
lacks the CRM required for limb initiation but is able to initiate limb formation in mouse 
transgenic embryos under control of a limb mesenchymal promoter. This indicates that 
changes in the CRMs rather than gene functions underlie the specialization of Tbx4 
and Tbx5 during limb evolution (Minguillon et al., 2009). It would be interesting to study 
the evolutionary and functional relationship of the cardiac CRMs of Tbx2 and Tbx3, as 
gene duplications can also result in the acquisition of new structures and functions in 
the developing heart (Olson, 2006). The orthologous human and chicken sequences of 
	
   	
    
	
  128 
the CRM of Tbx3 that interacts with HAND2 complexes in the heart display similar 
reporter activity as their murine counterpart in the AVC. This indicates evolutionary 
conserved functions of this CRM during Tbx3-mediated formation of the conduction 
system (van Weerd et al., 2014).  
 
 
 
Figure 28. Regulation of T-box genes cis-regulatory landscapes by HAND2 
(A) Evolution of Tbx 2/3/4/5 subfamily by gene duplications and unequal crossovers. Adapted from 
(Agulnik et al., 1996). (B) UCSC browser window showing the linkage of Tbx2/4 and Tbx3/5 genes and 
the HAND2 interacting regions identified by ChIP-Seq analysis in these two genomic landscapes. 
Distances to ChIP-Seq peaks are indicated relative to Tbx2 (upper panel) and Tbx3 (lower panel) TSS. 
 
During cardiac development, Tbx2 and Tbx3 are both upregulated in the SHF 
progenitors of Hand2-deficient embryos, while they are downregulated in limb buds 
(Osterwalder et al., in press). In contrast, the expression of Tbx4 and Tbx5 is not 
changed in any of the tissues. This shows that HAND2-mediated regulation of Tbx2 
and Tbx3 is common between the two clusters, whereas this is not the case for Tbx4 
and Tbx5. Indeed, the chromatin architecture profile of the Tbx3/Tbx5 landscape clearly 
establishes that these two genes are regulated independently (van Weerd et al., 2014). 
In summary, the cis-regulatory mechanisms controlling Tbx2 and Tbx3 expression are 
shared between cardiac and limb tissues. These mechanisms involve the action of the 
common trans-acting factor HAND2 on tissue-specific CRMs embedded in cis-
regulatory landscapes of likely similar architecture due to a common evolutionary origin. 
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8. Conclusions and Outlook 
The two major aims of this thesis were (1) to generate a new genetic tool to identify 
the transcriptional networks controlled by SMAD4 during mouse limb bud 
development, and (2) to analyze the transcriptional networks controlled by HAND2 
during mouse cardiac development. Both projects involved the use of endogenously 
tagged versions of these two transcription factors. 
 
The mouse line expressing the Smad43xFLAG allele that I generated and characterized 
is now ready to be used for ChIP-Seq analysis. This new allele will allow us 
identifying the direct targets of SMAD4 chromatin complexes in developing limb buds 
and in other tissues such as the embryonic heart. In particular, the dynamics of BMP 
signaling activity during the different phases of limb bud development and the 
consequential transcriptional response of its target genes can now be monitored in 
vivo by assessing the temporal occupancy of SMAD4-containing chromatin 
complexes. This will provide us more insights into the downstream molecular circuitry 
that controls initiation of limb bud outgrowth, patterning, and chondrogenic 
differentiation. Moreover, the question of how BMP signaling regulates the 
expression of Grem1 can now be investigated at the transcriptional level by the 
identification of the Grem1 CRMs that interact with SMAD4 complexes. The ChIP-
Seq data that this new mouse line will allow us to generate will also be intersected 
with ChIP-Seq data from additional transcription factors (e.g. GLI3), in order to 
understand how cis-regulatory landscapes integrate several signaling inputs and how 
it affects their transcriptional output. 
 
The analysis of the HAND23xFLAG ChIP-Seq data allowed me to uncover new direct 
transcriptional targets of HAND2 in the developing heart, such as Furin, Tbx2 and 
Tbx3. In addition, I identified a defect during the endothelial-mesenchymal transition 
in the atrioventricular canal of Hand2-deficient embryos and could establish that 
HAND2 is a key regulator of cardiac cushion formation by directly controlling the 
expression of Snai1. The functional analysis of the HAND2 target CRMs that I 
identified in the cis-regulatory landscapes of Snai1, Twist1 and Has2 is still ongoing 
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and could help us to determine if HAND2 controls EMT in additional 
developmental/pathological processes. Furthermore, the future use of AVC explant 
cultures will allow us to study the role of HAND2 during EndMT and cardiac cushion 
formation at the cellular level, and the conditional deletion of Hand2 in the 
endothelium using Tie2-Cre will also enable us to analyze further this EndMT 
phenotype. Finally, a cardiac-specific ChIP-Seq analysis will be an important 
complement to this study in order to identify additional CRMs that interact with 
HAND2 specifically during heart development. 
 
The data presented in my thesis constitute the first identification of the HAND2 
direct transcriptional targets during cardiogenesis. The use of an endogenously 
epitope-tagged form of HAND2 illustrates the power of such genetic tools to 
understand the functions of transcription factors during embryonic development.  
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9. Materials and Methods 
9.1. Genetic engineering of plasmids 
9.1.1. General cloning procedures 
DNA fragments used to construct plasmid vectors were either recovered from 
restriction enzyme digested vectors or BACs; or produced by PCR using the Expand 
High FidelityPLUS PCR System (Roche) with specific primers to introduce the desired 
restriction enzyme recognition sites at both ends. Following digestion of 
plasmids/BACs and inserts with compatible restriction enzymes (from Roche or 
NEB), fragments of interest were recovered from agarose gels and purified using 
QIAquick Gel Extraction Kit (Qiagen). De-phosphorylation was performed with the 
rAPid alkaline phosphatase kit (Roche). Ligation of compatible plasmids and inserts 
was done for 15min-1hr at room temperature (RT) using T4 Ligase (NEB). Then the 
ligated mixture was diyalised using MFTM nitrocellulose membrane filters (Millipore). 
Electrocompetent bacteria (XL1-Blue, XL10-Gold or DH5a) were electroporated with 
ligated vectors in Gene Pulser 0.2cm cuvettes using the Biorad MicroPulserTM. 
Afterwards, bacteria were plated on LB Agar plates containing the appropriate 
antibiotic selection. Plasmid DNA was purified by alkaline lysis using the Plasmid Midi 
Kit (Qiagen) or the NucleoBond® Xtra Midi kit (Machery Nagel) from bacteria grown 
in liquid cultures. Correct ligation and orientation of the insert was assessed by 
restriction digest or PCR. Alternatively, colony lifts onto nylon membrane were used 
and positive clones identified using a DIG-dUTP labeled probe. All construct inserts 
were sequenced (Microsynth).  
To generate linkers, 100nM of each oligonucleotide were mixed in 1x annealing 
buffer (0.1M NaCl, 10mM Tris-HCl pH 7.4) in 50µl and transferred to a water bath at 
85-95°C on a floating rack for annealing. Annealed linkers were cooled gradually to 
RT in H2O for 3-4hrs. For ligation, serial dilutions of 1µl annealed linkers (1:100, 
1:1000 or 1:5000) in 0.5x annealing buffer were used. Plasmids were not de-
phosphorylated for ligation of linkers, as oligonucleotides do not harbor a 5’ 
phosphate.  
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9.1.2. Construction of pBSK Smad43xFLAG targeting vector for Homologous 
Recombination 
The targeting vector was designed to introduce a sequence encoding the 3xFLAG 
epitope tag in frame into the 3’ end of Smad4 coding sequence. Additional 
modifications included a STOP codon after the 3xFLAG, which was followed by the 
endogenous Smad4 3’UTR and a SV40 polyadenylation site. A Neomycin selection 
cassette flanked by loxP sites was also inserted 366bp downstream of Smad4 locus 
as part of the 3’ homology arm. Firstly, 5’ and 3’ homology arms were recovered from 
pBACe3.6 encoding the bMQ420b13 clone, which covers the Smad4 coding 
sequence. The 5’ arm was subcloned into pBluescript II KS (pBSK, Stratagene) as an 
ApaI-ApaI 4277bp fragment encoding a part of Smad4 locus covering the intron 
10/11, exon 11, intron 11/12 and exon 12. The 3’ arm was inserted into the plasmid 
pcDNA3 (Invitrogen) as a BglII-BglII 6045bp fragment, which encodes a part of the 
3’UTR and the downstream intergenic region. The fragment containing the 3’ end of 
exon 12, the 3xFLAG-STOP and the 5’ part of the 3’UTR was obtained from a 
previously assembled pXCH-Smad43xFLAG vector (data not shown) as a 295bp ApaI-
BglII fragment. The floxed Neo cassette was recovered from the pLoxpNeo-2 vector 
(Michos et al., 2004) as a 2026bp EcoRI-XhoI fragment that was blunted. To 
generate the targeting vector, these DNA fragments were assembled in pBSK using 
a linker containing the following restriction sites: Asp718-MluI-ApaI-BglII-BamHI-BclI-
MluI-SacI. The Asp718 and SacI restriction sites in pBSK were destroyed by insertion 
of the linker. The BamHI site was used for screening purposes. The sequence of this 
linker is displayed in the Primers Tables in the chapter 9.7.2. DNA fragments were 
assembled sequentially as follows: first the ApaI-FLAG-BglII fragment, then the BglII-
3’arm-BglII fragment from pCDNA3 (inserted in the compatible BclI site on the linker), 
then the ApaI-5’arm-ApaI insert from pBSK, and finally the blunt Neo cassette in 
reverse orientation into a BmgBI site located in the 3’arm. For electroporation, the 
targeting fragment was released from its pBSK backbone as a 12’344bp MluI-MluI 
fragment (see Fig.29 for a detailed scheme).  
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Figure 29. Generation of the pBSK-Smad43xFLAG targeting vector for homologous 
recombination 
(A) 5’ and 3’ homology arms were recovered from pBACe3.6 clone bMQ420b13. (B) A fragment 
containing the 3’ end of exon 12, the 3xFLAG-STOP and the 5’ part of the 3’UTR was obtained from a 
previously assembled pXCH-Smad43xFLAG vector. (C) The floxed Neomycin cassette was recovered 
from the pLoxpNeo2 vector and blunted. The targeting vector was assembled in pBSK template vector 
using a linker containing the following restriction sites: Asp718-MluI-ApaI-BglII-BamHI-BclI-MluI-SacI. 
Fragments were cloned in the following order: (D) 3xFLAG containing fragment, (E) 3’arm, (F) 5’arm 
and (G) Neo cassette in reverse orientation. (H) For electroporation, the targeting fragment was 
released from pBSK as a MluI-MluI fragment. See main text for details. 
 
9.2. Cell culture 
9.2.1. Embryonic Fibroblasts (EMFIs) culture 
EMFIs were used as feeder cells for embryonic stem cells and grown at 37°C in 5% 
CO2. EMFI medium consists of DMEM containing 4.5g/l Glucose (Gibco 41966-029), 
10% FCS (Gibco 10270-106), 100U Penicillin, 0.1mg/ml Streptomycin (Pen Strep, 
Gibco 15140-122) and 2mM L-Glutamine (Gibco 25030-024). A frozen vial of EMFIs 
was thawed at 37°C in a water bath and diluted in a 15ml Falcon tube containing 
10ml of EMFI medium. After centrifugation at 1200rpm for 5min, the medium was 
removed by aspiration and the EMFIs resuspended in 3ml prewarmed medium. Cells 
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were distributed equally to five 10cm culture dishes (BD Falcon). Medium was 
changed every two days. When EMFIs became confluent, they were split using 
0.05% Trypsin EDTA (Gibco 25300-054) onto another plate (for a maximum of two 
passages) or treated with Mitomycin C (Sigma M-0503) to stop cell division. For 
trypsinization, EMFIs were rinsed with 4ml prewarmed trypsin and incubated in 3ml 
trypsin for 5min at 37°C. Single cells were collected in 7ml EMFI medium and spun 
for 5min at 1200 rpm. Cell pellets were resuspended in a small volume, diluted and 
seeded at 1:4-1:6 in 10cm dishes. Mitomycin C at 1mg/ml in DPBS (Gibco 14190-
094) (stored at 4°C in the dark for ≤ two weeks) was diluted to 10µg/ml in EMFI 
medium for treatment of cells. EMFIs plates were incubated at 37°C with 5% CO2 for 
2h, washed 3x with PBS and transferred back to the incubator in fresh EMFI medium. 
Growth-arrested EMFIs were kept in culture for maximally one week and their 
medium was changed every two days.  
 
9.2.2. Embryonic Stem (ES) cell culture 
ES cells were grown at 37°C with 7.5% CO2 on a layer of growth arrested EMFIs. 
ESC medium consists of Knockout DMEM (Gibco 10829-018) supplemented with 
15% Hyclone FBS (Thermo Scientific), 100U-0.1mg/ml Pen Strep, 2mM L-Glutamine, 
1mM β-mercaptoethanol (Gibco 31350-010), 1x Non-essential Amino Acids (Gibco 
11140-035), 1mM Sodium Pyruvate (Gibco 11360-039) and 103 units/ml ESGRO LIF 
(Millipore ESG1106). The medium was changed every day, and the ES cells split 
every two days using 0.05% Trypsin EDTA. After a brief wash in 4ml trypsin, cells 
were incubated in 3ml trypsin for 15min at 37°C. A single-cell suspension was 
obtained by gentle pipetting, and ES cells were separated from EMFIs by incubating 
the cells at 37°C for 15min. While EMFIs adhere to the surface of the dish, the 
floating ES cells were carefully recovered and transferred to a 15ml Falcon tube. 
After 5min centrifugation at 1200rpm, the ES cell pellet was resuspended in ES cells 
medium and split to 1:3-1:10 on growth arrested EMFIs. Alternatively, ES cells were 
grown on gelatin instead of EMFIs. A solution of 0.1% gelatin in H2O (Sigma G-2500) 
was used to coat culture dishes for 10min at RT. The gelatin solution was removed 
and the gelatin-coated dishes dried for 10min at RT before use. For freezing, 
trypsinized ES cell pellets were resuspended in ice-cold filtered freezing medium 
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(50% ES cells medium 40% FCS, 10% DMSO (Sigma D-8418)). 5-6 precooled 
Cryovials (NUNC) were filled with 1.5ml of ES cells recovered from a 10cm culture 
dish. Cryovials were transferred to -80°C in a Styrofoam box and transferred to liquid 
N2 the next day. 
 
9.2.3. ES cells electroporation and selection  
R1 ES cells (129 background) were thawed 6 days before electroporation and split 
twice, on day 2 and day 4. On day 6, the ES cells were trypsinized, pooled in 50ml 
Falcon tubes and centrifuged for 5min at 1200rpm. Then ES cells were resuspended 
in 3ml medium and counted using a Neubauer chamber. After re-centrifugation, the 
cells were resuspended in DPBS (Gibco 14190-094) at a final concentration of 1.875 
x 107 cells/ml. For electroporation, 35µg of linearized targeting vector (pBSK-
Smad43xFLAG) were added to Gene Pulser cuvettes (Biorad 165-2088) and then 0.8ml 
ES cells suspension was added (1.5 x 107 cells). Water was used as a control 
instead of DNA in some ES cell samples. Electroporation was done using Biorad 
Gene Pulser II set at 0.24kV and 475µF capacitance. Cuvettes were immediately 
transferred on ice and incubated for 20min after electroporation. The contents of the 
cuvettes were then pooled and transferred to a 50ml Falcon tubes containing 
prewarmed ES cell medium, and the cuvettes rinsed with ES cell medium to recover 
all cells. Medium was added to a total volume of 20ml, and the ES cell suspension 
was gently mixed before plating at 1:5 or 1:10 dilutions on gelatin-coated dishes 
containing ES cell medium. Non-electroporated ES cells were diluted and plated at 
similar dilutions as control. Medium was changed after 24h, and antibiotic selection 
started after 48h. For this, 190µg/ml of G-418 Geneticin (Gibco 10131-019) were 
used in ES cell medium with medium change everyday during 11-13 days. One dish 
for each condition/dilution (+DNA, -DNA, no electroporation) was maintained in 
culture medium without G-418 as selection control. In these dishes, the ES cells grew 
normally. In the dishes of ES cells under selection that were electroporated without 
DNA, no ES cell clones were observed. Following selection, ES cell clones were 
picked and transferred on growth arrested EMFIs in 48 well plates. The ES cell 
selection medium was changed everyday. Clones were passaged after two days. 
After two additional days, the clones were trypsinized and half of the cells transferred 
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to a fresh 48 well plate coated with gelatin, while the other half were plated on growth 
arrested EMFIs. Upon reaching confluency, the cells grown on gelatin were used to 
extract DNA for screening, while the plates with cells grown on EMFIs were frozen in 
freezing medium after two additional days and stored at -80°C. Screening of the 
correctly targeted clones was done by Southern Blotting (see below). Then, the 
plates containing positive clones were carefully thawed at 37°C and the medium was 
changed several times to remove all traces of DMSO. The recovery and growth of 
each clone was then individually monitored and the medium changed every day for 3-
4 days until growing colonies became visible. Clones were passaged to larger wells 
and finally to 10cm dishes to freeze several vials per expanded ES cell clone. 
 
9.2.4. ES cell clones screening by Southern Blot 
Extraction of DNA from confluent ES cells grown on gelatin-coated 48 multiwell plates 
was achieved as follows: each well was gently washed 3 times with 750µl PBS 
without disturbing the monolayer of cells, and 250µl lysis buffer (100mM Tris-HCl pH 
8.5, 5mM EDTA pH 8.0, 0.2% SDS, 200mM NaCl, 100µg Proteinase K) were then 
added in each well. The plates were incubated overnight at 55°C in a moist chamber. 
The next day, 500µl of absolute EtOH were added dropwise to the sides of the wells. 
The plates were incubated overnight at RT, which resulted in appearance of white 
strands of DNA. The plates were then carefully inverted to remove the EtOH and 
each well gently washed 3 times with 750µl of 70% EtOH. Finally, plates were dried 
overnight upside-down and then stored at RT. For Southern Blot screening, such 
precipitated DNAs were digested overnight in a volume of 100µl with 30 units of the 
appropriate restriction enzyme. The next day the reaction was spiked with 10 units 
and digested for additional 7hrs. Half of the content of the well was then loaded on a 
0.7% agarose gel containing 5% EtBr and ran in 1xTBE at 60V for ~24h until 
appropriate separation was achieved. The agarose gel was then depurinated in 
0.25M HCl for 10min; rinsed in H2O; washed 2 times 15min in denaturation solution 
(0.5M NaOH, 1.5M NaCl); rinsed in H2O; washed 2 times 15min in neutralization 
solution (0.5M Tris-HCl pH 7.5, 1.5M NaCl); rinsed in H2O and finally equilibrated for 
at least 15min in 20xSSC (3M NaCl, 150mM sodium citrate, pH 7.0). The separated 
DNA fragments were then transferred onto a positively charged nylon membrane 
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(Roche) by capillary transfer. The membrane was pre-soaked in H2O and equilibrated 
in 2xSSC, and the transfer was done overnight in 20xSSC. Following the transfer, the 
membrane was soaked in 2xSSX for 5min and dried for 1h at RT on a sheet of 
Whatman 3MM paper (Sigma). The membrane was subsequently baked for 2hrs at 
80°C in a sheet of 3MM paper, and stored at RT. Prehybridization of the membrane 
was done using a rolling bottle system with side DNA facing inside at 42°C for ≥1hr in 
prewarmed prehybridization solution (5xSSC, 50% deionized formamide, 0.1% N-
lauroylsarcosine, 0.02% SDS, 2% blocking solution). The blocking solution was 
prepared as 10% (w/v) Blocking Reagent (Roche) in 1x maleic acid buffer (0.1M 
C4H4O4 0.15M NaCl, pH 7.5) at 60°C. The prehybridization solution was replaced by 
prewarmed hybridization solution containing 4µl of DIG-dUTP labeled probes 
generated using the PCR DIG probe synthesis kit (Roche). Probes detected correct 
recombination of both the 5’ and 3’ homology arms. The presence of a single 
insertion was assessed by detection of the Neomycin cassette (see Fig.11A for the 
location of the probes). Clones were first screened using the 5’ probe, and positive 
clones further screened with the 3’ and Neo probes. The sequences of the primers 
used to generate these probes are shown in the chapter 9.7.2. Hybridization was 
done overnight at 42°C in rolling bottles. The next day, the membrane was washed 
twice for 15min with 2xSSC, 0.1% SDS at RT and twice for 15min with 0.2xSSC, 
0.1% SDS at 68°C in rolling bottles. The membrane was then rinsed in maleic acid 
wash buffer (0.1M C4H4O4 0.15M NaCl, 0.3% Tween-20, pH 7.5) and blocked with 
1% blocking solution in maleic acid buffer for 30min-3hrs. Subsequently, the 
membrane was incubated in 1% blocking solution in maleic acid buffer containing 
1:20’000 anti-digoxigenin-AP antibody (Roche) for 30min at RT. The membrane was 
then transferred to a plastic tray and washed 3 times for 15min in maleic acid wash 
buffer, and equilibrated in detection buffer (0.1M Tris-HCl, 0.1M NaCl, pH 9.5) for 
2min at RT. The specifically hybridized bands were detected as follows: the 
membrane was placed on an overhead foil and covered with detection buffer that 
contained 4µl/ml of CDP Star (Roche) for 5min at RT. The membrane was then 
exposed for 10min to Kodak BioMax MR films or Amersham HyperfilmTM ECL (GE 
Healthcare) and developed using the Fujifilm FPM-100A Desktop Processor. To allow 
re-hybridization to another probe, the membrane was washed extensively with H2O in 
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a plastic tray, transferred back to a rolling bottle and washed 2x for 15min with 0.2M 
NaOH, 0.1% SDS at 37°C. After rinsing in 2xSSC, the membrane was stored at 4°C 
in 2xSSC prior re-incubation in pre-hybridization solution. 
 
9.3. Mice husbandry and experiments with embryos 
9.3.1. Ethic statement 
All experiments conducted with mice were performed with strict respect of the Swiss 
law, 3R principles and Basel Declaration. They were classified as grade 0, implying 
minimal suffering. 
 
9.3.2. Mouse strains  
The following mouse strains were used for these studies: GRS1 transgene (Zuniga et 
al., 2012), Grem1 null (Michos et al., 2004), Shh loss-of-function (St-Jacques et al., 
1998), Gli3 extra-toes-J (Maynard et al., 2002) and Hand23xF (Osterwalder et al., in 
press) alleles were maintained in an NMRI background; the Smad4 conditional allele 
(Yang et al., 2002), Prx1-Cre transgene (Logan et al., 2002), CMV-Cre transgene 
(Schwenk et al., 1995) and Dre transgene (Anastassiadis et al., 2009) were 
maintained in a C57BL/6 background; and the Smad43xF and Hand2 null alleles (Galli 
et al., 2010) in a mixed background. All mice and embryos were genotyped by PCR 
for relevant alleles using primers listed in the chapter 9.7.2. 
 
9.3.3. Generation of LacZ reporter transgenic embryos 
Candidate CRM regions were either amplified by PCR from mouse genomic DNA 
(Has2 +2.4kb and Twist1 +130kb CRMs) or recovered as restriction fragment from a 
BAC (Snai1 +58/59kb CRM, BAC clone RP23-193B17) and cloned into a βglobin 
promoter-LacZ reporter-SV40 polyA vector. Transgenic embryos were generated by 
pronuclear injection at the Transgenic Mouse Core Facility (TMCF), Basel (Has2 
CRM) or by Cyagen for the Twist1 and Snai1 CRMs. Founder embryos were stained 
for LacZ activity as described below. The transgenic embryos for the candidate 
CRMs of Tbx2 and Tbx3 were generated by M.Shoukry and A.Visel (Genomics 
Division, Lawrence Berkeley National Laboratory) as described by (Osterwalder et 
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al., in press). See chapter 9.7.2 for the genomic coordinates of the candidate CRM 
regions and for the primers used for their amplification by PCR. 
 
9.3.4. Whole-mount LacZ staining of mouse embryos 
Embryos were isolated in ice-cold PBS and staged by counting their somites 
numbers, before fixation in 1% formaldehyde, 0.2% glutaraldehyde, 0.02% NP-40, 
0.01% sodium deoxycholate in PBS for 20-30min at 4°C. After washing the embryos 
3 times in PBS for 5min at RT, they were incubated overnight at 37°C in the dark in 
1mg/mL X-Gal in dimethyl formamide, 0.25mM K3Fe(CN6), 0.25mM K4Fe(CN6), 
0.01% NP-40, 0.4mM MgCl2, 1% sodium deoxycholate in PBS. ß-galactosidase 
activity results in expressing cells being colored in blue. The reaction was stopped by 
washing the embryos 3 times in PBS for 5min at RT. 
 
9.3.5. Whole-mount in situ hybridization (WISH) 
Embryos isolated in ice-cold PBS were transferred in 2ml Eppendorf tubes and fixed 
overnight in 4% paraformaldehyde (PFA) in PBS at 4°C. The next day they were 
washed 2 times in PBS-0.1%Tween-20 (PBT) and subsequently dehydrated in a 
gradient series of 25%, 50%, 75% MetOH/PBT and finally 2 times 100% MetOH. 
Such dehydrated embryos were stored at -20°C in MetOH. For the first day of the 
WISH, embryos were rehydrated in a reverse series of 75%, 50%, 25% MetOH/PBT 
followed by 2 washes in PBT (5min each). Embryos were then bleached in 6% 
hydrogen peroxide (H2O2)/PBT for 15min at RT and washed 3 times in PBT (5min at 
RT). This was followed by treatment with 10µg/ml proteinase K in PBT for 5min 
(E8.5) to 15min (E10.5), depending on the embryonic stage. It is important to not 
move the embryos during this step. Freshly prepared 2mg/ml glycine in PBT was 
used to inactivate the proteinase K (5min at RT). Then the embryos were washed 
twice in PBT for 5min at RT. Embryos were refixed in fresh 0.2% glutaraldehyde, 
0.1% Tween-20 in 4%PFA (in PBS) for 20min at RT and washed twice in PBT. Then 
they were equilibrated in 2ml prewarmed prehybridization buffer (50% deionized 
formamide, 5xSSC pH 4.5, 2% BCI blocking powder, 0.1% Tween-20, 0.5% CHAPS 
(Sigma), 50µg/ml yeast RNA (Sigma R8759), 5mM EDTA, 50µg/ml heparin (Sigma 
H5515)) at 70°C for 1hr or longer. The prehybridization buffer was then replaced by 
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1ml of fresh prewarmed hybridization buffer containing 10µl/ml of digoxigenin-labelled 
RNA riboprobe (see below) and incubated overnight at 70°C. 
On the second day, the probe-containing hybridization buffer was replaced by 
prewarmed prehybridization buffer, followed by a series of 75%, 50%, 25% 
prehybridization buffer in 2xSSC (0.3M NaCl, 0.03M sodium citrate pH 4.5). All these 
washing steps were performed for 5min at 70°C. Subsequently, the embryos were 
washed twice in 2xSSC, 0.1%CHAPS for 30min at 70°C. To remove unbound DNA 
probes, embryos were treated with 20µg/ml RNase A in 2xSSC,0.1% CHAPS for 
45min at 37°C. Embryos were then washed twice with 100mM maleic acid disodium, 
150mM NaCl pH 7.5 for 10min at RT and twice for 30min at 70°C. Three washes in 
freshly prepared TBST (140mM NaCl, 2.7mM KCl, 25mM Tris-HCl pH 7.5, 1% Tween 
20) of 5min each at RT were then done. This was followed by blocking in 10% lamb 
serum/TBST for at least 1hr at RT. This blocking solution was replaced with a 
solution containing anti-digoxigenin-AP Fab fragments (Roche) conjugated to alkaline 
phosphatase. These Fab fragments were diluted 1:5000 in 1% lamb serum in TBST. 
Embryos were incubated overnight at 4°C with gentle rocking. 
On the third day, embryos were washed 3 times in TBST for 5min at RT and 5 times 
in TBST for 1hr-1.5hrs at RT. This was followed by an overnight wash in TBST at 
4°C. All washes were performed on a rocking platform. On the fourth day, the 
embryos were washed 3 times in freshly prepared NTMT (100mM NaCl, 100mM Tris-
HCl pH 9.5), 50mM MgCl2, 1% Tween-20) for 10min at RT and transferred into 1ml 
BM purple AP substrate (Roche) at RT. Development of the WISH was performed in 
the dark and monitored every hour until reaching appropriate probe-specific signal 
intensity. The development was stopped by washing 5 times in PBT (10min) and 
twice in PBS (5min). Finally, embryos were post-fixed in 4% PFA in PBS and stored 
at 4°C. WISH pictures were taken using a Leica MZ FLIII stereomicroscope and the 
Leica Application Suite V3 software. 
 
9.3.6. Preparation of digoxigenin-labelled RNA riboprobe 
To prepare riboprobes for in-situ hybridization, the plasmid containing the cloned 
cDNA of interest were linearized and transcribed using the appropriate T3, T7 or SP6 
RNA polymerase in combination with the DIG RNA labeling kit (Roche). The resulting 
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dig-UTP riboprobes were purified by two steps of ethanol precipitation (including 
linearized polyacrylamide in the first one), resuspended in TE (10mM Tris HCl pH 
7.4, 1mM EDTA pH 8.0) and stored at -20°C. Before use, the riboprobes were heated 
for 5min at 85°C and equilibrated at 70°C in pre-hybridization buffer. Probes in 
hybridization buffer were stored at -20°C and re-used several times. 
 
9.4. Molecular Biology 
9.4.1. Immunocytochemistry 
Cultured cells were carefully washed 2 times with prewarmed PBS (Gibco, 37°C) and 
fixed 30min in 4% PFA in PBS at RT with gentle rocking. After 3 times washes in 
PBS for 5min each at RT, fixed cells were permeabilized with 0.3% Triton X-100 in 
PBT and blocked in 10% goat serum, 0.3% Triton X-100, 0.3% BSA (Sigma) in PBT 
for 1h at RT. Primary antibody incubation was performed overnight at 4°C in 1% goat 
serum, 0.3% Triton X-100, 0.3% BSA in PBS containing the relevant primary 
antibody at the appropriate dilution (see Antibodies Tables in chapter 9.7.1). The 
following day, after three 5min washes in PBT, the cells were incubated with 
secondary antibodies (see chapter 9.7.1) diluted in 1% goat serum in PBS for 1hr at 
RT in the dark. Cells were washed 3 times in PBT (5min) and incubated with 1µg/ml 
Hoechst-33258 (Calbiochem) in PBS for 5min to stain nuclei. After three 5min 
washes in PBT, the cells were stored in PBS at 4°C in a moist chamber. High-
resolution fluorescent images were acquired using the Leica SP5 confocal 
microscope. 
 
9.4.2. Protein detection by Western Blot (WB) 
Proteins were extracted either from cultured cells or from embryonic tissues 
dissected in ice-cold PBS. Cultured cells were carefully washed with prewarmed PBS 
(Gibco, 37°C), detached and pelleted by centrifugation (3min, 1000 rpm). The cells 
were then resuspended in PBS and pelleted again by centrifugation (5min, 5000 
rpm). After discarding the supernatant, cell pellets were snap-frozen in liquid N2 and 
stored at -80°C before further processing. For embryonic tissues dissected and 
collected in cold PBS in Eppendorf tubes, snap-freezing in liquid N2 and -80°C 
storage was performed after removing as much cold PBS as possible from the 
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dissected tissues. Cellular lysis of frozen cells or tissues was performed by gently 
resuspending the frozen sample in an appropriate volume of ice-cold complete RIPA 
buffer (50mM Tris-HCl pH 7.5, 1% NP-40, 0.25% Na-deoxycholate, 150mM NaCl, 
1mM EDTA, 0.4mM Pefabloc, 1x Complete Mini protease inhibitor cocktail (Roche), 
1mM activated Na3VO4, 1mM NaF) followed by a 30min incubation on ice. Lysed 
cells were then centrifuged 15min at 13’000 rpm (4°C) to remove cellular debris, and 
the supernatant was transferred to a new ice cold Eppendorf tube. The protein 
concentration was determined using the BiCinchoninic acid Assay (BC Assay, 
Pierce) and specific amounts of BSA as standard controls. Protein extracts were then 
aliquoted and stored at -80°C. 
For SDS-PAGE, protein extracts were transferred on ice and mixed with 5x protein 
gel sample buffer (GSB: 0.5M Tris-HCl pH 6.8, 2% SDS, 20% glycerol, 0.0025% 
bromophenol blue, with freshly added 5% β-mercapoethanol) to a final concentration 
of 20% GSB. Protein extracts were denatured for 5min at 98°C and cooled down on 
ice for 3min before being loaded on a 10% SDS polyacrylamide gel. Proteins were 
separated by electrophoresis in running buffer (25mM Tris base, 192mM Glycine, 
0.1% (w/v) SDS) for 30min at 80V and 2-3hrs at 100-120V. Following SDS-PAGE, 
the SDS acrylamide gel was equilibrated in transfer buffer (25mM Tris base, 192mM 
Glycine, 20% (v/v) MetoH) for 15min. The proteins were then transferred from the gel 
to a PVDV (polyvinylidene fluoride) Immobilon-P transfer membrane (Millipore). Prior 
to transfer, the membrane was activated for 1min in MetOH and equilibrated in 
transfer buffer for 15min. Wet transfer was then conducted at 4°C at 100V for 2hrs. 
Following transfer, the membrane was rinsed in TBST (0.01M Tris-HCl pH 8, 0.05% 
Tween-20, 0.15M NaCl) and then blocked in 5% (w/v) milk powder in TBST for 1h at 
RT. The membrane was then incubated with primary antibody diluted in 5% milk 
powder in TBST (see chapter 9.7.1 for dilutions) overnight at 4°C. The following day, 
the membrane was rinsed in TBST and washed 3 times for 15min in TBST. Then it 
was incubated with the appropriate HRP conjugated secondary antibody (see chapter 
9.7.1) diluted in 5% milk powder in TBST for 1hr at RT. After three 15min washes in 
TBST, ElectroChemiLuminescence (ECL) detection of the antibody-labeled proteins 
was performed for 5min at RT using a 1:1 mixture of the SuperSignalTM West Pico 
Chemiluminescent Substrate kit (Thermo Scientific) and the VisualizerTM Western 
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Blot Detection Kit (Millipore). The membrane was then exposed to Kodak BioMax MR 
film or Amersham HyperfilmTM ECL (GE Healthcare) and developed in the Fujifilm 
FPM-100A Desktop Processor. To detect another protein, the membrane was 
stripped in RestoreTM Western Blot Stripping Buffer (Thermo Scientific) for 5min at RT 
and extensively washed in TBST. After 30min of blocking, the membrane was 
incubated with primary antibody for 1hr at RT (for anti-actin antibody) or overnight at 
4°C. Subsequent steps were performed as described above. 
 
9.4.3. Immunoprecipitation (IP)  
Protein extracts from cultured cells or from dissected embryonic tissues were 
prepared as described above. For each IP reaction, 150µg of total protein extract 
were used together with 15µl (45µg) of Dynabeads® Protein G (Life Technologies) 
and 1µg of anti-FLAG M2 antibody (Sigma) in a total volume of 150µl. First, for each 
IP reaction 150µg of total protein extract (in complete RIPA buffer with 3x Complete 
Mini protease inhibitor cocktail, see above) were transferred to 0.2ml PCR 
microtubes (Thermo Scientific) and topped up to 150µl with modified RIPA buffer. 
1µg of anti-FLAG M2 antibody was added and the mixture was incubated for 3hrs at 
4°C on a rotating wheel. During this incubation time, appropriate amounts of 
Dynabeads were transferred to a 1.5ml Eppendorf tube containing 1ml of cold RIPA 
buffer (without proteases and phosphatases inhibitors: 50mM Tris-HCl pH 7.5, 1% 
NP-40, 0.25% Na-deoxycholate, 150mM NaCl, 1mM EDTA). Dynabeads were 
washed 3 times with 1ml cold RIPA buffer using a magnetic rack, then resuspended 
in an appropriate volume of cold RIPA buffer and equally divided into new Eppendorf 
tubes according to the number of samples and kept on ice. After the 3hrs of 
incubation, the mixture was used to resuspend the Dynabeads, transferred back in 
the microtubes and incubated overnight at 4°C on a rotating wheel. The following 
day, the Dynabeads solution was transferred back to a 1.5ml Eppendorf tube and put 
on a magnetic rack. The supernatant (=unbound protein fraction) was transferred to a 
new Eppendorf tube, and the beads were washed 5 times with 0.8ml of ice-cold 
complete RIPA buffer. Dynabeads were resuspended in 100µl of ice-cold complete 
RIPA buffer, transferred to a new tube to avoid co-elution of proteins bound to the 
tube, and finally resuspended in 20µl cold complete RIPA buffer. To elute the 
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immunoprecipitated proteins from the Dynabeads, 8µl of GSB containing 5% β-
mercapoethanol (see above) were added to each sample. Samples were heated at 
98°C for 5min and incubated 3min on ice. The magnetic rack was then used to 
separate the Dynabeads from the denatured immunoprecipitated protein complexes. 
The eluted proteins were transferred into a new tube and stored at -20°C if not 
directly loaded on a SDS-PAGE gel. In addition to the IPP samples, input control 
(20µg of total protein extract) and unbound protein fraction control (20µl of the 1µl/µg 
total protein extract recovered following the immunoprecipitation) were also analyzed 
on SDS-PAGE gels. Immunoblotting using primary biotinylated anti-FLAG M2 
antibody and Streptavidin-HRP secondary antibody was performed as described 
above for regular Western-Blotting. 
 
9.4.4. Chromatin Immunoprecipitation (ChIP) 
This ChIP protocol for embryonic tissues is adapted from (Visel et al., 2009a) for 
tissue collection and crosslinked chromatin preparation, and on (Kim et al., 2007) and 
(Vokes et al., 2008) for subsequent steps, and has been modified and optimized by 
Marco Osterwalder and Javier Lopez-Rios. Embryos were collected in ice-cold PBS, 
and dissected tissues (forelimbs/hindlimbs or hearts) from somites-matched embryos 
of the same genotype were pooled and collected in ice-cold PBS into 2ml Eppendorf 
tubes. Dissected tissues were washed 2 times with ice-cold DPBS containing Ca2+ 
and Mg2+ (Gibco) and transferred to a 2ml glass douncer (Tissue Grind Tube Size 
2ml, Kimble-Chase) on ice. Tissue disaggregation was achieved by applying 25 
strokes with pestle A (Tissue Grind Pestle LC 2ml, Kimble-Chase) followed by 25 
strokes with pestle B (Tissue Grind Pestle SC 2ml, Kimble-Chase). The solution 
containing nuclei was transferred back to a 2ml Eppendorf tube, and the douncer was 
rinsed with 0.3ml cold DPBS w/Ca2+Mg2+ that was also added to the sample. After 
centrifugation at 3000 rpm for 3min (4°C), the supernatant was discarded and nuclei 
were resuspended in 1.5ml RT DPBS w/Ca2+Mg2+ containing 150µl 11x crosslinking 
buffer (0.1M NaCl, 1mM EDTA, 0.5mM EGTA, 50mM Hepes pH 8.0; add 11% 
formaldehyde just before use). The mixture was incubated for 5min at RT with gentle 
horizontal shaking. To stop crosslinking, 75µl of 2.5M Glycine were added, followed 
by another incubation of 5min at RT with horizontal shaking. The samples were then 
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centrifuged at 3000 rpm for 3min (4°C), supernatants removed, and pellets 
resuspended in 1.5ml ice-cold DPBS w/Ca2+Mg2+. After re-centrifugation at 3000 rpm 
for 3min (4°C), the supernatants were discarded and the nuclear pellets snap-frozen 
in liquid N2 and stored at -80°C. In order to use sufficient material for the ChIP, 
crosslinked nuclear pellets from different embryo collections can be pooled in one 
single sample. Generally, 3 samples containing crosslinked nuclei from similar 
amounts of dissected embryos were processed for ChIP in parallel in one 
experiment. 
Before performing the ChIP, antibodies coupled to magnetic beads were prepared. 
For one ChIP sample, 20µl of Dynabeads® Protein G were used and transferred to a 
2ml Eppendorf tube containing 1ml freshly prepared ice-cold BSA (5mg/ml in DPBS 
w/Ca2+Mg2+). Beads were washed 6 times with 1ml cold BSA/PBS using a magnetic 
rack, resuspended in a volume corresponding to 2.5x the original volume of beads 
(50µl per sample) and transferred to a 2ml screw cap microtube (Starstedt). 2µg of 
anti-FLAG M2 antibody were used for each ChIP sample and incubated overnight on 
a rotating wheel at 4°C.  
The following day, the Dynabeads-antibodies complexes were transferred back to a 
2ml Eppendorf tube and washed 6 times with 1ml cold BSA/PBS before being 
resuspended in the original volume of suspended beads (20µl per sample) and kept 
on ice. In the meantime, snap-frozen crosslinked nuclear pellets were thawed on ice 
and resuspended in 6ml cold Lysis buffer (50mM Hepes pH 7.5, 140mM NaCl, 1mM 
EDTA pH 8.0, 10% Glycerol, 0.5% NP-40, 0.25% Triton X-100, 1x Complete Mini 
protease inhibitor cocktail (Roche)). If necessary, several crosslinked nuclear pellets 
were pooled and resuspended in 6ml of ice-cold Lysis buffer (see comment above). 
Lysates were incubated for 10min at 4°C with gentle rocking, followed by 10min 
centrifugation at 2500 rpm (4°C). Supernatants were discarded and the pellets 
resuspended in 2ml of RT Protein Extraction Buffer (0.2M NaCl, 1mM EDTA pH 8.0, 
0.5mM EGTA pH 8.0, 10mM Tris-HCl pH 8.0, 1x Complete Mini protease inhibitor 
cocktail) to which 3ml of Protein Extraction Buffer were added. The samples were 
incubated for 10min at RT on a rocking platform and the nuclei were pelleted by 
centrifuging 10min at 2500 rpm at 4°C. After discarding the supernatant, the nuclei 
were resuspended in 1ml ice-cold Chromatin Extraction Buffer (1mM EDTA pH 8.0, 
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0.5mM EGTA pH 8.0, 10mM Tris-HCl pH 8.0, 0.1% Na-Deoxycholate, 0.5% N-
lauroylsarcosine, 3x Complete Mini protease inhibitor cocktail). Samples were then 
transferred to Covaris TC 12x12 tubes and sonicated to shear the crosslinked 
chromatin using the S220 Covaris Ultra-sonicator. Each sample was sonicated for 
15min using the 5% duty cycle, 140 watts Peak Incident Power and 200 Cycles per 
Burst. The sheared chromatin was then transferred back to 1.5ml Eppendorf tubes, 
and insoluble debris were pelleted by centrifuging for 10min at 13’000 rpm (4°C). The 
supernatants were moved to new 2ml screw cap microtubes, and the volume was 
topped up to 1.060ml with Chromatin Extraction Buffer. At this stage, 2x 30µl aliquots 
were taken and separated to new Eppendorf tubes: one for input control and the 
other to assess the quality of the sonicated chromatin on an agarose gel. Both 
aliquots were kept overnight at 4°C to be treated identical to the ChIP sample. Then, 
300µl of ChIP cocktail Mix (130µl Triton X-100 10%, 3µl Na-Deoxycholate 10%, 26µl 
Complete protease inhibitor solution (from a 50x tablet dissolved in 1ml mQ H2O), 
131µl TE buffer (100mM Tris HCl pH 7.4, 10mM EDTA pH 8.0) and 10µl mQ H2O 
were added to each 1ml ChIP sample to adjust to RIPA buffer conditions (see below). 
For each ChIP sample, 20µl of the freshly washed Dynabead-antibody complexes 
were added and incubated overnight on a rotating wheel (4°C). 
The next day, the dynabeads were transferred to 1.5ml Eppendorf tubes containing 
1ml of freshly prepared cold RIPA buffer (50mM Hepes pH 8.0, 1mM EDTA pH 8.0, 
1% NP-40, 0.7% Na-Deoxycholate, 0.5M LiCl, 1x Complete Mini protease inhibitor 
cocktail), and subsequently washed 6 times with 1ml cold RIPA buffer on a magnetic 
rack. The beads were rinsed once with 1ml TE-plus (100mM Tris HCl pH 8.0, 10mM 
EDTA pH 8.0, 50mM NaCl, 1x Complete Mini protease inhibitor cocktail) and 
centrifuged for 3min at 1000 rpm (4°C). All residual liquid was removed from the 
beads using the magnetic rack, and the beads were resuspended in 100µl freshly 
prepared Elution Buffer (1mM EDTA, 1% SDS, 10mM Tris-HCl pH 8.0). Elution of the 
crosslinked protein-DNA complexes from the Dynabead-antibody complexes was 
performed at 65°C for 15min on a heat block shaking at 1300 rpm. Beads were then 
centrifuged for 1min at 13’000 rpm and retained in the tube using a magnetic rack, 
while 100µl of supernatant containing the protein-DNA complexes were transferred to 
a PCR microtube. In parallel, the 30µl input aliquot and the 30µl chromatin aliquot 
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(kept on ice) were also transferred to PCR microtubes containing 120µl of Elution 
Buffer. Reverse crosslinking was performed for all three samples by incubating them 
overnight at 65°C  (≥12hrs). 
The next day, samples were transferred back to 1.5ml Eppendorf tubes and treated 
with RNase A (from bovine pancreas, Sigma) in TE (100mM Tris HCl pH 8.0, 10mM 
EDTA pH 8.0) at a final concentration of 0.2µg/µl. After 1hr incubation at 37°C, 
Proteinase K was added to a final concentration of 0.2µg/µl and proteins were 
digested for 2hrs at 55°C. Finally, DNA was purified from all three samples using the 
QIAquick Gel Extraction Kit (Qiagen). Elution was achieved in two steps using 30µl 
Buffer EB each, and the eluted ChIP and input samples were aliqoted and stored at -
20°C before use for qPCR. To assess the quality of the sonication, half of the purified 
chromatin control samples were loaded on an agarose gel to estimate the range of 
DNA fragments sizes (between 150bp to ~1.5kb with an maximal intensity at ~300bp, 
data not shown).  
 
9.4.5. Extraction of RNA and cDNA synthesis 
RNA was extracted either from cultured ES cells or from embryonic tissues dissected 
in cold PBS. For cultured ES cells, trypsine was used to detach the cells. These cells 
were then preplated as described in chapter 9.2.2 to separate them from EMFIs. ES 
cells were recovered in a 15ml Falcon tube, centrifuged for 5min at 1200 rpm and 
resuspended in 1.5ml ES cell medium. After re-centrifugation (3min at 5000 rpm), the 
medium was discarded and the cell pellet covered with 100µl RNAlater® (Ambion) 
and left overnight at 4°C before storage at -20°C. 
For embryonic samples, the dissected tissues were transferred in ice-cold PBS in 
1.5ml Eppendorf tubes. After PBS removal, samples were covered with 100µl of 
RNAlater® and left overnight at 4°C before storage at -20°C. Total RNA was 
extracted using the RNeasy Micro Kit (Qiagen). The RNA concentration was 
assessed using a Nanodrop 2000 C (Thermo Scientific), and RNA samples were 
stored at -20°C. 
To synthetize cDNA, 10pg-5µg RNA were mixed with the following reagents: 1µl oligo 
(dT)12-18 (500ng); 1µl dNTP mix (10mM each of dATP, dGTP, dCTP and dTTP at 
neutral pH); sterile water to a total volume of 13µl. The reaction mixture was heated 
	
   	
    
	
  148 
at 65°C for 5min and incubated on ice for at least 1min. After brief centrifugation, the 
following reagents were added: 4µl 5x First Strand Buffer, 1µl 0.1M DTT, 1µl 
RNaseOUTTM 40U/µl, 1µl SuperscriptTM III RT 200U/µl (all from Invitrogen). The 
mixture was incubated 1hr at 50°C, and cDNA synthesis was terminated by heating 
for 15min at 70°C. cDNAs were stored at -20°C before amplification by PCR (to 
generate templates for in situ hybridization probes or for cloning purposes) or by 
qPCR (to quantify target genes expression). 
 
9.4.6. Real-time quantitative PCR (RT-qPCR) 
Real-time quantitative PCR was done using the Bio-Rad CFX96 Real-Time PCR 
System in combination with the iQ SYBR Green Supermix (Bio-Rad). qPCR was used 
to determine transgene copy numbers from genomic DNA (Tesson et al., 2002), to 
quantify gene expression from embryonic tissues or cultured cells cDNA, or to 
compute levels of enrichment of genomic regions following ChIP. Each qPCR 
reaction was done in a 20µl reaction containing 0.3µM of each primer diluted in EB 
buffer (10mM Tris-HCl pH 8.5), 50% of SYBR green, and DNA template diluted in 
MiliQ H2O. All primers sequences are shown in chapter 9.7.2. -­‐ For the GRS1 transgene copy number determination, 20ng of genomic DNA 
was used as template. Triplicates were analyzed, using primers amplifying the 
Dopamine Beta-Hydroxylase (DBH) genomic region as normalizers. 
Transgene relative quantification cycle (Cq) values were normalized to DBH 
Cq values. Results are reported as mean ± standard deviation (SD) of 
normalized fold expression levels (2-∆∆Cq) of transgenic individuals (n= 9 or 
more), relative to non-transgenic control littermates (n=3) encoding the two 
endogenous copies of the GRS1 region. -­‐ For gene expression quantification, 0.05µl of cDNA were used as template 
and analyzed in triplicate. Primers detecting the ribosomal protein L19 
(RPL19) transcripts were used as internal normalizer. Relative Cq values of 
target transcripts were normalized to the Cq values of RPL19, and normalized 
fold expression levels (2-∆∆Cq) are shown as mean ± SD relative to the mean 
value (set at 100%) of a control sample.  
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-­‐ For computation of enrichment levels of a region of interest (ROI) following 
ChIP, 1µl of immunoprecipitated genomic DNA or input DNA were used as 
template and analyzed in duplicate. Primers recognizing an unlinked amplicon 
in the β-actin locus (Galli et al., 2010) were used as normalizing control region 
(NCR). Fold-change enrichments between input samples and ChIP samples 
were calculated as follows:  
(CqROI ChIP) – (CqROI input) = ∆CqROI 
(CqNCR ChIP) – (CqNCR input) = ∆CqNCR 
Fold enrichment = 2 –(∆CqROI-∆CqNCR)  
All results are displayed as mean ± SD and are based on analyzing 3 
independent samples (90-100 hearts each for HAND23xFLAG ChIP). To avoid 
artifact bias of fold enrichment, a Cq of 32 was defined as minimum 
background value threshold.  
 
9.5. Histology 
9.5.1. Paraffin embedding procedure 
For paraffin embedding, embryos were dissected in ice-cold PBS and fixed overnight 
in 4% PFA in PBS (4°C). After three 5min washes in PBS, the embryos were 
dehydrated into EtOH using a graded series (25% EtOH/PBS, 50% EtOH/PBS, 75% 
EtOH/H2O, 100% EtOH). Each EtOH incubation was done for 10min to 1hr 
depending on the size of the embryos, in ice-cold EtOH solution (4°C). Embryos were 
then transferred to RT and left to warm for 30min. This was followed by two 
incubations in EtOH for 10min each at RT. Following dehydration, embryos were 
cleared in Xylene for twice 25min at RT and transferred to a 50:50 (v/v) 
Xylene/paraffin mixture for 30min at 60°C. Then they were incubated with freshly 
melted paraffin 5-10 times for at least 30min each at 60°C. Then the samples were 
embedded in fresh paraffin wax (60°C) using a stereomicroscope for proper 
positioning. Paraffin blocks were then transferred to a 4°C cooling plate overnight and 
then stored at RT. The Microm HM 355 microtome was used to cut sections of 7µm 
(for immunohistochemistry and other histological stainings) or 14µm (for section in-
situ hybridization) that were mounted on Superfrost Plus slides (Thermo Scientific) 
and stored at RT until use. 
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9.5.2. Preparation of frozen sections 
For some section in-situ hybridization and some immunohistochemistry stainings, 
samples were embedded in Optimum Cutting Temperature (O.C.T) compound 
(Tissue-Tek) for cryoprotection as follows. Embryos were dissected in ice-cold PBS 
and fixed for 2hrs at 4°C in 4% PFA in PBS and washes 3 times in PBS (5min). 
Embryos were then transferred to 10% sucrose/PBS (w/v), 20% sucrose/PBS and 
30% sucrose/PBS (1hr each) with gentle shaking at 4°C. Then the embryos were 
transferred into embedding molds, the 30% sucrose solution carefully removed with a 
plastic pipette and replaced by 50:50 (v/v) O.C.T/30% sucrose. Embryos were 
positioned using a stereomicroscope. Freezing was achieved by dipping and holding 
the bottom of the embedding mold into 2-Methylbutane cooled on dry ice in a 
Styrofoam box until the embedding medium was completely frozen. Samples were 
stored at -80°C and sectioned (10µm) using a Microm HM 500 OM Cryostat (-20°C). 
Frozen sections were mounted on Superfrost Plus slides and stored at -80°C before 
use. 
 
9.5.3. Immunohistochemistry 
IHC on paraffin sections 
Sections of embryonic tissues were deparaffinized with twice 10min in Xylene 
followed by twice 10min in 100% EtOH. Sections were rehydrated in a reverse 
EtOH/H2O series (70% EtOH/H2O, 50% EtOH/H2O, 30% EtOH/H2O, 5’ each), rinsed 
in H2O and washed twice 5min in PBS. Antigen retrieval was achieved by autoclaving 
the sections in 10mM Sodium Citrate (pH 6.0) with 0.05% Tween-20 for 5min at 
120°C. The sections were then cooled to RT (30min), washed twice in PBS (5min) 
and 4 times in PBT (PBS with 0.1% Tween-20, 5min). Sections were blocked in 10% 
goat serum in PBT for 1hr at RT and incubated overnight in a moist chamber in 1% 
goat serum in PBT containing primary antibody at the proper dilution (4°C) (see 
chapter 9.7.1). The following day, sections were washed three times 10min in PBT 
and incubated in 1% goat serum/PBT containing the appropriate secondary antibody 
for 1hr at RT (in the dark). The sections were then washed three times for 10min in 
PBT and twice in PBS (5min). Incubation in 1µg/ml Hoechst-33258/PBS 
(Calbiochem) for 5min counterstained nuclei. Sections were washed 5 times in PBS 
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(5min) and a drop of mounting medium Mowiol 4-88 (Calbiochem) was added. They 
were covered with a coverslip and the slides were dried overnight at RT in the dark. 
For immunohistochemistry and for TUNEL assays (see below), the Leica SP5 
confocal microscope was used to acquire high-resolution fluorescent images. Slides 
were then stored at 4°C. For double staining with two mouse primary antibodies, the 
anti-FLAG M2 antibody was directly labeled using the APEX™ Alexa Fluor® 488 
Antibody Labeling Kit (Life Technologies). Immunostaining was performed as follows: 
1) overnight incubation with mouse primary antibody (anti-NFATC1 or anti-TWIST1) 
2) 1hr incubation with goat anti-mouse Alexa 594 3) overnight incubation with Alexa 
488-labellled anti-FLAG M2 4) 1hr incubation with rabbit anti-Alexa488 and 5) 1hr 
incubation with goat anti-rabbit Alexa 488.  
 
IHC on frozen sections 
Sections were washed with PBS 3 times (5min), with 0.2% Triton X-100/PBS for 
20min, and again three times with PBS (5min). Sections were then blocked in 1% 
BSA in PBT for 1hr at RT, followed by incubation with primary antibodies (see 
chapter 9.7.1) in 1% BSA/PBS overnight (4°C). The second day, the sections were 
washed 3 times for 10min in PBS and once in PBT (5min). Incubation with the 
appropriate secondary antibodies diluted in 1% BSA/PBS was done for 1hr at RT in 
the dark. Sections were washed 3 times for 10min in PBS and once in PBT (5min), 
counterstained with 1µg/ml Hoechst-33258/PBS (5min), followed by final washes in 
PBS (≥ 5x 5min). Mowiol 4-88 was used for mounting before addition of a coverslip. 
Before analysis, slides were dried overnight at RT in the dark and stored at 4°C. 
 
9.5.4. TUNEL assay 
Cell death in embryonic tissues was detected on paraffin section using the In situ Cell 
Death Detection Kit (Fluorescein, Roche). Following deparaffinization, rehydration 
and two PBS washes (5min), sections were washed with Tris-HCl 10mM pH 7.5 
(5min) and permeabilized in 20µg/ml Proteinase K in Tris-HCl 10mM pH 7.5 (20min 
at RT). After two PBS washes (5min), sections were incubated with the TUNEL 
reaction mixture for 1hr at 37°C in a moist chamber in the dark. Then, the sections 
were washed 3 times in PBS (5min), and the nuclei counterstained with 1µg/ml 
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Hoechst-33258/PBS (5min). Finally, after two more PBS washes (5min), sections 
were mounted in Mowiol 4-88 and stored as described. 
 
9.5.5. Hematoxylin/Eosin staining 
Sections of paraffin embedded samples were deparaffinized and rehydrated as 
described above, and then washed extensively in tap water for 5min. Histological 
staining was done by incubating the sections 3min in filtered Hematoxylin solution 
(Sigma) and washing in tap water for 3min. Then the sections were incubated for 1-
3min in filtered 0.15% Eosin/EtOH. Sections were then incubated in 95% EtOH 
(5min), followed by two incubations in 100% EtOH (5min) and three incubations in 
Xylene (5min). For mounting, the sections were covered with a drop of Eukitt (Fluka) 
and a coverslip was added. Slides were stored as described. Pictures were acquired 
using a Zeiss Axioskop 2 Plus microscope. 
 
9.5.6. Alcian Blue staining 
To stain proteoglycans, sections of paraffin embedded samples were deparaffinized, 
rehydrated and washed in tap water as described above. Sections were washed for 
3min in 3% acetic acid in H2O (v/v), pH 2.5. Staining was performed for minimum 1hr 
in 1% Alcian Blue (Sigma) in 3% acetic acid solution (w/v), pH 2.5. After extensive 
washes in tap water, the sections were incubated in Fastred (Sigma) for 5min at RT 
to counterstain nuclei. Slides were mounted with Mowiol 4-88 and stored as describe. 
Protocol adapted from (Rivera-Feliciano and Tabin, 2006).  
 
9.5.7. In situ hybridization on sections 
For all steps prior to probe hybridization, 0.1% DEPC (v/v) solutions were used. 
Paraffin sections of embryos were deparaffinized twice in Xylene (5min) and twice in 
100% EtOH (5min). Sections were rehydrated as follows: 75% EtOH/H2O-DEPC, 
50% EtOH/H2O-DEPC, 25% EtOH/H2O-DEPC, and twice in PBS-DEPC (5min each). 
Following rehydration, sections were fixed in 4% PFA/PBS-DEPC (10min), rinsed in 
PBT-DEPC and washed twice in PBT-DEPC (5min). Sections were then incubated in 
1µg/ml Proteinase K in PBS-DEPC (10min) and washed twice in PBT-DEPC (5min). 
For in situ hybridization on frozen sections, the protocol was started after the 
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Proteinase K incubation. Post-fixation was done in 4% PFA/PBS-DEPC (5min), 
followed by a rinse in PBT-DEPC and two washes in PBT-DEPC (5min). Sections 
were blocked with 0.25% (v/v) Acetic Anhydride in 0.1M Triethanolamine (pH 8) for 
15min, rinsed in PBT-DEPC and washed three times in PBT-DEPC (5min). Sections 
were then incubated in 65°C prewarmed pre-hybridization buffer (10mM Tris-HCl pH 
7.5, 600mM NaCl, 1mM EDTA, 0.25% SDS, 10% Dextran Sulfate, 200µg/ml yeast 
tRNA (Gibco), 50% Formamide, 1x Denhartdt’s (0.02% (w/v) Ficoll 400, 0.02% (w/v) 
Polyvinilpyrrolidone, 0.02% BSA in H2O-DEPC)), covered with a coverslip and 
incubated at 65°C for 1hr. For hybridization, sections were incubated in prewarmed 
hybridization buffer containing 1% (v/v) DIG-labelled RNA probe, covered with a 
coverslip and incubated at 65°C overnight in a moist chamber. The second day, 
coverslips were removed from the slides by rinsing them in 5x SSC (20x SSC: 3M 
NaCl, 0.3M Tri-sodium citrate dehydrate, pH 4.5) prewarmed to 65°C followed by two 
washes in 5x SSC (5min each) at 65°C. Sections were then incubated in 1xSSC/50% 
formamide at 65°C (30min) and washed in TNE (50mM Tris-HCl pH 7.5, 2.5M NaCl, 
5mM EDTA) at 37°C for 10min. Next, the sections were incubated in 20µg/ml RNase 
A in TNE at 37°C (30min) and washed in TNE at 37°C (10min). Further washes 
included 2xSSC at 65°C (20min), two 0.2xSSC washes at 65°C (20min) and two 
MABT (200mM Maleic Acid, 300mM NaCl, pH 7.5, 0.1% Tween-20 (v/v)) at RT 
(5min). Sections were blocked in 20% lamb serum in MABT for 1hr at RT and 
incubated overnight in 2% lamb serum in MABT containing 1:2000 anti-DIG-AP 
(Roche) in a moist chamber (4°C). The third day, the sections were rinsed and then 
washed three times in MABT at RT (5min each). Then, the sections were equilibrated 
in NTMT (100mM NaCl, 100mM Tris-HCl pH 9.5, 50mM MgCl2, 0.1% Tween-20) at 
RT for 10min, and the signal developed using BM purple AP substrate (Roche). 
Development of the in-situ hybridization was performed in the dark at RT for 1hr to 3 
days depending on the probe, with regular monitoring using a stereomicroscope. The 
reaction was stopped by rinsing the sections with NTMT and washing them at least 
three times in PBS (5min each). The sections were post-fixed in 0.1% 
glutaraldehyde, 4% PFA/PBS for 20min, washed twice in PBS (5min) and rinsed in 
H2O. Sections were mounted in Mowiol 4-88 and stored as described. 
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9.6. Genomics online resources 
All genomic sequences for cloning purposes or sequence alignments were retrieved 
from ENSEMBL (Flicek et al., 2014) or UCSC browser (Karolchik et al., 2014), 
Alignments were performed using the ECR browser (Ovcharenko et al., 2004) or the 
ClustalW2 program (Larkin et al., 2007). Other useful online resources include the 
VISTA enhancer browser (Visel et al., 2007) and the Mouse Genome Informatics 
website (http://www.informatics.jax.org). 
 
9.7. Tables 
9.7.1. Antibodies tables 
Primary Antibodies 
Antigen Host Distributor Use Dilutions 
FLAG (M2)  monoclonal  mouse  Sigma, F1804  WB, IP, ICC, IHC, ChIP  
1:2000, 1µg Ab/150µg prot, 1:4000, 
1:1000, 2µg/sample 
FLAG BioM2-Biotin  monoclonal  mouse  Sigma, F9291  WB  1:2000 
ACTIN polyclonal  rabbit  Sigma, A2066  WB  1:10'000 
HA polyclonal  rabbit  Sigma, H6908 WB, IP, ICC 1:2000, 1:2000, 1µg Ab/150µg prot 
V5 monoclonal  mouse Invitrogen, R960-25 WB, IP, ICC 1:10'000, 1:2000, 1µg Ab/150µg prot 
SMAD4 monoclonal  rabbit  Abcam, ab-40759 WB 1:1000 
GLI3 polyclonal  rabbit  Genentech, 2676 WB, ChIP 1:1000, 2µg/sample 
TBX2 polyclonal  mouse Milipore, 07-318 IHC 1:2000 
TBX3 polyclonal  goat Santa Cruz, sc-31656 IHC 1:300 
ISL1 (Mab15) monoclonal  mouse DSHB, 40.2D6 IHC 1:100 
SOX9 polyclonal  rabbit  Milipore, ab-5535 ICC, IHC 1:5000, 1:10'000 
TWIST1 monoclonal  mouse Santa Cruz, sc-81417 IHC 1:500 
VE CADHERIN polyclonal  rabbit  Abcam, ab-33168 IHC 1:1000 
VIMENTIN monoclonal  mouse  Sigma, V2258 IHC 1:500 
NFATC1 monoclonal  mouse Santa Cruz, sc-7294 IHC 1:500 
COLLAGEN 2 monoclonal  mouse ThermoSci, MS-235-P1 ICC 1:100 	
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Secondary Antibodies 
Antigen Distributor Use Dilutions 
goat α mouse IgG, HRP conjugate  Millipore, 12-349  WB 1:20'000 
goat α rabbit IgG, HRP conjugate  Millipore, 12-348  WB 1:20'000 
Streptavidin-HRP  Jackson, 016-030-084  WB 1:20'000 
goat α mouse IgG (H+L) Alexa Fluor®488 F(ab’)2  Invitrogen, A-11017  iCC, IHC 1:1'000 
goat α mouse IgG (H+L) Alexa Fluor®594 F(ab’)2  Invitrogen, A-11020  IHC 1:1'000 
goat α rabbit IgG (H+L) Alexa Fluor®488 F(ab')2 Invitrogen, A-11070 IHC 1:1'000 
goat α rabbit IgG (H+L) Alexa Fluor®594  Invitrogen, A11037  ICC, IHC 1:1'000 
rabbit α goat IgG (H+L) Alexa Fluor®594  Invitrogen, A-11080 IHC 1:1'000 
rabbit α Alexa Fluor®488 IgG Invitrogen, A-11094  IHC 1:1'000 
Anti-Digoxigenin-AP, Fab fragments from sheep  Roche, 11 093 274 910  WISH, SB 1:5000, 1:20'000 	
  
9.7.2. Primers tables 	
  
Genotyping primers for mice and embryos 
Locus Forward primer Reverse primer Size Allele  
GRS1 
transgene 5’-GCCTCTTCGCTATTACGCCAGCT-3’ 5'-AATTAACCCTCACTAAAGGG-3'  300bp Tg 
Shh 
5’-ATGCTGGCTCGCCTGGCTGTGGAA-3’ 5’-GAAGAGATCAAGGCAAGCTCTGGC-3’ 500bp Wt 
5'-GGACACCATTCTATGCAGGG-3’ 5’-GAAGAGATCAAGGCAAGCTCTGGC-3’ 150bp ∆ 
Gli3 
5'-GGGTGAACAGCATCAAAATGGAG-3' 5'-ATAGCCATGTGGTGGTGCCCATG-3' 500bp Wt 
5'-TACCCCAGCAGGAGACTCAGATTAG-3' 5'-AAACCCGTGGCTCAGAGCAAG-3' 600bp Xtj 
Smad4 
5'-GGGCAGCGTAGCATATAAGAC-3' 5'-CCTGACCCAAACGTCACCTTC-3' 390bp + 450bp 
Wt + 
Floxed 
5'-AAGAGCCACAGGTCAAGCAG-3' 5'-CCTGACCCAAACGTCACCTTC-3' 500bp ∆ 
Cre 5'-GCCTGCATTACCGGTCGATGCAACGA-3' 5'-GTGGCAGATGGCGCGGCAACACCATT-3'  750bp Tg 
Grem1 
5'-ATGAATCGCACCGCATACACTG-3' 5'-TCCAAGTCGATGGATATGCAACG-3' 750bp Wt 
5'-GGCACATGGCTGAATATCGACGG-3' 5'-AAGCGCCTCCCCTACCCGGTA-3' 550bp ∆ 
Hand2 
5'-TGCTCTCCAGTCCTGTCTCTCT-3' 5'-CCGATCTGGACAGCTAGCAA-3' 330bp + 530bp 
Wt +  
Floxed 
5'-AGAAGAGGACCTCGGCAATT-3' 5'-CTGTGGTCTTGTTCGCGATT-3' 496bp ∆ 
5’-TGGAGGGCCACGGAAGGCGAGATG-3’ 5’-GACAGGGCCATACTGTAGTCG-3’ 209bp + 284bp 
Wt + 
3xFlag 	
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Smad4 Homologous Recombination targeting - cloning primers 
Linker Sequence Restriction sites 
Linker 
Up           5'-ACGCGTGGGCCCTTAATAGATCTGGATCCTGATCAACGCGTAGCT-3' 
MluI, ApaI, spacer, BglII, BamHI, 
BclI, MluI, X SacI 
Linker 
Down 3’-CATGTGCGCACCCGGGAATTATCTAGACCTAGGACTAGTTGCGCA-5’ 
X KpnI, MluI, ApaI, spacer, BglII, 
BamHI, BclI, MluI 
Smad4 Homologous Recombination targeting - Southern Blot probes primers 
Probe Forward primer Reverse primer Size 
5' probe 5'-ATGGAGGACCGTTGTAGAGTTC-3' 5'-TTGCTCCACAGGAGAACTAACA-3' 580bp 
3' probe 5'-AATGAGTCTTGCTGACCTTGC-3' 5'-GCCAGGATGTTGGATGAGTT-3' 515bp 
Neo 
probe 5'-AATCGGGAGCGGCGATACCGTAAAGC-3' 5'-GACGTTGTCACTGAAGCGGGAAGGG-3' 508bp 
Smad4 Homologous Recombination targeting - mice genotyping primers 
Locus Forward primer Reverse primer Size Allele  
Smad4 
3xF-HR 5'-ACAGCCTCCACACTTGTGCT-3' 5'-TGTCTGCTAAGAGCAAGGCA-3' 
396bp + 
501bp 
Wt +  
3xF HR 
Smad4 
3xF-HR 
Neo 
5'-CAGCCAGTTGTACCATGCAG-3' 5'-GCCTGAAGAACGAGATCAGC-3' 432bp Neor 
Smad4 
3xF-HR 
∆Neo 
5'-AGGACTTTCCCATGGACACTG-3' 5'-AGCACTGCCTGGTCAGATGA-3' 576bp + 610bp 
Wt +  
3xF ∆Neo 	
  	
  	
  
Candidates CRMs for transgenic reporters - cloning primers 
CRM Coordinates (mm9) Forward / Reverse primers Size Restr. site  
Has2  
+2.4kb Tg chr15:56,523,368-56,525,546 
5'-GAGAAGCTTGCAAGAAAAACACGATCTCA-3' 2218 
bp HindIII 5'-CACAAGCTTACGTTATACAGACGCGTTTG-3' 
Tbx2  
-32kb Tg chr11:85,612,756-85,614,268 
5'-ATGGCCACCTTTTCTTCTGC-3' 1513 
bp 5'-AAGCCTTCCTAAGCCACTGT-3' 
Tbx3  
-58kb Tg chr5:120,060,938-120,063,445 
5'-GGTCCTTGGAGACTGAGACA-3' 2508 
bp 5'-GAATAGCAGAGCACAG-3' 
Tbx3  
-18kb Tg chr5:120,100,229-120,102,755 
5'-GGGGTGAACTGTTGGAGAGA-3' 2527 
bp 5'-TCAGCTAGAGGTCACATGCA-3' 
Twist1 
+130kb Tg chr12:34,771,890-34,772,660 
5'-GAGAAGCTTTGAATGAACGTTTTTGTAACTGC-3' 
753bp HindIII 
5’-CACAAGCTTGAGCCACTGTGTTCTGTTGG-3’ 
Snai1 
+58/59kb Tg chr2:167,419,933-167,424,557 Released from BAC RP23-193B17 as HpaI/MfeI fragment 
4625 
bp 
Candidates CRMs for transgenic reporters - genotyping primers 
Locus Forward primer Reverse primer Size 
Has2  
+2.4kb Tg 5'-TAGGAAGGTAAGGACAGTTGTGG-3' 5'-AATGTGAGCGAGTAACAACCCG-3' 916bp 	
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ChIP qPCR primers 
ChIP 
Amplicon Forward primer Reverse primer Size 
Rank in 
Top2000 
Id1 BRE  
-1.1kb 5'-AGAATGCTCCAGCCCAGTTT-3' 5'-TGACGTCACCCATTCATAAAA-3' 93bp - 
Id1 -3kb 
(ctrl) 5'-TTCTTCTCTGGCTGCCAGTG-3' 5'-AACTGAGCCTTGCATCATGC-3' 140bp - 
Actb +1.8kb 
ctrl region 5'-GATCTGAGACATGCAAGGAGTG-3' 5'-GGCCTTGGAGTGTGTATTGAG-3' 115bp - 
Tbx3 -58kb 5'-TGTGGTCTGTCACTGTGCACTT-3' 5'-CCAGATTGCCATCACAGACAG-3' 131bp 216 
Tbx3 -59kb 
(ctrl) 5'-AACTCGGGTACACTCGCACA-3' 5'-ACAGAAAATAAGGCTGGCCC-3' 134bp - 
Tbx3 -18kb 5'-TCCCTCAGGAGCTCTGTCTG-3' 5'-AGGATTCCAGGGAGGTCTGT-3' 118bp 944 
Tbx2 -204kb  5'-CTCCCACTGATGGCTGAAAT-3' 5'-CCCAGGATGTGAACTGTCAGT-3' 138bp 164 
Tbx2 -199kb 
(ctrl) 5'-CTGTGTGCTACTCCGCATCA-3' 5'-CACTTTCCACTTGGGTGGTG-3' 112bp - 
Tbx2 -112kb 5'-AGGGGAAGGAGGTTAGATGG-3' 5'-GCCTGGGAAGAAAGGCTTC-3' 90bp 595 
Tbx2 -32kb 5'-GGCTCGCACCCTCTCTATTA-3' 5'-TTGATCAGCCGTCAGAAACT-3' 102bp 59 
Furin -43kb 5'-TGGCTGATGACTGCCCTTAT-3' 5'-AAAGCTGTGGAGGCAAGTGT-3' 80bp 11 
Furin -50kb 
(ctrl) 5'-CTACATGAGGGTTGGGGAGA-3' 5'-TGCTCTGCTGATGGCTAAAA-3' 100bp - 
Myocd 
+60kb 5'-TGGCTATTGTCCCTCCAGAC-3' 5'-GGATGATGTCAGGGCTTCTC-3' 73bp 1588 
Myocd -31kb 
(ctrl) 5'-AGCATCCCCTGAGAAAGTCA-3' 5'-AGGGGCACCTAAAGATTTCC-3' 110bp - 
Twist1 
+10kb 5'-CCTCTGGTTGACACAAAGCA-3' 5'-TGGGGACTAGGACACCAGAC-3' 124bp - 
Twist1 
+130kb 5'-ACACATTGACCTGGCTGTGA-3' 5'-AGGCAGACCTTCATTGAGGA-3' 92bp 1157 
Twist1 
+135kb (ctrl) 5'-AGGCTTGTCAGCACCTTGTT-3' 5'-AAGTGGGCTTTAGCATGTGG-3' 85bp - 
Snai1 +45kb 5'-ACTCTCCGGGGACAGCTAATA-3' 5'-CCCACTGCTTTGATCAGCTT-3' 120bp - 
Snai1 +58kb 5'-GTCAGAAAGGCAGCTTGGAG-3' 5'-GCTTCTCTGTCCCCTCCTTT-3' 85bp 1397 
Snai1 +59kb 5'-TCTGCTGGCCTCCAGATGT-3' 5'-TTGATAAAGCCCCTCTGTGC-3' 73bp 1397 
Snai1 +64kb 
(ctrl) 5'-CCACCTGTCTGCCCTTAGTC-3' 5'-GGGCCCTTTCTTGAACTACC-3' 71bp - 
Sox9 
+232kb 5'-GAGGCTTGTCTGGCACATTA-3' 5'-TCAGTTGGGAGTCCAGCAG-3' 84bp 1204 
Sox9 
+234kb (ctrl) 5'-GGAGGTCCCTTTAGGAAGGA-3' 5'-CTCCATCCTGTTCCCATTGA-3' 112bp - 
Has2 -4.3kb 
(ctrl) 5'-TTGTTCACTTGGGCATTTCA-3' 5'-CCATGAAGAGCACTTTCTGCT-3' 126bp - 
Has2 -0.9kb 5'-TTGCCTCTTGACAGCCTTTT-3' 5'-CAGTCTTGGCGTCATTGAAA-3' 70bp 1201 
Has2 +2.4kb 5'-AGAGGGAAATCCCAGGCTAA-3' 5'-CCAGCCAGAGTCCAGAGTTT-3' 139bp 1183 	
  
qPCR primers 
Locus Forward primer Reverse primer Size 
Smad4 exon 6-7 / 7-8 5'-CCATCATAACAGCACTACCACC -3' 5'-GCCAGTAATGTCCAGGATGG-3'  128bp 
Smad4 exon 8-9 5'-TTTCCAATCATCCTGCTCCTGA-3' 5'-AACGTCTCTCCTACCTGAACGTCC-3' 76bp 
Smad4 exon12-3'UTR 5'-GTGCTGGATTGAGATTCACC-3' 5'-CGTGGTGTGAGATCTCAGTCTA-3' 108bp 
Smad4 3xFlag-3'UTR 5'-AAAGATCACGACATCGACTA-3' 5'-GTGTGAGATCCAATTGTGAG-3'  70bp 
Rpl19 5'-ACCCTGGCCCGACGG-3' 5'-TACCCTTTCCTCTTCCCTATGCC-3' 53bp 
GRS1 5'-CGCTGAATTTACAGCATCACTT-3' 5'-AGCGGCACAGTTTGATGTC-3' 64bp 
Dbh 5'-AGGACATCAGCCACTCTGCT-3' 5'-AATTGTCTTGGTGGCCCTC-3' 117bp 
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12. Appendixes 
12.1. Generation of Smad43xFLAG mice using dRMCE 
12.1.1. Testing three epitope-tagged versions of SMAD4 in ES cells 
The first attempt to generate a mouse with an epitope tag fused in frame in the 
Smad4 coding sequence was done using dRMCE. This technique is based on dual 
recombination of the loxP and FRT sites present in numerous conditional alleles 
available as ES cell lines, for example from the EUCOMM and IKMC consortium 
(Osterwalder et al., 2010a). The co-electroporation of the pDIRE vector coding for the 
iCre and FLPo recombinases together with a pDREV targeting vector is designed to 
insert an epitope tag, a mutation or a reporter in a specific floxed locus at much 
higher efficiencies than homologous recombination (Osterwalder et al., 2010a). 
Several epitope-tagged versions of SMAD4 had been generated and used mainly for 
in-vitro expression studies in various cell lines over the past decades, without a 
consistent position of the epitope tag relative to the N-term or the C-term extremities 
of the protein. The choice of the epitope tag and its positions are important points to 
avoid potential interference with the physiological function of the target transcription 
factor. We thus took advantage of the high targeting efficiency with dRMCE to test 
three different epitope tags and assess their sensitivity and specificity before deciding 
which one using to generate a Smad4 epitope-tagged mouse strain. The three 
different epitope tags (FLAG, HA and V5) were inserted in frame of the C-terminal 
part of SMAD4 and multimerized (3x) to increase detection sensitivity (3xFLAG, 3xHA 
and 3xV5). In silico comparison of SMAD4 3D structure with the predicted 3D 
structures of the three different versions of the SMAD43xTAG protein using I-TASSER 
(Roy et al., 2010) did not show significant alteration in the conformation of the epitope 
tagged protein (data not shown). Overexpression of the three versions of the 
SMAD43xTAG protein in HEK293 cells showed that the three epitope tags are 
efficiently detected with high sensitivity using specific antibodies (data not shown). 
For dRMCE mediated cassette exchange, we used an existing floxed Smad4 
knockout-first tm1a allele generated by IKMC. This allele encodes a promotorless 
gene-trap selection cassette flanked by FRT sites, which is followed by loxP sites 
flanking Smad4 exon 9 (S4EC allele, Fig.30A).  
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Figure 30. Dual recombinase-mediated cassette exchange in mouse ES cells to engineer a 
Smad43xTAG allele  
(A) dRMCE targeting strategy. From top to bottom: the Smad4 wild-type allele (S4wt). The pDREV 
targeting vector containing a FRT site, Smad4 exons 9-12, 3 different versions of a 3x epitope tag 
(3xFLAG, 3xHA or 3xV5) fused in frame to Smad4 exon 12, a STOP codon, Smad4 3’UTR, SV40 pA 
signal, a Puromycin selection cassette flanked by rox sites, and a loxP site. The Smad4 EUCOMM 
conditional allele with a promoterless cassette flanked by FRT sites and Smad4 exon 9 flanked by 
loxP sites (S4EC). The Smad4 deleted EUCOMM allele following double iCre and FLPo recombination 
without insertion of a targeting element (S4∆E). The Smad4 targeted allele with dRMCE-mediated 
insertion of the targeting element from pDREV between the FRT and loxP sites (S43xT-dRMCE). The 
primers for PCR screening are indicated with arrows. The restriction sites used for Southern Blot are 
indicated in italics, and the Southern Blot probes are shown as green boxes. (B) PCR screening 
analysis of all Smad4 alleles. Primers used for each reaction are indicated on the right. For the S43xT-
dRMCE allele, the screening was performed both on the 3’ and on the 5’ sides. Clone Φ1C3 is a 
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positively targeted clone, χ5C3 is a S4∆E/+ clone, and χ1E4 a parental S4EC/+ clone. S4+/+ (green) and 
S4EC/+ (blue) ES cells were used as controls. (C) Table showing the number of PCR positive clones in 
relation to the total number of clones picked. In total, 116 of 168 ES cell clones were screened by 
PCR. 88 ES cell clones were correctly targeted on both 3’ and 5’ sides. (D) Southern Blot analysis for 
three ES cell clones of each replacement. S4+/+ (green) and S4EC/+ (blue) ES cells were used as 
controls. Top panel: ES cells DNA was digested with NdeI and blotted with the 5’ probe shown in (A). 
The sizes of the expected S4wt, S4EC or    S43xT-dRMCE bands are indicated on the left. Middle panel: 
EcoRV digestion in combination with the 3’ probe. Lower panel: detection of the Puro cassette after 
EcoRV digestion. 
 
 
Two ES cell clones of this EUCOMM conditional allele were used and targeted in 
parallel (A07 and G07). The targeting vector was designed to replace the 
promoterless cassette and exon 9 of the S4EC allele with the coding sequence of 
exon 9-12 with an in frame 3x epitope TAG, a STOP codon, the endogenous Smad4 
3’UTR and a polyadenylation site from SV40. These modifications are followed by a 
Puromycin selection cassette that is flanked by rox sites (Fig.30A). Following 
electroporation and Puromycin selection, 168 ES cell clones were picked (together 
with M.Osterwalder). Screening of positively targeted clones was done by PCR to 
discriminate between the different possible recombination events and the parental 
allele (Fig.30A,B). For the six conditions (two ES cell clones and three different tags), 
76% of the 116 screened ES cell clones were correctly exchanged (Fig.30C). This 
percentage is very close to the 69% obtained in a previous targeting of the S4EC allele 
(Osterwalder et al., 2010a). Southern Blot analysis using probes for both the 5’ and 3’ 
arms of the exchanged region and a probe detecting the Puro cassette confirmed 
correct recombination and single insertion of the targeting construct in all tested 
clones (Fig.30D). For each condition, three clones with normal karyotypes were 
analyzed further (data not shown).  
The three versions of the epitope-tagged SMAD4 proteins were detected in ES cells 
using specific antibodies. This showed that tagged SMAD4 was best detected by 
using the 3xFLAG and 3xV5 epitope tags (Fig.31A). As the Hand23xFLAG allele had 
produced high quality ChIP-Seq data from limb buds (Osterwalder et al., in press), we 
selected the Smad43xFLAG allele for further analysis. As immunoprecipitation is the 
crucial step in the ChIP-Seq process, we used the anti-FLAG M2 antibody to 
establish its ability to IPP the SMAD43xFLAG protein (Fig.31B). 
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Figure 31. Detection tests of 
SMAD43xTAG in ES cells 
(A) Western Blot detection of SMAD43xHA 
(left), SMAD43xV5 (middle) and 
SMAD43xFLAG (right) in protein extracts of 
two different S43xT-dRMCE/+ ES cell clones 
each. Wild-type ES cells were included 
as controls. SMAD43xTAG size: ~63kDa. 
(B) Immunoprecipitation using the anti-
FLAG M2 antibody on two S43xF-dRMCE/+ 
ES cell clones and wild-type cells. The 
top panel is blotted with a biotinylated 
anti-FLAG antibody and the lower panel 
with an anti-Actin antibody (size: 42kDa). 
On the left, 20µg of protein extracts were 
loaded as input controls. In the middle, 
the whole immunoprecipitate from 150µg 
of total proteins (1µg/µl) was loaded. On 
the right, 20µl of the unbound fraction 
after the IPP were loaded. The 
SMAD43xFLAG protein is detected in the 
input and IPP samples of the S43xF-
dRMCE/+ clones. All SMAD43xFLAG protein 
was immunoprecipitated as revealed by 
its absence in the unbound fraction (top 
right panel). ACTIN was used as a 
loading control and is present in similar 
amounts in all samples. (C) 
Immunofluorescence detection of the 
SMAD43xFLAG protein in undifferentiated ES cells (left panels) and after twelve days of differentiation 
into embryoid bodies (right panels). Two different   S43xF-dRMCE/+ ES cell clones were analyzed together 
with wild-type controls. Green: SMAD43xFLAG. Blue: Hoechst: Scale bar: 20µm.  
 
Finally, as SMAD4 is shuttling between cytoplasm and nucleus following activation of 
BMP signal transduction, immunocytochemistry was used to assess its cellular 
localization. In undifferentiated ES cells, the SMAD43xFLAG protein was detected both 
in the cytoplasm and in the nuclei (Fig.31C, left panel). Previous studies had shown 
that BMP signaling and consequential phosphorylation and nuclear translocation of 
SMAD1/5 are higher in differentiated ES cells (Fei et al., 2010; Galvin et al., 2010; 
James et al., 2005). Therefore, the SMAD43xFLAG protein distribution was assessed in 
embryoid bodies after 12 days of differentiation, at which Smad4 transcripts levels 
are the highest (M.O., unpublished result). Consistent with activation of BMP signal 
transduction in differentiating ES cells, we observed an increase in nuclear 
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SMAD43xFLAG proteins in comparison to undifferentiated ES cells (Fig.31C, right 
panel). We thus concluded that the SMAD43xFLAG protein was functional.  
 
12.1.2. Embryonic lethality of Smad43xFLAG homozygous embryos 
Three different Smad43xFLAG/+ ES cells clones (C57BL/6 background) were injected 
into BALB/c blastocysts at the Transgenic Mouse Core Facility (TMCF, Basel). Only 
one 80% chimeric male was obtained from clone Φ3A2 and no chimeras were 
obtained from the other two clones. This chimeric male was mated to C57BL/6 
females and germline transmission was observed in 6% of the offspring and 
confirmed by PCR genotyping (see primers F2/R2 in Fig.32F). As Smad4 is 
ubiquitously expressed, we could efficiently detect the SMAD43xFLAG protein from 
various embryonic tissues by Western Blot analysis of heterozygous embryos (E11.5, 
Fig.32A). Anti-FLAG immunoprecipitation from embryonic forelimbs of S43xFLAG/+ also 
established highly efficient and clear IP of SMAD43xFLAG proteins (E11.5, Fig.32B).  
Next, we wanted to assess a candidate direct target of SMAD4 by ChIP-qPCR in limb 
buds using the Smad43xFLAG allele. A good candidate is the BMP Responsive Element 
(BRE) located in the proximal promoter of Id1. The expression of Id1 is cleared from 
Smad4∆/∆m limb buds (E.P, unpublished result), and SMAD4 interacts in vitro with this 
BRE (Korchynskyi and ten Dijke, 2002; Lopez-Rovira et al., 2002; Katagiri et al., 
2002). This conserved BRE overlaps with a DNase HS region (ENCODE/UW) and a 
p300 ChIP-Seq peak in forelimb buds (E11.5) (Visel et al., 2009a) (Fig.32C, left 
panel).  Therefore, we assessed if the SMAD43xFLAG protein was interacting in vivo 
with this BRE by ChIP-qPCR from pooled wild-type and Smad43xFLAG/+ embryonic 
limb buds versus wild-type limb buds (E11.75, Fig.32C, right panel). We observed a 
small ~3x fold enrichment of Id1 BRE in the FLAG sample. 
In parallel, we attempted to generate homozygous Smad43xFLAG/3xFLAG mice. However, 
we observed that this was not possible due to early embryonic lethality similar to the 
lethality of Smad4∆/∆ embryos at E7.5 (Fig.32D, (Sirard et al., 1998). The likely 
explanation for this lethality is that the S43xFLAG-dRMCE allele was somehow damaged 
and its expression reduced to low levels. Indeed, quantification of the expression of 
Smad4 by RT-qPCR in embryonic limb buds showed that this was the case (E11.0, 
Fig.32E). 
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Figure 32. Expression of the Smad43xFLAG allele in mouse embryos 
(A) Western Blot detection of SMAD43xFLAG (top panel) and Actin (lower panel) from protein extracts of 
various embryonic tissues from a pool of S4+/+ and S43xF/+ embryos at E11.5. Protein extracts from 
wild-type forelimbs at E11.5 were used a control (green). (B) Immunoprecipitation analysis from 
forelimb buds at E11.5. (C) Anti-FLAG ChIP from S4+/+ and S43xF/+ E11.75 forelimbs. Left panel: UCSC 
browser window representing the BMP Responsive Element (BRE) located -1.1kb from Id1 TSS (black 
box). DNase HS and p300 ChIP-Seq profile from E11.5 limb buds are displayed above the placental 
mammal conservation (Cons) plot. Right panel: ChIP-qPCR for Id1 BRE in S4+/+ (green) and S43xF/+ 
(blue) samples. Mean ±SD (n=2) is shown. (D) Bright-field pictures of a S43xF/+ embryo at E9.0 (left) 
and dead S43xF/3xF embryo (right, white arrow). Scale bar: 0.5mm. (E) RT-qPCR analysis of Smad4 
transcripts in limb buds at E11.0. Top panel: schematic representation of the Smad4wt and 
Smad43xFLAG transcripts with the qPCR primers indicated by arrows. The area indicated by the red box 
in the Smad43xFLAG transcript corresponds to the targeted region introduced by the pDREV vector. RT-
qPCR amplification probed transcripts containing exons 6-8 (top left graph), exons 8-9 (top right 
graph), exon 12-3’UTR (bottom left graph) and Flag-3’UTR (bottom right graph) from the following 
genotypes: S4+/+ (green), S4∆/+ (red) and S43xF/+ (blue). The normalized fold expression is indicated 
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above each bar relative to the S43xF/+ embryos (bottom right graph) or wild-type control. (F) Smad4 
transcripts levels following removal of the Puro cassette. Top panel: schematic representation of the 
Smad43xF-dRMCE;∆Puro allele obtained by mating  S43xF/+ females with Dretg/+ males. F2/R2: primers used 
to genotype Smad43xFLAG versus Smad4wt allele. ∆PF/∆PR: primers used to genotype Smad43xF-
dRMCE;∆Puro allele. Bottom panel: RT-qPCR in limb buds at E11.75 to detect Smad4 transcripts encoding 
exons 6-8 (left) and exons 8-9 (right). The following genotypes were used: S4+/+ (green), S43xF/+ (blue) 
and S43xF-∆P/+ (grey). Normalized fold expression levels are indicated above each bar relative to the 
wild-type control. 
 
 
Assessing Smad4 expression at the junction between exons 6-8 (i.e. outside of the 
targeted region) and at the exons 8-9 junction (i.e. in the targeted region) showed that 
Smad4∆/+ embryos (Fig.32E, red) have ~50% of transcripts in comparison to 
Smad4+/+ embryos (Fig.32E, green). While the expression of coding exons 6-8 in 
Smad43xFLAG/+ embryos was reduced to 81% (Fig.32E, top left panel, blue), the 
expression of exons 8-9 dropped to 52% in Smad43xFLAG/+ embryos, similar to 
Smad4∆/+ embryos (Fig.32E, top right panel, blue). These results and others 
established that the S43xFLAG-dRMCE allele is severely hypomorphic, as the majority of 
the S43xFLAG-dRMCE transcripts appear truncated in the crucial 3’ part. The small 
fraction of full-length transcripts is sufficient to produce SMAD43xFLAG proteins at 
levels detectable by Western Blot and IP analysis (Fig.32A and Fig.32B), but not 
sufficient to sustain the viability of homozygous embryos (Fig.32D). 
As the presence of the neighboring Puromycin selection cassette in the S43xFLAG-
dRMCE allele (Fig.30A) could account for this reduction in transcription (Lewandoski, 
2007), we used Dre-recombinase expressing mice to remove the rox-flanked PGK-
Puro cassette (Anastassiadis et al., 2009). However, RT-qPCR analysis showed that 
the deletion of the Puro cassette did not rescue the expression levels of the S43xFLAG-
dRMCE allele and embryonic lethality of homozygous embryos (Fig.32F and data not 
shown).  
 
The reduced transcription level in the targeted region of the locus is thus likely due to 
a defect in the S43xFLAG-dRMCE allele itself. As the whole targeted region was fully 
sequenced and no mutation was detected, we suspect that the parental IKMC 
knockout-first conditional allele (S4EC) could have already been damaged. The 
automated, computer-assisted design of the targeting vector used to generate IKMC 
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alleles could introduce errors that cannot be detected until the knockout-first 
conditional allele is tested (Skarnes et al., 2011). In particular, we realized that the 
FRT-promoterless cassette-loxP is inserted in Smad4 intron 8-9 close to the 5’ end of 
exon 9. Thus, the presence of the remaining FRT site in this intron in the targeted 
allele may affect the correct splicing of this region. Such incorrectly spliced transcripts 
could be eliminated by nonsense-mediated RNA decay, resulting in the observed 
reduction in the amount of transcripts coding exons 8-9 (not shown) and 9-10 
(Fig.32E). Alternatively, the presence of the FRT site in intron 8-9 could have 
generated a cryptic polyA signal, leading to a majority of transcripts truncated after 
exon 8. These two possibilities have not been investigated further but provide 
potential explanations for the observed severe hypomorphic phenotype. 
As the Smad43xFLAG-dRMCE allele is not expressed at wild-type levels, we tested 
another cassette exchange strategy. We introduced the whole coding sequence and 
endogenous promoter of Smad4 with the 3xFLAG epitope tag in the non-essential 
Rosa26 locus using ES cells previously engineered for efficient RMCE (Tsanov et al., 
2012). The resulting Smad43xFLAG-R26 allele was expressed at levels lower than the 
Smad43xFLAG-dRMCE allele in ES cells (data not shown), and we decided to resort to 
conventional homologous recombination to generate a normally expressed 
Smad43xFLAG allele (see chapter 6.1.5). 
 
12.2. Additional methods relative to the dRMCE targeting 
12.2.1. Construction of the pcDNA3 Smad43xTag expression vectors 
The Smad4 coding sequence (CS) was first amplified by PCR using primers to 
introduce an Asp718 and NarI restriction sites at the 5’- and 3’- ends, respectively. A 
Kozak sequence (GCCGCCACC) was introduced as part of the 5’ primer between 
the Asp718 site and Smad4 ATG codon to enhance translation. This Asp718-Smad4 
CS-NarI fragment was inserted into a pBluescript II KS (pBSK, Stratagene) backbone 
vector previously constructed by J.Lopez-Rios (unpublished data) in frame with an 
epitope tag followed by a STOP codon. Two versions of this vector were used, one 
carrying a 3xFLAG and one with a 3xHA epitope tag. The whole Smad4 CS-3xTag-
STOP fragments from the pBSK-Smad43xFLAG and pBSK-Smad43xHA plasmids were 
then transferred into the pcDNA3 (Invitrogen) mammalian expression vector as an 
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Asp718-EcoRI fragment. This resulted in the pcDNA3 Smad43xFLAG and pcDNA3 
Smad43xHA expression vectors (Fig.33). A pcDNA3 vector expressing Smad4 with 
3xV5 epitope tag was also constructed (see below).  
 
12.2.2. Construction of the pDREV S43xTag targeting vectors for dRMCE 
Three versions of the pDREV targeting vector for dRMCE were constructed using the 
three different epitope tags (3xFLAG, 3x HA and 3xV5). All were designed to target 
the promoterless cassette of the knockout first Smad4tm1a(EUCOMM)Wtsi allele in ES cells 
by dual Recombinase Mediated Cassette Exchange (dRMCE, see (Osterwalder et 
al., 2010a). First, a synthetic fragment containing a part of Smad4 intron 9/10, the 
cDNA of coding exons 9-12, an in frame 3xV5 tag and a STOP codon was 
synthetized by GeneArt in the pMA vector (pMA-Tag). This fragment was flanked by 
BstBI restriction site on the 5’ end and by a EcoRI-MfeI-NdeI-PacI polylinker on the 3’ 
end. Subsequently, a BamHI-EcoRI fragment containing part of exon 12 and the 
3xV5 tag was released from the pMA-Tag vector and introduced into the pcDNA3 
expression vectors containing the Smad4 CS to replace the 3xFLAG tag with the 
3xV5 (pcDNA3-Smad43xV5 expression vector). In addition, BamHI-EcoRI fragments 
containing part of exon 12 and the 3xFLAG or 3xHA epitope tags were released from 
the pBSK-Smad43xTag vectors and introduced into the pMA-Tag to replace the 3xV5 
BamHI-EcoRI fragment. A PCR fragment encoding Smad4 3’UTR was amplified from 
cDNA with primers introducing MfeI and NdeI restriction sites on the 5’- and 3’- ends 
respectively. The Smad4 3’UTR was then cloned into the three different pMA-Tag 
vectors as an MfeI-NdeI fragment. Finally, a BstBI-PacI fragment containing the 3’ 
part of Smad4 coding sequence, the epitope tag and the 3’UTR was released from 
the three pMA-Tag vectors and transferred into the pDREV-0 targeting vector 
(Osterwalder et al., 2010a). These pDREV-Smad43xTag vectors were the ones used 
for dRMCE (Fig.33). 
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Figure 33. Generation of the pDREV-Smad43xTag targeting vectors for dRMCE and pCDNA3-
Smad43xTag expression vectors  
(A) The Smad4 coding sequence was amplified by PCR and (B) inserted in the pBSK vector 
containing either a 3xFLAG or 3xHA epitope tag. (C) The expression vectors were generated by 
subcloning Smad4 CS3xTag into pCDNA3. (D) A synthetic fragment containing the 3’ end of Smad4 CS 
and a 3xV5 epitope tag was assembled by GeneArt in the pMA vector. (E) The fragments containing 
the 3xFLAG or 3xHA epitope tags were released from pBSK Smad4 CS3xTag and exchanged with the 
equivalent 3xV5 fragment in the pMA vector. (F) The Smad4 CS3xV5 expression vector was generated 
by exchanging the 3xFLAG fragment with the 3xV5 fragment in the pCDNA3 vector. (G) The Smad4 
3’UTR was amplified by PCR and (H) inserted in the three different types of pMA-Tag templates. (I) 
The fragment containing the 3’ end of Smad4 CS, the epitope tag and the 3’UTR was recovered from 
the three versions of pMA-Tag templates and introduced into the pDREV-0 targeting vector by 
replacing the H2B-T2A Venus cassette. See main text for details. 
 
12.2.3. Transfection of HEK-293T cells  
Human Embryonic Kidney 293T cells (HEK-293T) were cultured in DMEM containing 
4.5g/l Glucose, 10% FCS, 100U-0.1mg/ml Pen Strep, 2mM L-Glutamine, 1x Non-
essential Amino Acids, 1mM Sodium Pyruvate at 37°C with 5% CO2. The pCDNA3-
Smad43xTag expression vectors were transfected into 60-80% confluent HEK-293T 
cells grown in 6-well plates using the FuGENE®6 Transfection Reagent (Promega). 
The pEGFP vector was co-transfected to assess the transfection efficiency, and the 
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empty pCDNA3 vector was transfected as negative control. HEK-293T cells were 
collected for protein extraction 24hrs after transfection.  
 
12.2.4. dRMCE: ES cells electroporation, selection and screening  
Two clones of the JM8.F6 ES cells carrying the Smad4 knockout first allele 
tm1a(EUCOMM)Wtsi (EUCOMM project ID 29509, called hereafter Smad4 
EUCOMM Conditional (S4EC)) were targeted in parallel with the three versions of the 
pDREV-Smad43xTag vector. ES cells were cultured and expanded for electroporation 
as described in the chapter 9.2.3 (see also ((Osterwalder et al., 2010b)). Briefly, 
S4EC/+ cells were co-electroporated with both a pDREV-Smad43xTag vector and the 
pDIRE vector, which encodes the iCre and Flpo recombinases for dRMCE 
(Osterwalder et al., 2010a). ES cells were selected for 9-11 days in 0.5µg/ml of 
Puromycin (Sigma P9620). After picking ES cell clones and expanding them in 48 
well plates, a part of the ES cells were collected to isolate DNA while the remainder 
was further expanded. The ES cell clones were screened by PCR and negative or 
mixed clones were eliminated. Positive clones were expanded into 10cm dishes and 
frozen in aliquots. 
The PCR screening strategy was designed to discriminate between the endogenous 
Smad4 wild-type allele (S4wt, primers F1/R5), the Smad4 EUCOMM conditional allele 
(S4EC, primers βgal/neo), the deleted EUCOMM allele (S4∆E, primers F1/R5) and 
positively targeted Smad43xTag-dRMCE allele both on both sides of the cassette 
exchange (primers PGK/R5 and F2/Rb). Correct targeting of the Smad4 locus was 
confirmed by Southern Blot analysis using both 5’ and 3’ probes and the Puromycin 
selection cassette. See Fig.30A for the location of the screening primers and 
Southern Blot probes; and chapter 12.2.6 for their sequences. 
 
12.2.5. Differentiation of ES cells to embryoid bodies 
Smad43xFLAG-dRMCE/+ ES cells into embryo bodies were differentiated using the 
protocol developed by (Kurosawa et al., 2003). 2x104 ES cells were resuspended in 
ES cell medium containing no LIF in order to induce differentiation and incubated at 
37°C in low-adherence conical 1.5ml screw cap micro tube (Starstedt) for 5 days. 
The embryoid bodies were transferred to µ-Slide 8 well (Ibidi) and cultured for up to 
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two weeks. The medium was changed every second day, and differentiated embryoid 
bodies were fixed for immunocytochemical analysis. 
 
12.2.6. dRMCE primers table 	
  
Smad4 dRMCE targeting - cloning primers 
Target Primer Used for 
S4_CS_Asp718 5’-ATAGGTACCGCCGCCACCATGGACAATATGTCTATAAC-3’ Forward for S4 CS with 5' Asp718, Kozak, ATG 
S4_CS_NarI 5'-TATGGCGCCGTCTAAAGGCTGTGGGTCC-3' Reverse for S4 CS with 3' NarI 
S4_3UTR_MfeI 5'-TATCAATTGGATCTCACACCACGGA-3' Forward for S4 3'UTR with 5' MfeI 
S4_3UTR_NdeI 5'-TCGCATATGTTCGTATAGTGACTCAG -3' Reverse for S4 3'UTR with 3' NdeI 
Smad4 dRMCE targeting - screening primers  
Locus Forward primer Reverse primer Size Allele  
Smad4  
F1-R5 5’-ACTAACTCTGTGTTCAGAGCCCCG-3' 5’-GCTGCCCAAATCAATAGCCA-3' 1265bp Smad4 Wt 
Smad4  
F1-R5 5’-ACTAACTCTGTGTTCAGAGCCCCG-3' 5’-GCTGCCCAAATCAATAGCCA-3' 559bp 
Smad4 ∆ 
EUCOMM 
Smad4 
PGK-R5 5’-GCAAAACCAAATTAAGGGCCA-3' 5’-GCTGCCCAAATCAATAGCCA-3' 456bp 
S4-3xTag 
3' rec 
Smad4  
F2-Rb 5’-GCAATCCAAACCAAGCATTGTC-3' 5’-CAGACAGACTGATGGCTGGA-3' 1395bp 
S4 -3xTag 
5' rec 
bgal-neo 5’-AGCAGAGCGGGTAAACTGGC-3' 5’–GCATCAGAGCAGCCGATTGTC-3' 557bp 
S4 
EUCOMM 
conditional 
Smad4 dRMCE targeting - Southern Blot probes primers 
Probe Forward primer Reverse primer Size 
5' probe 5’-ATGCAAAAAAAAGCTTAAGGGG-3' 5’-TTATAGGCAAGAGTCAACTCAAAGA-3' 475bp 
3' probe 5’-GAGCACCACCACGGCAAAGT-3' 5’-TGTTGCCTGCTGGTAAGGAA-3' 487bp 
Puro probe 5'-GCAAAACCAAATTAAGGGCCA-3' 5'-GGCCTTCCATCTGTTGCTGC-3' 334bp 
Smad4 dRMCE - mice genotyping primers 
Locus Forward primer Reverse primer Size Allele  
Smad4 5'-AACTAACTCTGTGTTCAGAGCCCCG-3' 5'-CAGGTGGATTTCAATGAGATAGGC-3' 429bp + 536bp 
Wt + 
3xFlag 
Dre 5’-TGCTGTTCCCTCCTATCCAC-3’ 5’-CGGAGTCCATCAGCCTAGAG-3’ 300bp Tg 
Puromycin 5’-GCAAAACCAAATTAAGGGCCA-3' 5’-GCTGCCCAAATCAATAGCCA-3' 456bp Puror 
S4-∆Puro 5´GGTTTGTCCAAACTCATCAATG-3' 5´GCTAAAACACAGCCTTGTTAAC-3' 498bp ∆Puro 	
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12.3. Manuscripts in preparation 
 “Mammalian NDR kinases are essential for cardiac development and impact 
on the Notch pathway” 
 
Debora Schmitz-Rohmer1, Simone Probst2, Alexander Hergovich1,4, Zhong-Zhou 
Yang3, Frédéric Laurent2, Rolf Zeller2 and Brian A. Hemmings1 
 
1 Friedrich Miescher Institut for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, 
Switzerland 
2 Department Biomedizin, Mattenstrasse 28, CH-4058 Basel, Switzerland 
3 Model Animal Research Center of NanJing University, 12 Xue-Fu Road, Pukou District, 
NanJing, P.R. China 210061 
4 current address: UCL Cancer Institut, University College London, London WC1E 6BT, 
United Kingdom 
 
The aim of this project is to understand the roles of NDR1 and NDR2 kinases during 
mouse embryonic development by generating double knockout animals. Among other 
phenotypes, the heart tube of Ndr-deficient embryos does not loop and is filled with 
cells that obstruct the cardiac lumen and prevent blood flow. Ndr-deficient embryos 
die by E10.0 from cardiac insufficiency. I contributed to thy project by performing 
Optical Projection Tomography (OPT) analysis of wild-type and Ndr-deficient 
embryos at E7.75-E8.0. Analysis of virtual sections from 3D reconstructed embryos 
allowed better visualization of the cardiac obstruction phenotype observed in Ndr-
deficient embryos. 
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“Generation of a bone organ in vivo through endochondral ossification by 
adipose-derived stromal cells” 
 
Rik Osinga1,2, Nunzia di Maggio2, Nima Allafi1, Andrea Barbero2, Frédéric Laurent3, 
Dirk J. Schaefer1, Ivan Martin2, Arnaud Scherberich2 
 
1 Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of 
Basel 
2 Laboratory of Tissue Engineering, Department of Surgery, University Hospital of Basel and 
Department of Biomedicine, University of Basel, Basel, Switzerland 
3 Department of Biomedizin, Mattenstrasse 28, CH-4058 Basel, Switzerland 
 
In this project, adipose-derived stromal cells (ASC) from human tissues were cultured 
in micromasses or on collagen scaffolds and implanted subcutaneously in nude mice 
to investigate their potential to form bone tissues by endochondral ossification. These 
pellets and scaffolds were harvested after a few weeks and sectioned for histological 
analysis. I performed in situ hybridization on some of these sections for the 
chondrocyte differentiation marker Indian Hedgehog. 
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2007 – 2009 University of Lausanne, Faculty of Biology and Medicine, School of Biology  
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2004 – 2007 University of Lausanne, Faculty of Biology and Medicine, School of Biology 
Bachelor of Science in Biology 
 
2000 – 2003 High school of Nyon – Matura School in Biology and Chemistry 
Matura work: “Can we learn by role playing games?” – Grade excellent 
Bachelor and Matura Certificate  
 
 
RESEARCH EXPERIENCE 
 
06/2010 – 09/2014 PhD in Genetics 
Supervisor:  Prof. Dr Rolf Zeller 
Department of Biomedicine, University of Basel  
“Identification of cis-regulatory modules in mouse embryonic limb buds and heart 
using endogenous epitope-tagged transcription factors” 
 
02/2008 – 01/2009 Master Thesis  
Supervisor: Dr Elena Buetti 
Institute of Microbiology, University Hospital of the canton of Vaud (CHUV) 
“Analysis of signaling pathways involved in the transcription of the Mouse 
Mammary Tumor Virus using mutant PKCδ and Src kinases” 
 
02/2008 – 05/2008 Assistant-student for a scientific forest inventory (“Bois de Chênes” reserve) 
Institute of Terrestrial Ecosystems of Swiss Federal Institute of Technology, 
Zürich (ETH) 
 
09/2007 – 12/2007 Research introduction internship 
Supervisor: Dr Liliane Michalik 
Center for Integrative Genomics, University of Lausanne  
“Cell protection during skin repair: do Nrf2 and PPARβ combine their efforts?” 
 
07/2007 – 09/2007  Summer Research Program in Life Sciences of the Swiss Federal Institute of 
Technology, Lausanne (EPFL) 
Supervisor: Prof. Winship Herr 
Center for Integrative Genomics, University of Lausanne 
“Characterization of CeHCF-1 in RNAi in Caenorhabditis elegans” 
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PUBLICATIONS 
A Zuniga, F Laurent, J Lopez-Rios, C Klasen, N Matt, R Zeller. Conserved cis-regulatory regions in a 
large genomic landscape control SHH and BMP-regulated Gremlin1 expression in mouse limb buds. 
BMC Developmental Biology, 2012,12:23. 
 
 
JD Benazet, E Pignatti, A Nugent, E Unal, F Laurent, R Zeller. Smad4 is required to induce digit ray  
primordia and to initiate the aggregation and differentiation of chondrogenic progenitors in mouse limb 
buds. Development 139, 4250-4260 (2012) 
 
CONFERENCES PARTICIPATION 
 
2014 Weinstein Cardiovascular Development Conference, Madrid, Spain – Poster  
 
2013 26th Mouse Molecular Genetics Meeting, Hinxton, UK – Selected speaker 
 
2011 9th [BC]2 Basel Computational Biology Conference, Basel, Switzerland – Poster  
 
2007 Life Science Summer Research Program, EPFL, Lausanne, Switzerland – Poster  
 
 
TECHNICAL SKILLS 
 
Animal handling Mouse care, husbandry and colony management. Embryo collection, in vivo 
wound healing experiments 
 
Molecular biology DNA and RNA extraction, PCR, RT-qPCR, molecular cloning with plasmids and 
BACs, chromatin immunoprecipitation, whole-mount in situ hybridization, 
Southern Blot, Western Blot 
 
Cell culture  HEK293, mouse embryonic stem cells. Gene targeting by cassette exchange 
and homologous recombination, immunocytochemistry, karyotyping, transfection, 
viral transduction, luciferase reporter assays 
 
Histology  Tissue preparation and sectioning with microtome and cryostat, 
immunohistochemistry, section in situ hybridization, TUNEL assay, 
hematoxylin/eosin and alcian blue stainings 
 
Microscopy  Light, fluorescent and confocal microscopy, optical projection tomography 
 
 
PROFESSIONALS AND SOFT SKILLS 
 
• Creativity 
• Initiative 
• Flexibility/adaptability 
• Highly organized  
• Work well under pressure 
• Problems solving skills 
• Team building and leadership 
• Project management  
• Event planning 
 
 
ASSOCIATIONS MEMBERSHIP 
 
Department of Biomedicine PhD Club, Basel 
2011 – 2014 Co-founder. Organization of scientific retreats, career days and social events for the 
PhD, MD-PhD and Master students of the Department 
 
Association of Biology students, University of Lausanne 
2006 – 2008 Responsible for events and animation for Bachelor and Master students 
 
Scout group « Groupe de la Harpe », Rolle-Aubonne (VD) 
1994 – 2008 Organization of weekly outdoors activities, weekends and summer camps for 7-11 kids 
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TEACHING EXPERIENCE 
 
2011-2013  Assistant in Developmental Biology practical for medicine students, University of Basel  
 
2014 Supervision of a 1st year PhD student regarding mouse colony management and 
molecular biology 
 
SWISS MILITARY SERVICE 
 
Rank  First Lieutenant 
Function Platoon leader in Medical Logistics 
Corps  Cp EM hôp 2 
 
2009   School of Logistics Officers 1/10 (Bern) 
Developing personal skills in management and leadership. Learning military techniques 
and tactics specifically applied to the army medical and logistics  corps 
 
2009 – 2010 Practical job as platoon leader, School of Hospital Recruits 41/3 (Moudon, VD) 
Organizing and teaching basic military training for a platoon of medical soldiers 
 
2004  School of Hospital Recruits 41/1 (Moudon, VD) 
Basic military training as a medical soldier with specialization in emergency room 
 
ADDITIONAL TRAININGS AND DIPLOMAS 
 
2013 Leadership Level 1 Diploma – Swiss Managers Organization  
Group animation and dynamics, adult pedagogy, giving feedback, stress management, oral 
communication techniques, work techniques, ethics, co-workers motivation 
 
2011 Optical Projection Tomography training in MRC Technology, Edinburgh, Scotland 
 
2010 Certificate “Managing my time at the group/team level” – Swiss association for the Training of 
Executives (SVF-ASFC) 
 
2009 Military sport instructor certificate 
 
2007 Laboratory animal science course – Swiss Veterinary Office of canton of Vaud 
Legislation, ethical principles, biology and handling of laboratory animals, anesthesia, blood 
sampling and microsurgery  
 
2004 Diploma of Health Care Assistant – Swiss Red Cross 
 
2003 JV base training 
Health promotion and addictions prevention in youth associations of canton of Vaud 
 
2002 Instructor license in trekking and sports camps – Youth + Sports (J+S), Swiss Federal Office of 
Sports 
 
2002 Rescuer Certificate  
 
AWARDS AND FELLOWSHIPS 
 
2009 Honorary Certificate – Prof. Nicole Galland, School of Biology Director, University of Lausanne 
 For active involvement as member of the committee of the association of students 
 
2007 Summer Research Fellowship – School of Life Sciences, EPFL 
 For the participation to the Summer Research Program in Life Sciences 
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